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CHAPTER 1 
General Introduction 
1.1. Dissertation Organization 
  The six chapters of this dissertation exemplify the application of aryne chemistry in 
medicinally-relevant, nitrogen-containing heterocycle synthesis.  The arynes discussed in this 
dissertation are generated from Kobayashi’s aryne precursors1 that leads to novel synthetic 
methodology.  Chapter 1 begins by detailing the overall organization of this dissertation and 
follows with a brief review of arynes, which provides the reader with a general understanding of 
this highly reactive intermediate and its application in various organic transformations. 
  Chapter 2 is an article published in Tetrahedron in 2012 (Scheme 1).2  This chapter describes 
the chemical reactivity of 2,3-pyridyne in the presence of amines.  We have found that amines 
attack the 2-position of 2,3-pyridyne exclusively to afford the corresponding 2-aminopyridines.  
In addition, a series of benzonaphthyridinones have been synthesized by reacting 2,3-pyridyne 
with o-aminobenzoates. 
Scheme 1. The pyridyne project. 
R1R2NH
N N
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R2
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MeCN, rt
slow addition
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N N
R5
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yields: 36% - 65% yields: 32% - 72%
 
  Chapter 3 describes a project involving the reaction of β-lactams and arynes, which has been 
submitted to The Journal of Organic Chemistry (Scheme 2).  In this process, the aryne inserts 
into carbon-nitrogen bond of the β-lactam to form a 2,3-dihydroquinolin-4-one, which 
2 
subsequently reacts with another molecule of aryne to form an acridone by extrusion of a molecule 
of ethylene.  2,3-Dihydroquinolin-4-ones react under the same reaction conditions to afford 
acridones.  This is the first example of ethylene extrusion in aryne chemistry. 
Scheme 2. The reaction of β-lactam and aryne. 
 
  Chapter 4 describes a project, which was published in Organic Letters in 20103 and in The 
Journal of Organic Chemistry in 2011 (Scheme 3).4  This project involves a rapid and efficient 
synthesis of 2H-indazoles using a [3 + 2] dipolar cycloaddition of sydnones and arynes.  A series 
of 2H-indazoles have been prepared in good to excellent yields using this protocol, and subsequent 
Pd-catalyzed coupling reactions can be applied to the halogenated products to generate a 
structurally diverse library of indazoles.  This methodology has been highlighted in Synfacts.5 
Scheme 3. The sydnone project. 
 
  Chapter 5 describes a project soon to be submitted for publication that details a methodology for 
synthesizing 2H-isoindoles and 9,10-dihydro-9,10-epiminoanthracenes from arynes and 
münchnones (Scheme 4).  2H-Isoindoles have been generated from arynes and münchnones by a 
[3 + 2] dipolar cycloaddition process under very mild reaction conditions.  Due to the high 
reactivity of 2H-isoindoles with arynes, 9,10-dihydro-9,10-epiminoanthracenes are ultimately 
formed in the presence of arynes in good to excellent yields. 
Scheme 4. The münchnone project. 
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Lastly, Chapter 6 makes some general conclusions about the previous chapters. 
1.2. The Nature of Benzyne 
  Benzyne or 1,2-dehydrobenzene is an extremely reactive species due to the nature of its strained 
triple bond (see Figure 1).  This intermediate cannot be isolated under most reaction conditions; 
thus, it must be trapped in situ.  The pair of p orbitals that make up the benzyne triple bond are 
unlike typical alkyne p orbitals, which are parallel to each other.  Instead, one pair of benzyne p 
orbitals is parallel to each other (and part of the pi system), whereas the other pair of p orbitals is 
strained in order to accommodate the triple bond within the ring system. 
Figure 1. Two pairs of benzyne triple bond p orbitals. 
 
  Generally speaking, arynes are thought to be quite electrophilic.  Thus, a broad range of 
nucleophiles are capable of reacting with an aryne, and this reactivity has been exploited to a great 
extent in organic synthesis.  Thus, the major types of reactions, which involve arynes, are briefly 
reviewed in section 1.4.  Additionally, there are several excellent reviews that cover various 
aspects of aryne chemistry.6 
1.3. A Brief Review of Aryne Generation 
  Benzyne was first proposed by Wittig in 19427 and confirmed by Roberts in 1956.8  A numbers 
of methods have been developed to generate arynes since then.  A major method of generating 
4 
arynes involves 1,2-elimination as shown in equations 1,9 2,10 and 311.  Another strategy that has 
been employed for the generation of arynes involves the retro-cycloaddition of 
1-aminobenzotriazoles (eq. 4).12 
 
X
Y
M
Y
-MY
(2)
M = Metal: Li, Mg, Zn, Pd, La
X = Cl, Br, I
Y = F, Cl, OTf, OTs
 
 
 
  In 1983, Kobayashi first introduced a new mild method for generating benzyne by the 
fluoride-induced 1,2-elimination of o-(trimethylsilyl)aryl triflates (eq 5).1  Synthetic chemists 
have been attracted to Kobayashi’s method for its convenience, efficiency, tolerance of 
functional groups, and mild reaction conditions.  Thus, aryne chemistry has quickly developed 
into a hot field. 
 
1.4. A Brief Introduction to Aryne Reactions 
  The synthetic applications of arynes are remarkably diverse, and a large number of aryne 
reactions found in the literature can be classified into several main categories: arylations, 
insertions, annulations, and transition metal-catalyzed reactions.   
1.4.1. Arylation Reactions 
5 
  Due to the electrophilicity of the aryne triple bond, a number of nucleophiles can react with 
arynes leading to arylated products.  Kobayashi’s method for aryne formation lends itself 
particularly well to arylation reactions, and our group has reported a mild and efficient method to 
achieve this (eq. 6).13 
 
1.4.2. Insertion Reactions 
  When the nucleophile is tethered to an electrophile, the nucleophilic addition can trigger 
subsequent electrophilic trapping of the aryl anion, leading to a formal σ-bond cleavage.  Amide 
functionality is one such tethered nucleophile-electrophile pair, where the nitrogen and the 
carbonyl group serve as the nucleophile and the electrophile, respectively.14  One typical example 
reported by Greaney is shown in equation 7.14f 
 
A C-H unit can act as a nucleophile when it’s adjacent to one or two strong 
electron-withdrawing groups.  Thus, C-C insertion is also possible.9e,9f,15  The insertion of arynes 
into Te-Te,16 S-S,17 Si-Si,18 N-Si,19 C-Si,20 C-Sn,21 Sn-S,22 Se-Se,23 I-I,24 C-S,25 C-Cl,26 and C-O27 
bonds have also been reported. 
1.4.3. Annulation Reactions 
  Aryne annulation reactions involve several different reaction types.  One typical reaction 
arises when the aryl anion generated by nucleophilic attack on an aryne is trapped by an 
intramolecular electrophile to form a ring structure.  This type of aryne reaction can rapidly 
produce various heterocycles under mild reaction conditions.  For example, the synthesis of 
6 
xanthones, thioxanthones, and acridones by this method has been reported by our group (eq. 8).28  
Five-membered ring heterocycles can also be achieved through a similar mechanism as shown in 
equation 9.29 
 
 
  Another type of annulation, which involves 1,3-dipoles, follows a [3 + 2] cycloaddition 
mechanism.  Many examples with 1,3-dipoles exemplify the utility and generality of arynes in 
cycloaddition reactions.  It is common that 1,3-dipoles contain heteroatoms.  Thus, this 
methodology appears to be a useful way to prepare various heterocycles.  For example, 
substituted benzotriazoles have been prepared by the [3 + 2] cycloaddition of azides and arynes 
as shown in equation 10.30  Our group has developed a methodology for the synthesis of 
benzisoxazoles using nitrile oxides (generated in situ from a chloroxime, eq. 11).31 
 
 
  Arynes, due to their triple bonds, can also act as a dienophile in Diels-Alder reactions.  This 
method has proven valuable in the construction of numerous polycyclic systems.  When 
Kobayashi first introduced his benzyne precursor, furan was used as the reacting partner to trap 
the benzyne generated in situ (eq. 12).1  An example of an intramolecular Diels-Alder reaction 
can be seen in Danheiser’s work in which a highly condensed polycyclic structure is formed (eq. 
7 
13).32 
OTf
TMS
+ (12)O
F-
O
 
 
1.4.4. Transition Metal-Catalyzed Aryne Reactions 
  The triple bond of an aryne should be able to coordinate with a transition metal catalyst. 
Kobayashi’s fluoride-induced aryne generation has allowed for the development of many useful 
transition metal-catalyzed aryne reactions, because of its mild reaction conditions.  Palladium 
is one of the most widely used metals for catalyzing reactions involving arynes.  As an early 
example reported by Peña, the use of catalytic amounts of Pd(PPh3)4 enabled the process of 
aryne cyclotrimerization (eq. 14).33  Many examples of transition metal-catalyzed processes 
using aryl halides and catalytic palladium have been reported.34  One example involves the 
three-component coupling of arynes, an alkyne, and aryl halides to afford a variety of 
functionally diverse phenanthrenes in good yields (eq. 15).34e  A useful annulation for the 
synthesis of fluorenones is also made possible by employing catalytic amounts of palladium (eq. 
16).35 
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1.5. Conclusions 
  Arynes have proven very useful intermediates in a number of important organic 
transformations.  The chemistry community has witnessed tremendous growth in the field of 
aryne chemistry since the discovery and utilization of Kobayashi’s method for aryne generation.  
The potential application of arynes in organic synthesis is sure to be a very active area of 
research for the foreseeable future. 
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CHAPTER 2 
Nucleophilic Addition to 2,3-Pyridyne and Synthesis of Benzonaphthyridinones 
Reprinted from Tetrahedron 2012, 68, 2819, Copyright (2012), with permission from Elsevier. 
Yuesi Fang and Richard C. Larock* 
Department of Chemistry, Iowa State University, Ames, IA 50011, U.S.A. 
 
2.1. Abstract 
R1R2NH
N N
R1
R2
2 CsF
MeCN, rt
slow addition
N
TMS
OTf
R3R4N
MeO2C
2 CsF
MeCN, rt
slow addition
N N
R5
R3
O
R5
yields: 36% - 65% yields: 32% - 72%
 
A study of the nucleophilic addition of amines to 2,3-pyridyne has been carried out. 2-
-Aminopyridines have been generated exclusively. A series of benzonaphthyridinones have been 
synthesized by reacting 2,3-pyridyne and o-aminobenzoates. 
2.2. Introduction 
  Heterocyclic compounds have attracted significant attention for decades, because of their 
considerable biological activity and potential medicinal applications. Among the various 
heterocycles, benzonaphthyridinones and dibenzonaphthyridinones (Figure 1) are known as 
antimicrobial alkaloids,1 anticancer agents,2 and compounds that can reverse multidrug 
resistance.3  
Figure 1. A Representative Benzonaphthyridinone and a Dibenzonaphthyridinone. 
14 
 
  However, synthetic approaches to these heterocycles remain limited. Quéguiner reported a 
process involving nucleophilic aromatic substitution to afford the benzonaphthyridinone core 
(Scheme 1).4 This ring system can also be prepared from 2-(phenylamino)nicotinic acid using 
either the strong acid PPA5 or microwave irradiation6 (Scheme 2). Dibenzonaphthyridinones 
have also been synthesized using PPA and a high temperature.7  
Scheme 1. Synthesis of Benzonaphthyridinone Involving Nucleophilic Aromatic Substitution. 
 
Scheme 2. Synthesis of Benzonaphthyridinone under Harsh Conditions. 
 
  Benzyne, a highly reactive intermediate, was first proposed by Wittig8 in 1942 and confirmed 
by Roberts9 in 1956. Kobayashi in 1983 reported a novel way to generate arynes from silylaryl 
triflates in the presence of fluoride.10 The Larock group has had an extensive ongoing research 
program in aryne chemistry in recent years.11 We have reported nucleophilic addition reactions of 
arynes,12 and later, a synthesis of xanthones, thioxanthones, and acridones from substituted 
benzoates involving nucleophilic attack on arynes, followed by ring closure.13 The exciting 
possibility of extending this methodology to hetarynes14 to generate polyheterocycles has now 
been examined. 
2,3-Pyridyne has been the target of considerable research for decades.15 Classic approaches to 
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this interesting intermediate include oxidation of an aminotriazolopyridine16 and a halogen-metal 
exchange-elimination sequence starting from 3-bromo-2-chloropyridine and employing a lithium 
reagent.17 3-(Trimethylsilyl)pyridin-2-yl triflate (1a) has been prepared by Effenberger and its 
fluoride-induced desilylation-elimination process generating 2,3-pyridyne has been reported.18 In 
a classic elimination-addition reaction of 3-halopyridine using KNH2/NH3,15a both 2- and 
3-adducts have been reported with the former predominating. Fleming reported one example of 
the addition of acetic acid to 2,3-pyridyne to form the 2-substituted product.19 One example of 
the amination of 2,3-pyridyne has been reported in 2009, but not fully investigated.20 Herein, we 
report a study of the nucleophilic addition reactions of 2,3-pyridyne and amines, and a synthesis 
of benzonaphthyridinones from 2,3-pyridyne and o-aminobenzoates. 
2.3. Results and discussion 
Our initial work began with a study of the nucleophilic addition of N-methylaniline to 
2,3-pyridyne. The 2,3-pyridyne precursor, 3-(trimethylsilyl)pyridin-2-yl triflate, was prepared 
using a literature procedure18 and the method was extended to the preparation of the 
2,3-quinolyne precursor 3-(trimethylsilyl)quinolin-2-yl triflate (Scheme 3). We first allowed 
3-(trimethylsilyl)pyridin-2-yl triflate to react with 2.0 equiv of CsF and 1.0 equiv of 
N-methylaniline in acetonitrile (MeCN) at room temperature for 24 h (eq 1). The tertiary amine 
N-methyl-N-phenylpyridin-2-amine was obtained in a 33% yield. Although two possible 
regioisomers could be formed in this reaction, we found that nucleophilic attack occurs 
exclusively at the 2-position of the 2,3-pyridyne, and the 2-pyridinylamine was the only 
observed product, albeit in only a relatively low yield. 
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Scheme 3. Preparation of the 2,3-Pyridyne and 2,3-Quinolyne Precursors. 
 
 
N
TMS
OTf
+ PhNHCH3 N N
Ph
Me
2 CsF
MeCN
33%
(1)
 
Computational chemists have reported years ago that the cumulenic structure (structure B, 
Figure 2) is favored for 2,3-pyridyne,21 which makes the 2-position more susceptible to be 
attacked by nucleophiles. This cumulenic structure also makes pyridyne extraordinarily reactive, 
which apparently results in unexpected side reactions leading to a low yield. We have actually 
stirred the pyridyne precursor with the fluoride source in the absence of any other reagents to 
check the reactivity and relative stability of pyridyne. It appears that the precursor disappears 
within an hour, and the pyridyne generated immediately turns into intractable tars, which we 
believe are the major by-products of the pyridyne chemistry. 
Figure 2. The Cumulenic Structure of 2,3-Pyridyne. 
 
We have examined a number of different reaction conditions in an attempt to eliminate any 
undesired side reactions and improve the yield of the aminopyridine (Table 1). The yield was not 
improved when we changed the solvent (entries 2-6). The product was, in fact, totally different 
when we used tetrahydrofuran (THF) as the solvent. In THF, the THF acted as the nucleophile 
apparently attacking the pyridyne first to afford the final ring-opened, amine-containing product 
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3aa’ in up to a 58% yield (entries 7-9, Scheme 4). The yield was also not improved when we 
tried a different fluoride/base system (entry 10) or reaction temperature (entry 11). We did find 
that higher yields can be achieved when we changed the stoichiometry of the reactants 1a and 2a. 
A yield of 50% has been achieved when employing twice as much of the pyridyne precursor 1a 
(entry 12). The yield also improved when we reversed the ratio of 1a and 2a (entry 13), although 
the improvement was not as large as in the previous case (44% vs 50% in entry 12). Since the 
pyridyne precursor is less readily available than the amine, we decided to employ an excess of 
the amine in all further studies. However, the yield did not increase further when we used 3 equiv 
and 4 equiv of 2a (entries 14 and 15). The yield did, however, reach 49% when we diluted the 
reaction solution (entries 16 and 17). It appears that the pyridyne itself is so reactive that it 
causes side reactions. Thus, a lower concentration of pyridyne appears to reduce unwanted side 
reactions. 
Table 1. Optimization of the Nucleophilic Amination of 2,3-Pyridyne.a 
 
entry 
1a 
(equiv) 
2a 
(equiv) 
fluoride 
source (equiv) 
solvent (mL) 
T (ºC)/time 
(h) 
yieldb 
(%) 
1 1 1 CsF (2) MeCN (4) rt, 24 33 
2 1 1 CsF (2) DME (4) rt, 24 18 
3 1 1 CsF (2) DMF (4) rt, 24 trace 
4 1 1 CsF (2) MeCN (3)/Tol (1) rt, 24 32 
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Table 1 continued 
5 1 1 CsF (2) MeCN (2)/Tol (2) rt, 24 30 
6 1 1 CsF (2) MeCN (1)/Tol (3) rt, 24 29 
7 1 1 CsF (2) THF (4) rt, 48c 36d 
8 1 1 CsF (2) THF (4) 50, 24 58d 
9 1 1 TBAF (2) THF (4) rt, 24 trace 
10 1 1 
CsF 
(2)/Cs2CO3 (2) 
MeCN (4) rt, 24 35 
11 1 1 CsF (2) MeCN (4) 0→rt, 24 31 
12 2 1 CsF (4) MeCN (4) rt, 24 50 
13 1 2 CsF (2) MeCN (4) rt, 24 44 
14 1 3 CsF (2) MeCN (4) rt, 24 43 
15 1 4 CsF (2) MeCN (4) rt, 24 43 
16 1 2 CsF (2) MeCN (8) rt, 24 49 
17 1 4 CsF (2) MeCN (8) rt, 24 49 
a
 All reactions were carried out on a 0.25 mmol scale. b Isolated yield. c The pyridyne precursor 
remained unreacted. d Product 3aa’. 
Scheme 4. Nucleophilic Attack of THF and the Formation of Compound 3aa’. 
N
O
N O
N O
NPhMe
3aa'
PhNHCH3
N O
PhNCH3
 
A second round of optimization has been carried out based on the idea that a lower 
concentration of pyridyne reduces side reactions (Table 2). We prepared a solution of 1a in 4 mL 
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of MeCN (solution A) and a solution of 2a and CsF in 4 mL of MeCN (solution B). Solution A 
was slowly added to solution B by using a syringe pump over a long period of time. We found 
that the yield improved significantly (compare entry 1 and entry 2), because of the slow addition. 
The loading of 2a was subsequently reduced to 1 equiv, which did not affect the yield very much 
(entry 3). A longer addition time also did not improve the yield (entry 4). Therefore, we decided 
to use this optimized slow addition approach (entry 3) in all further investigations of this process. 
Table 2. Further Optimization of the Nucleophilic Amination of 2,3-Pyridyne.a 
 
entry 1a (equiv) 2a (equiv) solvent (mL) time (h) yieldb (%) 
1 1 2 MeCN (8) 24 49 
2 1 2 MeCN (4+4)c 8+16d 66 
3 1 1 MeCN (4+4)c 8+16d 65 
4 1 1 MeCN (4+4)c 12+12d 65 
a
 All reactions were carried out on a 0.25 mmol scale with 2 equiv of CsF at room temperature. b 
Isolated yield. c A solution of 1a in 4 mL of MeCN (solution A) and a solution of 2a and CsF in 4 
mL of MeCN (solution B) were prepared separately. d Solution A was slowly added to solution B 
with a syringe pump over a period of time; the resulting solution was stirred for an additional 
period of time. 
A number of 2-pyridinylamines have been synthesized by reacting 2,3-pyridyne with a number 
of simple amines (Table 3). As can be seen, both secondary and tertiary amines have been 
obtained. However, tertiary amine products have not been observed in the reaction of 
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2,3-pyridyne and primary amines (entries 2-8). Halogens, such as iodine, can be tolerated under 
our reaction conditions to afford the corresponding halogenated products (entries 3 and 4). Both 
an electron-rich (entry 5) and an electron-deficient aniline (entry 6) have reacted well with 
pyridyne, although the electron-deficient aniline led to a lower yield. The yield was somewhat 
lower when the amine bears a sterically bulky group next to the amino group (entry 7). Aliphatic 
amines react as well under our reaction conditions to afford the corresponding products (entries 8 
and 9). The quinolyne precursor 1b reacted in the same fashion, again tolerating a halogen (entry 
10). Unfortunately, we failed to achieve ethers in a satisfactory yield by reacting 2,3-pyridyne 
and phenols due to the lower nucleophilicity of oxygen than nitrogen. 
Table 3. Synthesis of 2-Aminopyridines from 2,3-Pyridyne and Various Amines.a 
 
entry 
aryne 
precursor 
amine product 
yieldb 
(%) 
1  
1a 
PhMeNH 
2a 
 
3aa 
65 
2  
PhNH2 
2b 
 
3ab 
58 
3   
2c 
 
3ac 
57 
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Table 3 continued 
4   
2d 
 
3ad 
64 
5   
2e 
 
3ae 
61 
6   
2f 
 
3af 
47 
7   
2g 
 
3ag 
46 
8   
2h 
 
3ah 
60 
9  
Bn2NH 
2i 
 
3ai 
57 
10  
1b 
 
2j 
 
3bj 
36 
a
 All reactions were carried out on a 0.25 mmol scale with 2 equiv of CsF at room temperature. A 
solution of 1 in 4 mL of MeCN (solution A) and a solution of 2 and CsF in 4 mL of MeCN 
(solution B) were prepared separately. Solution A was slowly added to solution B with a syringe 
pump over 8 h, the resulting solution was stirred for an additional 16 h. b Isolated yield. 
Next, a polycyclic system has been achieved by reacting 2,3-pyridyne and o-aminobenzoates. 
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In this process, a plausible mechanism is proposed in Scheme 5. The deprotonated (Scheme 5, 
Route A) or neutral amino group (Scheme 5, Route B) attacks the 2-position of the pyridyne, 
generating a carbanion, which is then trapped intramolecularly by the ester group of the 
o-aminobenzoate to form the benzonaphthyridinone. 
Scheme 5. Proposed Mechanism for the Formation of Benzonaphthyridinone. 
 
Using this basic process, a variety of benzonaphthyridinones and a dibenzonaphthyridinone 
have been synthesized from 2,3-pyridyne and 2,3-quinolyne using our slow addition reaction 
conditions (Table 4). It is worth noting that primary amines led to a complex mixture in this 
chemistry; therefore, only secondary amines have been employed for this synthesis. 
N-Methylbenzonaphthyridinone has been synthesized in a modest 56% yield by reacting 
2,3-pyridyne and methyl 2-(methylamino)benzoate (entry 1). N-Allylbenzonaphthyridinone has 
been generated from the corresponding N-(allylamino)benzoate in a 48% yield (entry 2). Halides 
from chloride to iodide are tolerated under our reaction conditions (entries 2-6). The yields are 
moderate in these cases. It is interesting to compare entries 3-5 and entry 6, where we observe 
that the yield is higher when the halogen atom is para to the ester group of the benzoate. This 
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trend is more obvious in entry 7, where an electron-withdrawing group is present para to the 
ester group, which makes the ester group more electrophilic, leading to a higher yield. A tertiary 
amine (entry 8) reacted as well as the secondary amines, affording the same product 5aa as in 
entry 1. This example shows that the neutral amine itself is nucleophilic enough for this 
transformation to take place (Scheme 6), suggesting that Route B in Scheme 5 is perhaps more 
favorable. 2,3-Quinolyne reacts the same way as 2,3-pyridyne, and the dibenzonaphthyridinone 
5ba has been formed by reacting the quinolyne with 4a (entry 9). 
Table 4. Synthesis of Benzonaphthyridinones and a Dibenzonaphthyridinone.a 
 
entry 
aryne 
precursor 
amine product 
yieldb 
(%) 
1  
1a 
 
4a 
 
5aa 
56 
2  
 
4b 
 
5ab 
48 
3   
4c 
 
5ac 
53 
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Table 4 continued 
4  
MeO2C
MeHN
Br
 
4d 
 
5ad 
52 
5   
4e 
 
5ae 
48 
6   
4f 
 
5af 
66 
7   
4g 
 
5ag 
72 
8   
4h 
 
5aa 
50 
9  
1b 
 
4a 
 
5ba 
32 
a
 All reactions were carried out on a 0.25 mmol scale with 2 equiv of CsF at room temperature. A 
solution of 1 in 4 mL of MeCN (solution A) and a solution of 4 and CsF in 4 mL of MeCN 
(solution B) were prepared separately. Solution A was slowly added to solution B with a syringe 
pump over 8 h, the resulting solution was stirred for an additional 16 h. b Isolated yield. 
Scheme 6. The Reaction of 2,3-Pyridyne and Methyl 2-(Dimethylamino)benzoate. 
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We have also tested a 2-hydroxybenzoate and a 2-mercaptobenzoate in this annulation process 
(Scheme 7). Again, the phenol group did not react well with the pyridyne apparently due to its 
lower nucleophilicity, while the sulfur-containing polyheterocycle 5ai has been formed from the 
2-mercaptobenzoate, but in only a 34% yield. 
Scheme 7. The Reaction of 2,3-Pyridyne and 2-Hydroxy- and 2-Mercaptobenzoate. 
 
2.4. Conclusions 
  Some nucleophilic amination reactions of 2,3-pyridyne and 2,3-quinolyne have been studied. 
We have found that nucleophilic attack of the amine occurs at the 2-position of 
2,3-pyridyne/2,3-quinolyne exclusively, which is consistent with previous computational 
conclusions. 2,3-Pyridyne and 2,3-quinolyne appear to be so reactive that they cause unwanted 
side reactions. A slow addition procedure has thus been employed to reduce the side reactions. A 
variety of 2-pyridinylamines have thus been prepared using primary and secondary amines. 
When secondary and tertiary o-aminobenzoates are employed in this process, 
benzonaphthyridinones can be synthesized in reasonable yields. 
2.5. Experimental section 
General information. All reagents purchased from commercial sources were used as received. 
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The solvent THF was distilled over Na/benzophenone. Anhydrous toluene and MeCN were used 
as received. The aryne precursors were prepared according to a literature procedure.18 Silica gel 
for column chromatography was supplied as 230-400 mesh from commercial source. Powdered 
CsF was used as received and stored in a desiccator. 
All melting points were measured and are uncorrected. The 1H and 13C NMR spectra were 
recorded and are referenced to the residual solvent signals (7.26 ppm for 1H in CDCl3 and 77.2 
ppm for 13C in CDCl3). 
All aryne nucleophilic addition reactions and annulations were carried out in oven-dried 
glassware and were magnetically stirred. A nitrogen atmosphere was not used, except that a 
balloon of nitrogen was attached to the reaction flask to allow for the extra volume of added 
solution. A syringe pump was employed for the slow addition reaction conditions. 
Preparation of pyridyne and quinolyne precursors. These aryne precursors were prepared 
following the literature procedure.18 
3-(Trimethylsilyl)pyridin-2-yl triflate (1a). Colorless oil: 1H NMR (300 MHz, CDCl3) δ 8.33 
(dd, J = 4.8, 2.1 Hz, 1 H), 7.92 (dd, J = 7.2, 2.1 Hz, 1 H), 7.31 (dd, J = 7.2, 5.1 Hz, 1 H), 0.37 (s, 
9 H). 
3-(Trimethylsilyl)quinolin-2-yl triflate (1b). Colorless oil: Rf = 0.33 (20:1 petroleum 
ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.36 (s, 1 H), 7.98 (d, J = 8.4 Hz, 1 H), 7.85 (d, J = 
8.4 Hz, 1 H), 7.76 (td, J = 7.6, 0.8 Hz, 1 H), 7.59 (t, J = 7.2 Hz, 1 H), 0.43 (s, 9 H); 13C NMR 
(100 MHz, CDCl3) δ 158.6, 148.8, 146.3, 131.4, 128.5, 127.7, 127.5, 127.4, 124.4, 118.8 (CF3, 
123.6, 120.4, 117.2, 114.1), -1.2; LRMS (EI) 349 (M); HRMS (EI) calcd for C13H14F3NO3SSi (M) 
349.0416, found 349.0422; IR (KBr, cm-1) 3064 (w), 2959 (m), 2904 (w), 1590 (m). 
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General procedure for the synthesis of 2-pyridinylamines. To an oven-dried 4 dram vial 
equipped with a stir bar were added 0.25 mmol of amine and 76 mg of CsF (0.5 mmol, 2.0 
equiv). MeCN (4 mL) was added and the vial was sealed with a rubber septum equipped with a 
balloon of nitrogen. A solution of 0.25 mmol of aryne precursor in 4 mL of MeCN was prepared 
separately, and was added to the reaction vial slowly by using a syringe pump while stirring. 
After the addition was complete, the reaction mixture was allowed to stir for additional time and 
quenched with water, and extracted with EtOAc three times. The combined organic layers were 
washed with brine, dried over Na2SO4, filtered, and concentrated under vacuum. The residue was 
purified by column chromatography (petroleum ether/EtOAc) to afford the 2-pyridinylamine. 
N-Methyl-N-phenylpyridin-2-amine (3aa). Following the general procedure, this product 
was isolated as a yellow oil: Rf = 0.24 (20:1 petroleum ether/EtOAc); 1H NMR (300 MHz, 
CDCl3) δ 8.23 (dd, J = 4.8, 0.9 Hz, 1 H), 7.40 (m, 2 H), 7.30 (m, 2 H), 7.21 (m, 2 H), 6.60 (td, J 
= 6.0, 0.9 Hz, 1 H), 6.53 (d, J = 8.4 Hz, 1 H), 3.48 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 159.0, 
148.0, 147.0, 136.7, 129.9, 126.5, 125.6, 113.3, 109.4, 38.6; LRMS (EI) 184 (M), 183 (M-H); 
HRMS (EI) calcd for C12H11N2 (M-H) 183.0922, found 183.0928. The structure of this 
compound was assigned based on the 1H NMR coupling pattern and was confirmed by 
comparison with the reported 1H and 13C NMR spectral data.22 
N-Phenylpyridin-2-amine (3ab). Yellow oil: Rf = 0.11 (20:1 petroleum ether/EtOAc); 1H 
NMR (300 MHz, CDCl3) δ 8.21 (dt, J = 5.1, 0.9 Hz, 1 H), 7.49 (td, J = 7.8, 1.2 Hz, 1 H), 7.33 (d, 
J = 4.5 Hz, 4 H), 7.05 (m, 1 H), 6.88 (d, J = 8.4 Hz, 1 H), 6.82 (s, 1 H), 6.73 (td, J = 3.6, 0.9 Hz, 
1 H); 13C NMR (75 MHz, CDCl3) δ 156.2, 148.6, 140.7, 137.9, 129.5, 123.0, 120.5, 115.2, 108.4; 
LRMS (EI) 170 (M), 169 (M-H); HRMS (EI) calcd for C11H10N2 (M) 170.0844, found 170.0847. 
28 
N-(2-Iodophenyl)pyridin-2-amine (3ac). Yellow solid: mp 65-67 ºC; Rf = 0.35 (5:1 
petroleum ether/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.25 (dd, J = 5.1, 1.2 Hz, 1 H), 7.83 (td, 
J = 7.2, 1.2 Hz, 2 H), 7.52 (td, J = 7.2, 1.8 Hz, 1 H), 7.31 (td, J = 7.8, 1.2 Hz, 1 H), 6.80 (m, 3 H), 
6.65 (s, 1 H); 13C NMR (75 MHz, CDCl3) δ 155.4, 148.6, 141.3, 139.6, 138.0, 129.2, 124.4, 
120.4, 116.1, 109.7, 91.6; LRMS (EI) 296 (M); HRMS (EI) calcd for C11H9IN2 (M) 295.9810, 
found 295.9816; IR (KBr, cm-1) 3380 (s), 3192 (w), 3012 (m), 2954 (m), 2925 (m), 2866 (m), 
1599 (s), 1573 (m), 1515 (s). 
N-(3-Iodophenyl)pyridin-2-amine (3ad). Yellow oil: Rf = 0.33 (5:1 petroleum ether/EtOAc); 
1H NMR (300 MHz, CDCl3) δ 8.22 (d, J = 4.5 Hz, 1 H), 7.75 (s, 1 H), 7.52 (td, J = 7.8, 1.5 Hz, 1 
H), 7.33 (t, J = 8.4 Hz, 2 H), 7.02 (m, 2 H), 6.85 (d, J = 8.4 Hz, 1 H), 6.77 (dd, J = 6.9, 5.1 Hz, 1 
H); 13C NMR (75 MHz, CDCl3) δ 155.4, 148.5, 142.2, 138.0, 131.5, 130.8, 128.4, 119.0, 115.8, 
109.1, 94.8; LRMS (EI) 296 (M); HRMS (EI) calcd for C11H9IN2 (M) 295.9810, found 295.9816; 
IR (KBr, cm-1) 3378 (s), 3190 (w), 3012 (m), 2929 (m), 2860 (m), 1595 (s), 1573 (m). 
N-(2,4-Dimethylphenyl)pyridin-2-amine (3ae). Yellow oil: Rf = 0.22 (2:1 petroleum 
ether/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.15 (d, J = 4.2 Hz, 1 H), 7.41 (td, J = 7.2, 1.8 Hz, 
1 H), 7.25 (t, J = 3.6 Hz, 1 H), 7.08 (s, 1 H), 7.01 (d, J = 7.8 Hz, 1 H), 6.60 (m, 2 H), 6.31 (s, 1 
H), 2.32 (s, 3 H), 2.23 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 157.5, 148.6, 137.8, 135.8, 134.7, 
131.9, 131.3, 127.6, 124.2, 114.4, 107.2, 21.1, 18.1; LRMS (EI) 198 (M); HRMS (EI) calcd for 
C13H14N2 (M) 198.1157, found 198.1159. 
N-(4-Nitrophenyl)pyridin-2-amine (3af). Yellow solid: mp 167-168 ºC (lit23 174-176 ºC); Rf 
= 0.41 (1:1 petroleum ether/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.34 (d, J = 4.2 Hz, 1 H), 
8.20 (d, J = 9.3 Hz, 2 H), 7.64 (m, 3 H), 6.94 (m, 3 H); 13C NMR (75 MHz, CDCl3) δ 153.9, 
29 
148.5, 147.1, 141.4, 138.3, 125.9, 117.6, 116.9, 111.5; LRMS (EI) 215 (M), 214 (M-H); HRMS 
(EI) calcd for C11H9N3O2 (M) 215.0695, found 215.0699. 
N-(2-tert-Butylphenyl)pyridin-2-amine (3ag). White solid: mp 122-123 ºC; Rf = 0.18 (5:1 
petroleum ether/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.16 (d, J = 4.2 Hz, 1 H), 7.46 (d, J = 
7.5 Hz, 1 H), 7.40 (t, J = 7.2 Hz, 1 H), 7.32 (d, J = 7.5 Hz, 1 H), 7.20 (m, 2 H), 6.66 (t, J = 6.0 
Hz, 1 H), 6.45 (d, J = 8.4 Hz, 1 H), 6.30 (s, 1 H), 1.41 (s, 9 H); 13C NMR (75 MHz, CDCl3) δ 
158.3, 148.7, 145.9, 138.8, 137.8, 128.8, 127.4, 127.3, 126.1, 114.3, 107.2, 35.2, 30.8; LRMS (EI) 
226 (M); HRMS (EI) calcd for C15H18N2 (M) 226.1470, found 226.1475. 
N-[2-(Cyclohex-1-en-1-yl)ethyl]pyridin-2-amine (3ah). Yellow oil: Rf = 0.13 (5:1 petroleum 
ether/EtOAc); 1H NMR (300 MHz, CDCl3) δ 8.08 (dd, J = 4.5, 1.2 Hz, 1 H), 7.42 (td, J = 7.2, 
1.8 Hz, 1 H), 6.55 (t, J = 5.7 Hz, 1 H), 6.37 (d, J = 8.4 Hz, 1 H), 5.53 (s, 1 H), 4.50 (s, 1 H), 3.30 
(dd, J = 12.3, 6.9 Hz, 2 H), 2.27 (t, J = 6.6 Hz, 2 H), 1.98 (m, 4 H), 1.60 (m, 4 H); 13C NMR (75 
MHz, CDCl3) δ 159.0, 148.4, 137.6, 134.8, 124.0, 112.8, 106.6, 39.9, 37.8, 28.0, 25.4, 23.0, 22.6; 
LRMS (EI) 202 (M); HRMS (EI) calcd for C13H18N2 (M) 202.1470, found 202.1474. 
N,N-Dibenzylpyridin-2-amine (3ai). Yellow oil: Rf = 0.27 (20:1 petroleum ether/EtOAc); 1H 
NMR (300 MHz, CDCl3) δ 8.20 (dt, J = 5.1, 0.9 Hz, 1 H), 7.31 (m, 11 H), 6.58 (td, J = 5.1, 0.9 
Hz, 1 H), 6.45 (d, J = 8.7 Hz, 1 H), 4.79 (s, 4 H); 13C NMR (75 MHz, CDCl3) δ 158.8, 148.2, 
138.6, 137.6, 128.8, 127.2, 127.1, 112.4, 106.1, 51.0; LRMS (EI) 274 (M); HRMS (EI) calcd for 
C19H18N2 (M) 274.1470, found 274.1473. 
N-(4-Bromophenyl)quinolin-2-amine (3bj). Brown solid: mp 143-145 ºC; Rf = 0.56 (2:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 8.8 Hz, 1 H), 7.80 (d, J = 
8.0 Hz, 1 H), 7.61 (m, 4 H), 7.46 (d, J = 8.8 Hz, 2 H), 7.32 (t, J = 7.2 Hz, 1 H), 6.90 (d, J = 8.8 
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Hz, 1 H), 6.75 (s, 1 H); 13C NMR (100 MHz, CDCl3) δ 153.8, 147.6, 139.6, 138.0, 132.2, 130.1, 
127.6, 127.1, 124.4, 123.7, 121.6, 115.2, 112.2; LRMS (EI) 299 (M); HRMS (EI) calcd for 
C15H11BrN2 (M) 298.0106, found 298.0111. 
N-Methyl-N-[4-(pyridin-2-yloxy)butyl]aniline (3aa’). Yellow oil: Rf = 0.49 (20:1 petroleum 
ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.14 (d, J = 4.0 Hz, 1 H), 7.54 (td, J = 10.0, 4.0 Hz, 
1 H), 7.20 (m, 2 H), 6.84 (m, 1 H), 6.69 (m, 4 H), 4.31 (t, J = 6.0 Hz, 2 H), 3.38 (t, J = 8.0 Hz, 2 
H), 2.93 (s, 3 H), 1.77 (m, 4 H); 13C NMR (100 MHz, CDCl3) δ 164.1, 149.5, 147.0, 138.7, 129.3, 
116.7, 116.2, 112.4, 111.3, 65.7, 52.7, 38.5, 26.9, 23.7; LRMS (ESI) 257 (M+H); HRMS (ESI) 
calcd for C16H21N2O (M+H) 257.1648, found 257.1654; IR (KBr, cm-1) 3091 (w), 2945 (m), 
2884 (m), 2867 (m), 1596 (s), 1569 (m). 
General procedure for the synthesis of benzonaphthyridinones. The 
benzonaphthyridinones were prepared from the corresponding o-aminobenzoates and aryne 
precursors following the same procedure used for the synthesis of 2-pyridinylamines. The 
residue was purified by column chromatography (petroleum ether/EtOAc + 1% TEA) to afford 
the benzonaphthyridinones. 
10-Methylbenzo[b][1,8]naphthyridin-5(10H)-one (5aa). Yellow solid: mp 214-215 ºC; Rf = 
0.24 (3:1 petroleum ether/EtOAc + 1% TEA); 1H NMR (300 MHz, CDCl3) δ 8.79 (m, 2 H), 8.55 
(dd, J = 8.1, 1.5 Hz, 1 H), 7.79 (td, J = 7.2, 1.5 Hz, 1 H), 7.63 (d, J = 8.4 Hz, 1 H), 7.35 (t, J = 
7.5 Hz, 1 H), 7.25 (m, 1 H), 4.15 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 178.6, 153.5, 151.3, 
142.6, 137.0, 134.6, 127.8, 122.8, 122.1, 117.6, 117.4, 115.6, 31.0; LRMS (EI) 210 (M), 209 
(M-H); HRMS (EI) calcd for C13H10N2O (M) 210.0793, found 210.0796. 
10-Allyl-8-bromobenzo[b][1,8]naphthyridin-5(10H)-one (5ab). Yellow solid: mp 145-146 
31 
ºC; Rf = 0.25 (5:1 petroleum ether/EtOAc + 1% TEA); 1H NMR (400 MHz, CDCl3) δ 8.78 (d, J 
= 6.4 Hz, 2 H), 8.38 (d, J = 8.4 Hz, 1 H), 7.71 (s, 1 H), 7.43 (d, J = 8.4 Hz, 1 H), 7.29 (m, 1 H), 
6.08 (m, 1 H), 5.41 (s, 2 H), 5.26 (d, J = 10.0 Hz, 1 H), 5.07 (d, J = 17.2 Hz, 1 H); 13C NMR 
(100 MHz, CDCl3) δ 178.0, 154.0, 150.9, 142.6, 137.0, 131.7, 129.7, 129.4, 125.6, 121.5, 119.1, 
118.5, 117.34, 117.32, 46.0; LRMS (EI) 314 (M); HRMS (EI) calcd for C15H11BrN2O (M) 
314.0055, found 314.0053; IR (KBr, cm-1) 3084 (w), 2954 (m), 2924 (m), 2870 (w), 1639 (m), 
1587 (s). 
7-Iodo-10-methylbenzo[b][1,8]naphthyridin-5(10H)-one (5ac). Yellow solid: mp 198-199 
ºC; Rf = 0.13 (8:1 petroleum ether/EtOAc + 1% TEA); 1H NMR (400 MHz, CDCl3) δ 8.78 (m, 3 
H), 7.99 (d, J = 9.2 Hz, 1 H), 7.38 (d, J = 9.2 Hz, 1 H), 7.25 (m, 1 H), 4.11 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 177.2, 153.8, 151.1, 142.8, 141.9, 137.0, 136.4, 124.4, 118.0, 117.8, 117.4, 
85.5, 31.1; LRMS (EI) 335 (M); HRMS (EI) calcd for C13H9IN2O (M) 335.9760, found 335.9765; 
IR (KBr, cm-1) 3083 (w), 2954 (m), 2915 (m), 2869 (w), 1635 (m), 1585 (s). 
7-Bromo-10-methylbenzo[b][1,8]naphthyridin-5(10H)-one (5ad). Yellow solid: mp 
202-203 ºC; Rf = 0.18 (5:1 petroleum ether/EtOAc + 1% TEA); 1H NMR (400 MHz, CDCl3) δ 
8.73 (m, 2 H), 8.55 (s, 1 H), 7.78 (d, J = 8.8 Hz, 1 H), 7.46 (d, J = 8.8 Hz, 1 H), 7.26 (m, 1 H), 
4.09 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 177.3, 153.8, 151.1, 141.3, 137.2, 136.9, 130.1, 
123.9, 118.0, 117.6, 117.2, 115.6, 31.1; LRMS (EI) 288 (M); HRMS (EI) calcd for C13H9BrN2O 
(M) 287.9898, found 287.9904. 
7-Chloro-10-methylbenzo[b][1,8]naphthyridin-5(10H)-one (5ae). Yellow solid: mp 
210-212 ºC; Rf = 0.5 (2:1 petroleum ether/EtOAc + 1% TEA); 1H NMR (400 MHz, CDCl3) δ 
8.76 (m, 2 H), 8.45 (s, 1 H), 7.68 (d, J = 9.2 Hz, 1 H), 7.57 (d, J = 9.2 Hz, 1 H), 7.25 (m, 1 H), 
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4.13 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 177.5, 153.8, 151.1, 141.0, 137.0, 134.6, 128.2, 
126.9, 123.6, 118.0, 117.4, 117.2, 31.2; LRMS (EI) 244 (M); HRMS (EI) calcd for C13H9ClN2O 
(M) 244.0403, found 244.0408. 
8-Bromo-10-methylbenzo[b][1,8]naphthyridin-5(10H)-one (5af). Yellow solid: mp 234-235 
ºC; Rf = 0.4 (3:1 petroleum ether/EtOAc + 1% TEA); 1H NMR (400 MHz, CDCl3) δ 8.77 (m, 2 
H), 8.37 (d, J = 8.8 Hz, 1 H), 7.80 (s, 1 H), 7.44 (d, J = 8.4 Hz, 1 H), 7.28 (t, J = 6.0 Hz, 1 H), 
4.12 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.0, 153.7, 151.2, 143.3, 136.9, 129.8, 129.3, 
125.5, 121.4, 118.5, 118.1, 117.5, 31.1; LRMS (EI) 288 (M); HRMS (EI) calcd for C13H9BrN2O 
(M) 287.9898, found 287.9901; IR (KBr, cm-1) 3084 (w), 2951 (w), 2917 (m), 2870 (m), 2849 
(w), 1637 (m), 1587 (m). 
Methyl 10-methyl-5-oxo-5,10-dihydrobenzo[b][1,8]naphthyridine-8-carboxylate (5ag). 
Yellow solid: mp 225-226 ºC; Rf = 0.12 (5:1 petroleum ether/EtOAc + 1% TEA); 1H NMR (400 
MHz, CDCl3) δ 8.78 (m, 2 H), 8.56 (d, J = 8.0 Hz, 1 H), 8.34 (s, 1 H), 7.92 (d, J = 8.4 Hz, 1 H), 
7.27 (m, 1 H), 4.20 (s, 3 H), 4.02 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.2, 166.4, 153.9, 
151.4, 142.1, 136.9, 135.0, 128.1, 125.0, 122.0, 118.0, 117.6, 117.5, 52.9, 31.2; LRMS (EI) 268 
(M); HRMS (EI) calcd for C15H12N2O3 (M) 268.0848, found 268.0854; IR (KBr, cm-1) 3082 (w), 
2954 (m), 2923 (m), 2871 (w), 1730 (s), 1638 (s), 1614 (m), 1593 (s). 
6-Methyldibenzo[b,g][1,8]naphthyridin-11(6H)-one (5ba). Yellow solid: mp 229-231 ºC; Rf 
= 0.27 (5:1 petroleum ether/EtOAc + 1% TEA); 1H NMR (400 MHz, CDCl3) δ 9.32 (s, 1 H), 
8.53 (d, J = 7.6 Hz, 1 H), 8.00 (m, 2 H), 7.80 (m, 2 H), 7.60 (d, J = 8.4 Hz, 1 H), 7.47 (t, J = 7.6 
Hz, 1 H), 7.31 (t, J = 7.6 Hz, 1 H), 4.22 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 179.7, 157.1, 
150.1, 143.7, 139.2, 135.2, 132.8, 129.7, 128.1, 127.8, 124.8, 122.4, 121.6, 121.5, 117.8, 115.4, 
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31.0; LRMS (EI) 260 (M); HRMS (EI) calcd for C17H12N2O (M) 260.0950, found 260.0955; IR 
(KBr, cm-1) 3064 (w), 2954 (w), 2917 (m), 2871 (m), 2850 (w), 1608 (s). 
5H-Thiochromeno[2,3-b]pyridin-5-one (5ai). White solid: mp 236-238 ºC (lit24 233-234 ºC); 
Rf = 0.24 (5:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.83 (m, 2 H), 8.60 (d, J = 
8.0 Hz, 1 H), 7.70 (m, 2 H), 7.53 (td, J = 8.0, 1.6 Hz, 1 H), 7.46 (dd, J = 8.0, 4.4 Hz, 1 H); 13C 
NMR (100 MHz, CDCl3) δ 180.8, 158.9, 153.5, 138.0, 137.7, 133.2, 130.1, 129.0, 127.0, 126.65, 
126.62, 121.8; LRMS (EI) 213 (M); HRMS (EI) calcd for C12H7NOS (M) 213.0248, found 
213.0253. 
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Formation of Acridones by Ethylene Extrusion in the Reaction of Arynes with β-Lactams 
and Dihydroquinolinones 
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3.1. Abstract  
 
  N-Unsubstituted β-lactams react with a molecule of aryne by insertion into the amide bond to 
form a 2,3-dihydroquinolin-4-one, which subsequently reacts with another molecule of aryne to 
form an acridone by extrusion of a molecule of ethylene. 2,3-Dihydroquinolin-4-ones react 
under the same reaction conditions to afford identical results. This is the first example of 
ethylene extrusion in aryne chemistry. 
3.2. Introduction  
Benzyne is a highly reactive intermediate, which was first proposed by Wittig in 19421 and 
confirmed by Roberts in 1956.2 Since the discovery of the Kobayashi aryne precursor,3 various 
nucleophiles have been shown to react with arynes by nucleophilic addition to open the strained, 
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triple bond of the aryne.4 When the nucleophile is tethered to an electrophile, the nucleophilic 
addition can trigger subsequent electrophilic trapping of the aryl anion, leading to a formal σ-bond 
cleavage.5 Amide functionality is one such tethered nucleophile-electrophile pair, where the 
nitrogen and the carbonyl serve as the nucleophile and the electrophile, respectively. Although 
amides typically undergo simple NH arylation,4,6 amides with more electrophilic carbonyl groups, 
including trifluoroacetamides, trifluoromethanesulfinamides,7 ureas,8 and DMF9 have been shown 
to undergo carbonyl-nitrogen cleavage. Another class of substrates that could potentially exhibit 
such reactivity is a strained or twisted amide,10 where the poor n-pi conjugation makes the amide 
behave more like an independent amine and ketone. To the best of our knowledge, the reactivity of 
such amides towards arynes has received little attention.11 We wish to report our initial results in 
this interesting area. 
The substrates we have chosen to study are β-lactams. The angular strain of β-lactams renders 
poor conjugation of the nitrogen to the carbonyl. Thus, β-lactams have a stronger C=O double 
bond and a more basic nitrogen than regular amides.12 We envisioned that the nitrogen atom of the 
β-lactam should exhibit greater nucleophilicity toward arynes than normal amides, thus leading to 
eventual C(O)-N bond cleavage to afford dihydroquinolinones (Scheme 1). While this outcome 
proved correct, we have observed some interesting subsequent chemistry, which we now report. 
Scheme 1. Originally anticipated reaction of a β-lactam with an aryne 
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3.3. Results and Discussion 
Initial discovery. We initiated our study using the N-unsubstituted β-lactam 1a as the starting 
material (Scheme 2). Stirring lactam 1a with 1.0 equiv of the parent aryne precursor 2a in the 
presence of 2.0 equivs of CsF as the fluoride source afforded three products in addition to 
unreacted 1a: the simple N-arylation product 1b, product 3a’ resulting from C(O)-N bond 
insertion and subsequent N-arylation, and acridone 4a. Much to our surprise, not only was the 
originally anticipated product 3a not observed, but dihydroquinolinone 3a’ was identified as only 
a minor product by GC-MS analysis. The major product of this reaction was acridone 4a. It thus 
appeared that the initial insertion products 3a and/or 3a’ were also reactive toward arynes, if not 
even more so than lactam 1a, and thus served merely as intermediates, eventually leading to 
acridone 4a. For this to happen, however, the C2-C3 unit of the dihydroquinolinone 3a and/or 3a’ 
must have been lost as a molecule of ethylene during the course of the reaction. It is very rare that 
aryne reactions lead to the extrusion of a neutral molecule.13 To the best of our knowledge, this is 
the first example of ethylene extrusion in aryne chemistry. 
Scheme 2. Initial Results Leading to an Acridone from a β-Lactam 
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To test our hypothesis that 2,3-dihydroquinolin-4-ones 3a/3a’ are reactive with arynes, pure 3a 
from a commercial source was subjected to our standard aryne reaction conditions. We thus found 
that as long as sufficient aryne was present, acridone 4a was indeed formed under quite mild 
conditions, regardless of the fluoride source or the solvent used (Table 1). Thus, the intermediacy 
of dihydroquinolinone 3a during the generation of acridone 4a from β-lactam 1a is confirmed. 
Table 1. Formation of an Acridone from a 2,3-Dihydroquinolin-4(1H)-one.a 
 
entry equiv of 2a  fluoride source (equiv) conditions yieldb (%) 
1 2 CsF (4) MeCN, rt, 1d 65 
2 2.4 CsF (4.8) MeCN, rt, 1d 77 
3 2.4 CsF (4.8) THF, 65 ºC, 1d 72 
4 2.4 TBAF (4.8) THF, rt, 1d 59 
5 2.4 TBAT (4.8) toluene, rt, 1d 50 
a
 All reactions were carried out on a 0.25 mmol scale in 4 mL of solvent. b Isolated yield of 
acridone 4a. 
  To gain further evidence for the mechanism, an experiment was carried out to trap the extruded 
ethylene (the C2-C3 unit of the 2,3-dihydroquinolin-4-one). Thus, the reaction was repeated in a 
sealed vessel, and bromine was injected into the vessel after 10 h. GC-MS analysis of the crude 
reaction mixture revealed the presence of a large quantity of 1,2-dibromoethane, which supports 
the generation of ethylene in this reaction (Scheme 3). 
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Scope of the β-lactam. Encouraged by these findings, we first studied the scope of the reaction 
between various β-lactams and arynes. Although we have suggested that the reaction proceeds 
through the intermediacy of a dihydroquinolinone (such as 3a and/or its N-arylated product 3a’), 
all attempts to isolate such an intermediate have thus far been unsuccessful, even when using a 1 : 
1 stoichiometry of the β-lactam and the aryne precursor. The best yields of acridone 4 have been 
achieved by employing 3.5 equivalents of the aryne precursor (Fig. 1) for the N-unsubstituted 
β-lactam 1a or 2.4 equivalents for the N-substituted β-lactams 1b and 1c. As seen in Table 2, 
compounds 4b and 4c can be obtained in reasonable yields from the symmetrical aryne precursors 
2b and 2c (entries 2 and 3), respectively. The aryne derived from 2e is known to be attacked 
preferentially by nucleophiles at the meta position (with respect to the OMe group) for both 
electronic and steric reasons.4,14 In our studies, compound 4d was formed in a surprisingly high 
yield as a single regioisomer (entry 4). N-Substituted β-lactams have also been examined in this 
reaction (entries 5-7). However, the N-phenyl lactam 1b proved unreactive under our standard 
reaction conditions, and the N-allyl lactam 1c was only marginally reactive, affording no more 
than a trace of the desired product 4e. The N-benzyl lactam 1d was slightly more reactive, 
affording compound 4f in a 13% isolated yield (entry 7). It is worth pointing out that the yields of 
these three reactions did not improve very much even when the reactions were performed at a 
higher temperature. We also examined one α,α-disubstituted β-lactam 1e (entry 8). In this case, 
the anticipated chemistry would require the extrusion of an olefin much larger than ethylene. 
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Gratifyingly, we were able to identify the desired product 4a in a 30% yield, indicating that 
extrusion of a molecule as large as 4-methylenehepta-1,6-diene is possible.  
Figure 1. Aryne Precursors. 
Table 2. Scope of the β-Lactam.a 
 
entry β-lactam aryne precursor product yieldb (%) 
1  
1a 
2a 
 
4a 
50 
2 1a 2b 
 
4b 
45 
3 1a 2c 
N
O
MeO
MeO OMe
OMe
MeO
OMe
 
4c 
40 
43 
4 1a 2e 
 
4d 
83 
Table 2 continued 
5  
1b 
2ª 4a nrc,d 
6 
 
1c 
2ª 
 
4e 
traced,e 
7  
1d 
2a 
 
4f 
13d 
8 
 
1e 
2a 4a 30 
a
 All reactions were carried out on a 0.25 mmol scale in 4 mL of MeCN with 3.5 equiv of the aryne 
precursor and 7 equiv of CsF. b Isolated yield. c All lactam starting material was recovered. d 2.4 
Equiv of 2a and 4.8 equiv of CsF were employed. e Detected by GC-MS. 
Scope of the dihydroquinolinone. Due to the limited availability of β-lactams and the fact that 
incorporation of three molecules of aryne results in limited variability in the substitution pattern of 
the acridone product, we felt that the use of 2,3-dihydroquinolin-4-ones (series 3) as the starting 
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material would be more synthetically useful. Thus, we next focused our efforts on studying the 
reaction of dihydroquinolinones 3 with arynes.  
We first examined N-unsubstituted substrates (Table 3). As shown previously, we have had 
preliminary success in the reaction of 3a with 2a (cf. entry 2, Table 1). Expanding the scope of the 
dihydroquinolinones 3 revealed that alkyl, ether, and chloride substituents are well tolerated, 
affording the corresponding acridones in good to excellent yields (entries 1-3). However, 
6-fluorodihydroquinolinone (3e) proved unreactive (entry 4), presumably due to the 
electron-withdrawing nature of the fluoride. Different aryne precursors (cf. Fig. 1) have also been 
shown to react smoothly (entries 5-8), and compound 4n has been obtained as a single regioisomer 
in a 90% yield (entry 8). 
Table 3. Scope of the N-Unsubstituted 2,3-Dihydroquinolin-4-ones.a 
 
entry dihydroquinolinone aryne precursor product yieldb (%) 
1 
 
3b 
2a 
 
4g 
88 
2 
 
3c 
2a 
 
4h 
75 
45 
3 
 
3d 
2a 
 
4i 
80 
Table 3 continued 
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4j 
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5 3a 2b 
 
4k 
73 
6 3a 2c 
 
4l 
85 
7 3a 2d 
 
4m 
69 
8 3a 2e 
 
90 
46 
4n 
a
 All reactions were carried out on a 0.25 mmol scale with 2.4 equiv of 2 and 4.8 equiv of CsF in 4 
mL of MeCN. b Isolated yield. c Detected by GC-MS.  
 N-Substituted 2,3-dihydroquinolin-4-ones were next examined (Table 4). Compared with the 
results in Table 3, the yields using N-substituted 2,3-dihydroquinolin-4-ones are noticeably lower. 
Thus, the N-methyl dihydroquinolinone 3f reacted with 1.2 equivs of benzyne precursor 2a to 
afford acridone 4o in a 63% yield (entry 1), a 14% drop from the corresponding N-unsubstituted 
precursor 3a (cf. entry 2, Table 1). Similarly, substrates 3g through 3i were all smoothly 
transformed into the corresponding acridones 4p through 4r in moderate yields (entries 2-4). Other 
than a methyl group on the nitrogen, an allyl group can also be tolerated as seen in the reaction of 
substrate 3j, which afforded acridone 4e in a 48% yield (entry 5). However, placing a phenyl group 
on the nitrogen resulted in much lowered reactivity, as dihydroquinolinone 3a’ afforded only a 
trace of acridone 4a, as detected by GC-MS (entry 6), indicating that the nucleophilicity and/or 
steric hindrance of the nitrogen is crucial to the reaction. This chemistry has also been extended to 
substituted aryne precursors. Thus, silyl triflates 2f and 2g reacted with dihydroquinolinone 3f to 
afford the desired products in 57% and 60% yields, respectively (entries 7 and 8). Not surprisingly, 
since these two precursors are neither electronically nor sterically biased, mixtures of two 
regioisomers were obtained.  
Table 4. Scope of the N-Substituted 2,3-Dihydroquinolin-4-ones.a 
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entry dihydroquinolinone aryne precursor product 
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Table 4 continued 
7 3f 2f 
 
4s + 4s’ 
57d 
(1:1) 
8 3f 2g 
 
4t + 4t’ 
60d 
(1:2) 
a
 All reactions were carried out on a 0.25 mmol scale with 1.2 equiv of 2 and 2.4 equiv of CsF in 4 
mL of MeCN.. b Isolated yield. c Detected by GC-MS. d Inseparable mixtures of regioisomers. The 
ratios were obtained by 1H NMR spectroscopy. No attempts were made to identify the major 
isomer. 
Mechanistic discussion. Based on the above results, we propose the following mechanistic 
picture for this overall process (Scheme 4). First, the nitrogen atom of the β-lactam (1a) reacts with 
one molecule of the aryne to form intermediate A. Although A could undergo a simple proton 
transfer to afford lactam 1b (as shown in Scheme 2), this is apparently a minor route and a 
non-productive one with respect to the formation of acridone 4a, since lactam 1b does not readily 
react with arynes (see entry 5, Table 2). Thus, the aryl anion of intermediate A apparently 
nucleophilically adds to the carbonyl, and the resulting highly strained intermediate B collapses to 
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furnish dihydroquinolinone 3a with release of the ring strain. Compound 3a presumably then 
reacts with a second molecule of aryne to afford intermediate C. Once again proton transfer from 
C to form dihydroquinolinone 3a’ is apparently a minor and non-productive route (see entry 6, 
Table 4). In a fashion similar to the conversion of A to B, intermediate C most likely cyclizes to D, 
and subsequent extrusion of ethylene either by the arrow-pushing sequence described in Scheme 4 
or by a retro-Diels-Alder process leads to the acridone E. Finally, acridone E undergoes NH 
arylation by a third molecule of aryne to afford the final major product acridone 4a. In other words, 
the formation of acridone 4a from lactam 1a proceeds through the intermediacy of compounds 3a 
and E, and compounds 1b and 3a’ are much less important intermediates en route to acridone 4a. 
Scheme 4. Mechanistic pathway 
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Possibilities for the extrusion of small molecules other than ethylene. Inspired by the finding 
that dihydroquinolinone 3a apparently reacts with an aryne to afford structures like intermediate D 
(Scheme 4), we were prompted to investigate other substrates that might afford a similar 
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intermediate. It has been shown that a 5-membered ring urea can undergo C(O)-N cleavage upon 
reaction with arynes to afford products similar to compound 3.8 Thus, we examined the reaction of 
the cyclic carbamate 3-methyloxazolidin-2-one (5) with benzyne generated from 2a. Gratifyingly, 
we were able to isolate acridone 4o in a 33% yield (Scheme 5). This reaction is quite interesting on 
its own, because mechanistically, the first C(O)-N cleavage presumably results in a 
seven-membered ring intermediate 6, whose subsequent reaction with benzyne must apparently 
extrude a molecule of ethylene oxide. Again, to the best of our knowledge, such a process is 
unprecedented in aryne chemistry. 
Scheme 5. Extrusion of Ethylene Oxide in the Reaction of Benzyne with 
3-Methyl-2-oxazolidinone. 
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3.4. Conclusions 
  In summary, we have demonstrated that the reaction of β-lactams or 2,3-dihydroquinolin-4-ones 
with arynes could afford respectable yields of acridones through the extrusion of ethylene. This 
chemistry speaks for the tendency of intermediates like A and C to readily undergo intramolecular 
nucleophilic cyclization rather than the seemingly easier proton transfer process. Further study has 
suggested that the extrusion of molecules larger than ethylene, such as 
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4-methylenehepta-1,6-diene and an epoxide, are also possible in aryne processes.  
3.5. Experimental Section 
General Information. The solvent THF was distilled over Na/benzophenone, and 
dichloromethane was distilled over CaH2. Anhydrous MeCN, DMF, and DCE were used as 
received. The aryne precursors were used as received. Silica gel for column chromatography was 
supplied as 230-400 mesh from a commercial source. Powdered CsF and TBAF (1 M in THF 
solution) were used as received and stored in a desiccator. 
All melting points are uncorrected. The 1H and 13C NMR spectra were recorded and are 
referenced to the residual solvent signals (7.26 ppm for 1H and 77.2 ppm for 13C in CDCl3, 2.05 
ppm for 1H and 30.19 ppm for 13C in acetone-d6). A QTOF analyzer was used for all of the HRMS 
measurements. 
β-Lactams. Compound 1a was commercially available and was used as received. The rest were 
prepared as follows. 
1-Phenylazetidin-2-one (1b).15 To a suspension of 1.8 mL (20 mmol) of aniline and 3.3 g (24 
mmol) of K2CO3 in 20 mL of DCM at 0 ºC was added dropwise 2.5 mL (24 mmol) of 
3-bromopropanoyl chloride. The mixture was stirred at 0 ºC for minutes and allowed to warm up to 
room temperature for another 3 h. The reaction was quenched with water and extracted with 
EtOAc three times. The combined organic layers were evaporated and the residue was 
recrystallized in a hot solution of 1:1 petroleum ether/EtOAc to afford 3.42 g (ca. 15 mmol, ~75% 
as is) of 3-bromo-N-phenylpropanamide as white crystals. This solid was then dissolved in DMF 
and cooled to 0 ºC. To this solution was added 1.57 g (16.5 mmol) of sodium tert-butoxide in one 
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portion and the mixture was allowed to warm up to room temperature gradually. The reaction was 
quenched with water after 3 h and extracted with EtOAc. The combined organic layers were 
evaporated and the residue was recrystallized from a hot solution of 1:1 petroleum ether/EtOAc to 
afford 1.76 g (60% overall yield) of 1-phenylazetidin-2-one as a red solid: mp 78-80 ºC (lit16 78-79 
ºC); 1H NMR (400 MHz, CDCl3) δ 7.53-7.32 (m, 5 H), 3.72 (t, J = 6.4 Hz, 1 H), 3.63 (t, J = 4.8 Hz, 
1 H), 3.12 (t, J = 4.8 Hz, 1 H), 2.95 (t, J = 6.4 Hz, 1 H). 
1-Allylazetidin-2-one (1c). The above procedure was applied to 1.14 g (20 mmol) of allylamine 
and 2.5 mL (24 mmol) of 3-bromopropanoyl chloride, followed by 1.52 g (16 mmol) of sodium 
tert-butoxide to afford 1.22 g (55% overall yield) of lactam 1c as a colorless oil: 1H NMR (400 
MHz, CDCl3) δ 5.80-5.70 (m, 1 H), 5.22 (d, J = 5.2 Hz, 1 H), 5.19 (s, 1 H), 3.82 (d, J = 6.0 Hz, 2 H), 
3.22 (t, J = 4.0 Hz, 2 H), 2.94 (t, J = 4.0 Hz, 2 H). 
1-Benzylazetidin-2-one (1d). The above procedure was applied to 2.14 g (20 mmol) of 
benzylamine and 2.5 mL (24 mmol) of 3-bromopropanoyl chloride, followed by 1.57 g (16.5 
mmol) of sodium tert-butoxide to afford 1.87 g (58% overall yield) of lactam 1d as a colorless oil: 
1H NMR (300 MHz, CDCl3) δ 7.39-7.23 (m, 5 H), 4.38 (s, 2 H), 3.14 (t, J = 3.9 Hz, 2 H), 2.95 (t, J 
= 3.9 Hz, 2 H). 
3,3-Diallylazetidin-2-one (1e).17 A mixture of 0.71 g (10 mmol) of azetidin-2-one (1a), 2.25 g 
(15 mmol) of tert-butyldimethylsilyl chloride, and 2.08 mL (15 mmol) of triethylamine in 20 mL 
of DCM was stirred for 12 h at room temperature. The mixture was then washed with water and the 
aqueous phase was extracted with EtOAc three times. The combined organic layers were washed 
with brine, dried over Na2SO4, filtered, and concentrated to afford a colorless oil consisting of 
N-tert-butyldimethylsilylazetidin-2-one and residual TBSCl. This mixture was dissolved in THF, 
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cooled to -78 ºC under an N2 atmosphere, and charged with 6.67 mL (1.8 M THF solution) of LDA. 
After being stirred for 2 h at -78 ºC, 1.04 mL (12 mmol) of allyl bromide was added and the 
mixture was gradually warmed up to room temperature for another 12 h. The reaction was 
quenched with water and extracted with EtOAc. The combined organic layers were washed with 
brine, dried over Na2SO4, filtered, and concentrated. The residue was purified by column 
chromatography (5:1 petroleum ether/ EtOAc) to afford 0.52 g (2.3 mmol) of 
3-allyl-1-(tert-butyldimethylsilyl)azetidin-2-one. This intermediate was treated with the above 
allylation procedure again to afford 0.3 g (1.1 mmol) of 
3,3-diallyl-1-(tert-butyldimethylsilyl)azetidin-2-one. This product was dissolved in 10 mL of 
methanol and 0.334 g (2.2 mmol) of CsF was added. After being stirred for 2 h, the mixture was 
quenched with water and extracted with EtOAc. The combined organic layers were washed with 
brine, dried over Na2SO4, filtered, and concentrated to afford 0.15 g (1.0 mmol, 10% overall yield 
from 1a) of 3,3-diallylazetidin-2-one as a red oil: 1H NMR (400 MHz, CDCl3) δ 6.32 (s, 1 H), 
5.85-5.74 (m, 2 H), 5.12 (d, J = 6.4 Hz, 2 H), 5.08 (s, 2 H), 3.07 (s, 2 H), 2.39 (d of ABq, JAB = 14.1 
Hz, JAX = 6.7 Hz, JBX = 7.9 Hz, 2 H), 2.31 (d of ABq, JAB = 14.1 Hz, JAX = 6.7 Hz, JBX = 7.9 Hz, 2 
H). 
N-Unsubstituted 2,3-Dihydroquinolin-4-ones. Compounds 3a and 3e were commercially 
available and used as received. The remaining dihydroquinolinones were prepared as follows. 
6-Methyl-2,3-dihydroquinolin-4(1H)-one (3b).15,18 Following the procedure described above 
for the synthesis of compound 1b, 2.14 g (20 mmol) of p-toluidine, 2.5 mL (24 mmol) of 
3-bromopropanoyl chloride, and 1.57 g (16.5 mmol) of sodium tert-butoxide were employed to 
obtain 1.92 g of N-(p-tolyl)azetidin-2-one. To a solution of 1.61 g (10 mmol) of 
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1-(p-tolyl)azetidin-2-one in 20 mL of DCE at 0 ºC was added 2 mL (22 mmol) of TfOH. The 
mixture was allowed to warm up to room temperature and stirred for 2 h. The reaction was 
quenched with aq. NaHCO3 and extracted by EtOAc three times. The combined organic layers 
were washed with brine, dried over Na2SO4, filtered, and concentrated. The residue was purified 
by column chromatography (2:1 petroleum ether/EtOAc) to afford 1.19 g (40% overall yield from 
p-toluidine) of dihydroquinolinone 3b as a yellow solid: mp 80-82 ºC (lit16 82-84 ºC); 1H NMR 
(400 MHz, CDCl3) δ 7.65 (s, 1 H), 7.13 (dd, J = 8.4, 1.6 Hz, 1 H), 6.59 (d, J = 8.4 Hz, 1 H), 4.26 (s, 
1 H), 3.55 (td, J = 8.0, 1.6 Hz, 2 H), 2.68 (t, J = 6.8 Hz, 2 H), 2.24 (s, 3 H). 
6-Methoxy-2,3-dihydroquinolin-4(1H)-one (3c). Following the procedure described above 
for the synthesis of compound 1b, 2.46 g (20 mmol) of p-anisidine, 2.5 mL (24 mmol) of 
3-bromopropanoyl chloride, and 1.62 g (17 mmol) of sodium tert-butoxide were employed to 
obtain 2.3 g of N-(4-methoxyphenyl)azetidin-2-one. Next, 1.77 g (10 mmol) of 
N-(4-methoxyphenyl)azetidin-2-one was treated with 2 mL (22 mmol) of TfOH as described 
above to yield 1.28 g (47% overall yield from 4-methoxyaniline) of dihydroquinolinone 3c as a 
yellow solid: mp 110-112 ºC (lit16 113-114 ºC); 1H NMR (400 MHz, CDCl3) δ 7.32 (d, J = 2.8 Hz, 
1 H), 6.98 (dd, J = 8.8, 2.8 Hz, 1 H), 6.64 (d, J = 8.8 Hz, 1 H), 4.17 (s, 1 H), 3.77 (s, 3 H), 3.54 (t, 
J = 6.0 Hz, 2 H), 2.69 (t, J = 6.0 Hz, 2 H). 
6-Chloro-2,3-dihydroquinolin-4(1H)-one (3d). Following the procedure described above for 
the synthesis of compound 1b, 2.55 g (20 mmol) of 4-chloroaniline, 2.5 mL (24 mmol) of 
3-bromopropanoyl chloride, and 1.57 g (16.5 mmol) of sodium tert-butoxide were employed to 
obtain 2.18 g of N-(4-chlorophenyl)azetidin-2-one. Next, 1.82 g (10 mmol) of 
N-(4-chlorophenyl)azetidin-2-one was treated with 2 mL (22 mmol) of TfOH as described above 
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to yield 1.12 g (37% overall yield from 4-chloroaniline) of dihydroquinolinone 3d as a yellow 
solid: mp 123-125 ºC (lit16 125-126 ºC); 1H NMR (300 MHz, CDCl3) δ 7.81 (d, J = 2.7 Hz, 1 H), 
7.23 (dd, J = 8.4, 2.7 Hz, 1 H), 6.63 (d, J = 8.4 Hz, 1 H), 4.40 (s, 1 H), 3.58 (td, J = 7.8, 1.5 Hz, 2 H), 
2.69 (t, J = 7.5 Hz, 2 H). 
N-Substituted 2,3-Dihydroquinolin-4-ones. Compound 3a’ was commercially available and 
used as received. The other N-substituted dihydroquinolinones were prepared as follows. 
1-Methyl-2,3-dihydroquinolin-4(1H)-one (3f). To an oven-dried vial was added 0.367 g (2.5 
mmol) of 2,3-dihydroquinolin-4(1H)-one (3a) and 5 mL of DMF, followed by 0.15 g (3.75 mmol, 
60% dispersed in mineral oil) of NaH. The mixture was stirred under a N2 atmosphere at room 
temperature for 2 h, and charged with 0.31 mL (5 mmol) of MeI. The vial was then capped and 
heated in an 80 ºC oil bath for 12 h. After being quenched with water, the mixture was extracted 
with EtOAc three times. The combined organic layers were washed with brine, dried over Na2SO4, 
filtered, and concentrated. The residue was purified by column chromatography (2:1 petroleum 
ether/EtOAc) to afford 0.173 g (1.07 mmol, 43% yield) of dihydroquinolinone 3f as a yellow oil: 
1H NMR (400 MHz, CDCl3) δ 7.90 (dd, J = 8.0, 1.2 Hz, 1 H), 7.40 (td, J = 4.4, 1.6 Hz, 1 H), 
6.77-6.70 (m, 2 H), 3.47 (t, J = 7.2 Hz, 2 H), 2.99 (s, 3 H), 2.74 (t, J = 7.2 Hz, 2 H). 
1,6-Dimethyl-2,3-dihydroquinolin-4(1H)-one (3g). The above procedure used for the 
synthesis of dihydroquinolinone 3f was applied to 0.402 g (2.5 mmol) of dihydroquinolinone 3b, 
0.15 g (3.75 mmol,) of NaH, followed by 0.31 mL (5 mmol) of MeI to afford 0.197 g (45% overall 
yield) of compound 3g as a yellow oil: 1H NMR (400 MHz, CDCl3) δ 7.72 (s, 1 H), 7.23 (dd, J = 
8.0, 1.2 Hz, 1 H), 6.65 (d, J = 7.6 Hz, 1 H), 3.42 (t, J = 7.2 Hz, 2 H), 2.95 (s, 3 H), 2.72 (t, J = 7.2 
Hz, 2 H), 2.25 (s, 3 H). 
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6-Methoxy-1-methyl-2,3-dihydroquinolin-4(1H)-one (3h). The above procedure used to 
synthesize compound 3f was applied to 0.442 g (2.5 mmol) of dihydroquinolinone 3c, 0.15 g (3.75 
mmol) of NaH, followed by 0.31 mL (5 mmol) of MeI to afford 0.205 g (43% overall yield) of 
compound 3h as a yellow oil: 1H NMR (300 MHz, CDCl3) δ 7.41 (d, J = 2.4 Hz, 1 H), 7.07 (dd, J 
= 8.1, 2.4 Hz, 1 H), 6.70 (d, J = 8.1 Hz, 1 H), 3.79 (s, 3 H), 3.39 (t, J = 7.5 Hz, 2 H), 2.94 (s, 3 H), 
2.73 (t, J = 7.5 Hz, 2 H). 
6-Chloro-1-methyl-2,3-dihydroquinolin-4(1H)-one (3i). The above procedure used to 
synthesize compound 3f was applied to 0.454 g (2.5 mmol) of dihydroquinolinone 3d, 0.15 g (3.75 
mmol) of NaH, followed by 0.31 mL (5 mmol) of MeI to afford 0.200 g (41% overall yield) of 
compound 3i as a yellow oil: 1H NMR (300 MHz, CDCl3) δ 7.83 (d, J = 2.7 Hz, 1 H), 7.31 (dd, J = 
9.0, 2.7 Hz, 1 H), 6.65 (d, J = 9.0 Hz, 1 H), 3.46 (t, J = 7.2 Hz, 2 H), 2.97 (s, 3 H), 2.72 (t, J = 7.2 
Hz, 2 H). 
1-Allyl-2,3-dihydroquinolin-4(1H)-one (3j). The above procedure used to synthesize 
compound 3f was applied to 0.367 g (2.5 mmol) of dihydroquinolinone 3a, 0.15 g (3.75 mmol) of 
NaH, followed by 0.605 g (5 mmol) of allyl bromide to afford 0.182 g (39% overall yield) of 
compound 3i as a yellow oil: 1H NMR (400 MHz, CDCl3) δ 7.90 (dd, J = 8.0, 1.6 Hz, 1 H), 7.36 (td, 
J = 4.4, 1.6 Hz, 1 H), 6.73-6.70 (m, 2 H), 5.90-5.82 (m, 1 H), 5.28-5.20 (m, 2 H), 3.99 (d, J = 5.2 
Hz, 2 H), 3.52 (t, J = 7.2 Hz, 2 H), 2.72 (t, J = 7.2 Hz, 2 H). 
3-Methyloxazolidin-2-one (5). This compound was commercially available and used as 
received. 
General procedures for aryne reactions affording acridones.  
Compounds 4a through 4d were prepared according to the following procedure (representative 
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procedure for β-lactams where 3.5 equiv of arynes were used): to an oven-dried vial was added 
0.875 mmol of aryne precursor, 0.25 mmol of β-lactam, 4 mL of MeCN, and 0.266 g (1.75 mmol) 
of CsF sequentially. A nitrogen atmosphere was not required, except that a balloon of nitrogen was 
attached to the reaction vial for the ventilation of ethylene. The reaction was allowed to stir for 24 
h before being quenched with aq. Na2CO3 and extracted with EtOAc. The combined organic layers 
were washed with brine, dried over Na2SO4, filtered, and concentrated. The residue was purified 
by column chromatography (petroleum ether/ EtOAc) to afford the desired products. 
10-Phenylacridin-9(10H)-one (4a). The representative procedure was employed to afford 33.9 
mg (0.13 mmol, 50% yield) of 4a as a yellow solid: mp 271-273 ºC (lit19 276 ºC); Rf = 0.38 (2:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.58 (dd, J = 8.0, 1.2 Hz, 2 H), 7.71 (t, J = 
8.0 Hz, 2 H), 7.65 (t, J = 8.0 Hz, 1 H), 7.49 (td, J = 8.0, 1.6 Hz, 2 H), 7.37 (d, J = 7.6 Hz, 2 H), 7.27 
(t, J = 8.0 Hz, 2 H), 6.75 (d, J = 8.4 Hz, 2 H); 13C NMR (75 MHz, CDCl3) δ 178.3, 143.3, 139.2, 
133.4, 131.3, 130.2, 129.8, 127.5, 122.0, 121.7, 117.0; HRMS (APCI) calcd for C19H14NO (M+H) 
272.1070, found 272.1076. 
10-(3,4-Dimethylphenyl)-2,3,6,7-tetramethylacridin-9(10H)-one (4b). The representative 
procedure was employed to afford 39.9 mg (0.11 mmol, 45% yield) of 4b as a yellow solid: mp 
306-308 ºC; Rf = 0.37 (2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.31 (s, 2 H), 
7.42 (d, J = 8.0 Hz, 1 H), 7.06-7.04 (m, 2 H), 6.53 (s, 2 H), 2.45 (s, 3 H), 2.37 (s, 3 H), 2.35 (s, 6 H), 
2.23 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 177.7, 143.2, 141.9, 140.0, 138.1, 137.0, 132.0, 130.8, 
130.4, 127.3, 127.0, 120.2, 117.3, 21.0, 20.2, 19.9, 19.3; HRMS (ESI) calcd for C25H26NO (M+H) 
356.2009, found 356.2012. 
10-(3,4-Dimethoxyphenyl)-2,3,6,7-tetramethoxyacridin-9(10H)-one (4c). The 
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representative procedure was employed to afford 45.1 mg (0.10 mmol, 40% yield) of 4c as a brown 
solid: mp 256-257 ºC; Rf = 0.25 (2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.92 
(s, 2 H), 7.14 (d, J = 8.0 Hz, 1 H), 6.98 (dd, J = 8.0, 1.2 Hz, 1 H), 6.85 (d, J = 1.6 Hz, 1 H), 6.18 (s, 
2 H), 4.04 (s, 3 H), 4.01 (s, 6 H), 3.87 (s, 3 H), 3.68 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 175.2, 
154.0, 151.0, 149.9, 145.7, 139.2, 132.0, 122.3, 115.4, 112.4, 112.3, 106.4, 98.4, 56.51, 56.49, 56.3, 
56.1; HRMS (ESI) calcd for C25H26NO7 (M+H) 452.1704, found 452.1708. 
1,8-Dimethoxy-10-(3-methoxyphenyl)acridin-9(10H)-one (4d). The representative 
procedure was employed to afford 74.9 mg (0.21 mmol, 83% yield) of 4d as a brown solid: mp 
250-253 ºC; Rf = 0.11 (pure EtOAc); 1H NMR (400 MHz, acetone-d6) δ 7.65 (t, J = 8.0 Hz, 1 H), 
7.39 (t, J = 8.4 Hz, 2 H), 7.25 (d, J = 8.0 Hz, 1 H), 6.96-6.94 (m, 2 H), 6.79 (d, J = 8.4 Hz, 2 H), 
6.27 (d, J = 8.4 Hz, 2 H), 3.96 (s, 6 H), 3.87 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 179.2, 163.1, 
161.6, 145.7, 142.1, 134.1, 123.7, 122.8, 120.6, 116.4, 115.0, 110.0, 104.8, 57.1, 56.3; HRMS (ESI) 
calcd for C22H20NO4 (M+H) 362.1387, found 362.1389. 
Compounds 4f through 4n were prepared according to the following procedure (representative 
procedure for N-substituted β-lactams/N-unsubstituted 2,3-dihydroquinolin-4-ones where 2.4 
equiv of arynes were used): the general procedure used above for the synthesis of compound 4a 
was applied to 0.6 mmol of aryne precursor, 0.25 mmol of N-substituted β-lactam/N-unsubstituted 
2,3-dihydroquinolin-4-one starting material, 4 mL of MeCN, and 0.182 g (1.2 mmol) of CsF to 
afford the desired products. 
10-Benzylacridin-9(10H)-one (4f). The representative procedure was employed to afford 9.3 
mg (0.03 mmol, 13% yield) of 4f as a brown solid: mp 178-180 ºC (lit20 176-179 ºC); Rf = 0.37 (2:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.60 (dd, J = 8.0, 1.2 Hz, 2 H), 7.64 (td, J 
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= 8.0, 1.6 Hz, 2 H), 7.38-7.15 (m, 9 H), 5.61 (s, 2 H); 13C NMR (100 MHz, CDCl3) δ 178.5, 142.8, 
135.7, 134.3, 129.5, 128.1, 125.9, 122.8, 121.9, 115.4, 109.5, 51.1; HRMS (ESI) calcd for 
C20H16NO (M+H) 286.1226, found 286.1229. 
2-Methyl-10-phenylacridin-9(10H)-one (4g). The representative procedure was employed to 
afford 62.7 mg (0.22 mmol, 88% yield) of 4g as a yellow solid: mp 220-221 ºC; Rf = 0.38 (2:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.57 (d, J = 7.2 Hz, 1 H), 8.36 (s, 1 H), 
7.71-7.63 (m, 3 H), 7.46 (t, J = 7.6 Hz, 1 H), 7.35-7.29 (m, 3 H), 7.23 (t, J = 7.6 Hz, 1 H), 6.73 (d, 
J = 8.8 Hz, 1 H), 6.66 (d, J = 8.4 Hz, 1 H), 2.44 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.1, 
143.1, 141.4, 139.2, 134.9, 133.2, 131.3, 131.2, 130.2, 129.6, 127.4, 126.6, 121.82, 121.77, 121.4, 
116.9, 116.8, 20.9; HRMS (ESI) calcd for C20H16NO (M+H) 286.1226, found 286.1233. 
2-Methoxy-10-phenylacridin-9(10H)-one (4h). The representative procedure was employed 
to afford 56.4 mg (0.19 mmol, 75% yield) of 4h as a yellow solid: mp 158-159 ºC; Rf = 0.24 (2:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.58 (d, J = 7.2 Hz, 1 H), 7.96 (d, J = 1.2 
Hz, 1 H), 7.69-7.63 (m, 3 H), 7.47 (t, J = 7.6 Hz, 1 H), 7.36 (d, J = 8.8 Hz, 2 H), 7.24 (d, J = 7.6 Hz, 
1 H), 7.13 (dd, J = 7.6, 1.2 Hz, 1 H), 6.76 (d, J = 8.4 Hz, 1 H), 6.72 (d, J = 8.4 Hz, 1 H), 3.93 (s, 3 
H); 13C NMR (100 MHz, CDCl3) δ 177.7, 154.8, 142.8, 139.2, 138.2, 133.1, 131.2, 130.2, 129.7, 
127.3, 124.2, 122.5, 121.4, 121.2, 118.7, 116.8, 106.2, 56.0; HRMS (ESI) calcd for C20H16NO2 
(M+H) 302.1176, found 302.1182. 
2-Chloro-10-phenylacridin-9(10H)-one (4i). The representative procedure was employed to 
afford 61.1 mg (0.20 mmol, 80% yield) of 4i as a yellow solid: mp 228-230 ºC (lit21 229-230 ºC); 
Rf = 0.45 (2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.52 (d, J = 8.4 Hz, 1 H), 
8.49 (d, J = 2.8 Hz, 1 H), 7.73-7.67 (m, 3 H), 7.51 (td, J = 8.0, 1.2 Hz, 1 H), 7.42-7.37 (m, 3 H), 
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7.26 (t, J = 7.6 Hz, 1 H), 6.76 (d, J = 8.4 Hz, 1 H), 6.71 (d, J = 8.4 Hz, 1 H); 13C NMR (100 MHz, 
CDCl3) δ 177.1, 143.2, 141.7, 138.8, 133.7, 133.5, 131.4, 130.0, 127.6, 127.4, 126.5, 122.7, 122.1, 
121.8, 118.8, 117.6, 117.1; HRMS (ESI) calcd for C19H13ClNO (M+H) 306.0680, found 306.0688. 
10-(3,4-Dimethylphenyl)-2,3-dimethylacridin-9(10H)-one (4k). The representative 
procedure was employed to afford 59.8 mg (0.18 mmol, 73% yield) of 4k as a yellow solid: mp 
245-247 ºC; Rf = 0.37 (2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.56 (d, J = 8.0 
Hz, 1 H), 8.31 (s, 1 H), 7.46-7.41 (m, 2 H), 7.21 (t, J = 8.0 Hz, 1 H), 7.08-7.05 (m, 2 H), 6.77 (d, J 
= 8.4 Hz, 1 H), 6.58 (s, 1 H), 2.43 (s, 3 H), 2.36 (s, 3 H), 2.35 (s, 3 H), 2.23 (s, 3 H); 13C NMR (100 
MHz, CDCl3) δ 177.9, 143.7, 143.3, 142.0, 139.8, 138.2, 136.8, 132.8, 132.0, 130.8, 127.3, 127.2, 
127.0, 121.9, 121.1, 120.0, 117.4, 117.3, 117.0, 20.9, 20.1, 19.9, 19.3; HRMS (ESI) calcd for 
C23H22NO (M+H) 328.1696, found 328.1704. 
10-(3,4-Dimethoxyphenyl)-2,3-dimethoxyacridin-9(10H)-one (4l). The representative 
procedure was employed to afford 83.2 mg (0.21 mmol, 85% yield) of 4l as a yellow solid: mp 
234-235 ºC; Rf = 0.62 (pure EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.51 (dd, J = 8.0, 1.2 Hz, 1 H), 
7.86 (s, 1 H), 7.43 (td, J = 8.0, 1.2 Hz, 1 H), 7.21 (t, J = 8.0 Hz, 1 H), 7.11 (d, J = 8.4 Hz, 1 H), 6.95 
(dd, J = 8.4, 1.6 Hz, 1 H), 6.84 (d, J = 1.6 Hz, 1 H), 6.79 (d, J = 8.8 Hz, 1 H), 6.18 (s, 1 H), 4.00 (s, 
3 H), 3.95 (s, 3 H), 3.86 (s, 3 H), 3.66 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 176.5, 154.5, 151.0, 
149.8, 145.7, 143.0, 139.7, 132.5, 131.7, 127.0, 122.2, 121.4, 121.3, 116.8, 115.7, 112.5, 112.4, 
106.4, 98.5, 56.4, 56.32, 56.28, 56.0; HRMS (ESI) calcd for C23H22NO5 (M+H) 392.1492, found 
392.1490. 
5-(2,3-Dihydro-1H-inden-5-yl)-2,3-dihydro-1H-cyclopenta[b]acridin-10(5H)-one (4m). 
The representative procedure was employed to afford 60.6 mg (0.17 mmol, 69% yield) of 4m as a 
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yellow solid: mp 176-178 ºC; Rf = 0.48 (2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) 
δ 8.57 (d, J = 8.0 Hz, 1 H), 8.41 (s, 1 H), 7.51-7.43 (m, 2 H), 7.24-7.21 (m, 1 H), 7.15 (s, 1 H), 7.07 
(d, J = 8.0 Hz, 1 H), 6.79 (d, J = 8.0 Hz, 1 H), 6.66 (s, 1 H), 3.10-2.98 (m, 6 H), 2.87 (t, J = 7.6 Hz, 
2 H), 2.24 (t, J = 7.6 Hz, 2 H), 2.08 (t, J = 7.6 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 178.2, 151.5, 
147.6, 145.8, 143.4, 142.9, 138.5, 137.5, 132.8, 127.7, 127.3, 126.6, 125.9, 121.9, 121.8, 121.1, 
121.0, 117.1, 112.4, 33.8, 33.2, 33.0, 32.0, 26.0, 25.8; HRMS (ESI) calcd for C25H22NO (M+H) 
352.1696, found 352.1705. 
1-Methoxy-10-(3-methoxyphenyl)acridin-9(10H)-one (4n). The representative procedure 
was employed to afford 74.6 mg (0.22 mmol, 90% yield) of 4n as a pale white solid: mp 221-222 
ºC; Rf = 0.52 (2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.52 (d, J = 7.6 Hz, 1 H), 
7.56 (t, J = 8.0 Hz, 1 H), 7.41 (t, J = 7.6 Hz, 1 H), 7.32 (t, J = 8.4 Hz, 1 H), 7.20 (t, J = 7.2 Hz, 1 H), 
7.13 (d, J = 8.0 Hz, 1 H), 6.91 (d, J = 7.2 Hz, 1 H), 6.84 (s, 1 H), 6.66 (t, J = 9.6 Hz, 2 H), 6.33 (d, 
J = 8.4 Hz, 1 H), 4.01 (s, 3 H), 3.82 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 177.9, 161.9, 161.6, 
145.7, 142.2, 140.7, 133.4, 132.8, 131.8, 127.4, 123.6, 122.0, 121.7, 116.5, 115.5, 115.3, 112.7, 
109.3, 102.9, 56.4, 55.7; HRMS (ESI) calcd for C21H18NO3 (M+H) 332.1281, found 332.1285. 
Compounds 4e, 4o through 4r, and the inseparable mixtures of 4s + 4s’ and 4t + 4t’ were 
prepared according to the following procedure (representative procedure for N-substituted 
2,3-dihydroquinolin-4-ones where 1.2 equiv of arynes were used): the general procedure used 
above for the synthesis of acridone 4a was applied to 0.3 mmol of aryne precursor, 0.25 mmol of 
N-substituted 2,3-dihydroquinolin-4-one, 4 mL of MeCN, and 0.091 g (0.6 mmol) of CsF to afford 
the desired product. 
10-Allylacridin-9(10H)-one (4e). The representative procedure was employed to afford 28.2 
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mg (0.12 mmol, 48% yield) of 4e as a yellow solid: mp 131-132 ºC (lit22 132-134 ºC); Rf = 0.36 
(2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.55 (d, J = 7.6 Hz, 2 H), 7.69 (t, J = 
7.6 Hz, 2 H), 7.39 (d, J = 8.8 Hz, 2 H), 7.28 (t, J = 7.6 Hz, 2 H), 6.18-6.09 (m, 1 H), 5.31 (d, J = 
10.8 Hz, 1 H), 5.10 (d, J = 17.2 Hz, 1 H), 4.96 (s, 2 H); 13C NMR (100 MHz, CDCl3) δ 178.4, 142.4, 
134.1, 130.8, 127.6, 122.7, 121.4, 117.6, 115.2, 49.5; HRMS (ESI) calcd for C16H14NO (M+H) 
236.1070, found 236.1067. 
10-Methylacridin-9(10H)-one (4o). The representative procedure was employed to afford 32.9 
mg (0.16 mmol, 63% yield) of 4o as a yellow solid: mp 201-203 ºC (lit23 201-203 ºC); Rf = 0.22 
(2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.53 (d, J = 7.2 Hz, 2 H), 7.68 (t, J = 
6.4 Hz, 2 H), 7.46 (d, J = 8.0 Hz, 2 H), 7.25 (t, J = 6.4 Hz, 2 H), 3.82 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 178.2, 142.7, 133.9, 127.9, 122.6, 121.4, 114.9, 33.8; HRMS (ESI) calcd for C14H12NO 
(M+H) 210.0913, found 210.0918. 
2,10-Dimethylacridin-9(10H)-one (4p). The representative procedure was employed to afford 
34.6 mg (0.16 mmol, 62% yield) of 4p as a yellow solid: mp 149-151 ºC (lit24 153 ºC); Rf = 0.25 
(2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.53 (d, J = 8.0 Hz, 1 H), 8.31 (s, 1 H), 
7.66 (t, J = 7.2 Hz, 1 H), 7.49-7.43 (m, 2 H), 7.36 (d, J = 8.8 Hz, 1 H), 7.22 (d, J = 7.6 Hz, 1 H), 
3.80 (s, 3 H), 2.44 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 178.1, 142.6, 140.8, 135.3, 133.7, 131.0, 
127.9, 127.2, 122.6, 122.5, 121.1, 114.9, 114.8, 33.7, 20.8; HRMS (ESI) calcd for C15H14NO 
(M+H) 224.1070, found 224.1075. 
2-Methoxy-10-methylacridin-9(10H)-one (4q). The representative procedure was employed 
to afford 32.9 mg (0.14 mmol, 55% yield) of 4q as a yellow solid: mp 139-141 ºC (lit25 138 ºC); Rf 
= 0.12 (2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.54 (d, J = 8.0 Hz, 1 H), 7.92 
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(d, J = 2.8 Hz, 1 H), 7.66 (td, J = 7.6, 1.2 Hz, 1 H), 7.46-7.42 (m, 2 H), 7.31 (dd, J = 9.2, 3.2 Hz, 1 
H), 7.23 (d, J = 7.6 Hz, 1 H), 3.92 (s, 3 H), 3.82 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 177.6, 
154.5, 142.2, 137.5, 133.7, 127.9, 124.5, 123.3, 121.9, 121.0, 116.7, 114.8, 106.8, 55.9, 33.8; 
HRMS (ESI) calcd for C15H14NO2 (M+H) 240.1019, found 240.1021. 
2-Chloro-10-methylacridin-9(10H)-one (4r). The representative procedure was employed to 
afford 30.5 mg (0.13 mmol, 50% yield) of 4r as a yellow solid: mp 171-173 ºC; Rf = 0.21 (2:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.44 (d, J = 7.6 Hz, 1 H), 8.39 (s, 1 H), 
7.68 (t, J = 8.0 Hz, 1 H), 7.53 (dd, J = 9.2, 2.0 Hz, 1 H), 7.43 (d, J = 8.8 Hz, 1 H), 7.36 (d, J = 9.2 
Hz, 1 H), 7.23 (d, J = 7.2 Hz, 1 H), 3.79 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 177.0, 142.4, 
140.9, 134.2, 133.8, 127.8, 127.3, 126.8, 123.3, 122.4, 121.7, 116.7, 115.0, 34.0; HRMS (ESI) 
calcd for C14H11ClNO (M+H) 244.0524, found 244.0523. 
2,10-Dimethylacridin-9(10H)-one and 3,10-dimethylacridin-9(10H)-one (4s + 4s’). The 
representative procedure was employed to afford 31.8 mg (0.14 mmol, 57% total yield) of 4s + 4s’ 
as a yellow solid: Rf = 0.25 (2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.54-8.51 
(m, 2 H), 8.39 (d, J = 8.0 Hz, 1 H), 8.30 (s, 1 H), 7.65 (t, J = 7.6 Hz, 2 H), 7.47 (dd, J = 8.4, 2.0 Hz, 
1 H), 7.43 (d, J = 8.8 Hz, 2 H), 7.35 (d, J = 8.8 Hz, 1 H), 7.22 (d, J = 10.0 Hz, 3 H), 7.05 (d, J = 8.0 
Hz, 1 H), 3.79 (s, 3 H), 3 78 (s, 3 H), 2.48 (s, 3 H), 2.43 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 
178.1, 177.9, 144.8, 142.8, 142.7, 142.6, 140.8, 135.3, 133.7, 131.0, 127.8, 127.4, 123.1, 123.0, 
122.7, 122.6, 122.5, 121.2, 121.0, 120.7, 114.85, 114.82, 33.73, 33.71, 22.8, 20.8; HRMS (ESI) 
calcd for C15H14NO (M+H) 224.1070, found 224.1072. 
2-Methoxy-10-methylacridin-9(10H)-one and 3-methoxy-10-methylacridin-9(10H)-one 
(4t + 4t’). The representative procedure was employed to afford 35.9 mg (0.15 mmol, 60% total 
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yield) of 4t + 4t’ as a yellow solid: Rf = 0.18 (2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, 
CDCl3) δ 8.53 (d, J = 8.0 Hz, 1 H), 8.49 (d, J = 7.6 Hz, 0.5 H), 8.43 (d, J = 8.8 Hz, 0.5 H), 7.91 (d, 
J = 2.8 Hz, 1 H), 7.67-7.61 (m, 1.5 H), 7.44-7.38 (m, 2.5 H), 7.30 (dd, J = 9.2, 3.2 Hz, 1 H), 
7.25-7.21 (m, 1.5 H), 6.81 (dd, J = 8.8, 2.0 Hz, 0.5 H), 6.72 (s, 0.5 H), 3.91 (s, 3 H), 3.90 (s, 1.5 H), 
3.81 (s, 3 H), 3.72 (s, 1.5 H); 13C NMR (100 MHz, CDCl3) δ 177.6, 177.2, 164.3, 154.5, 144.5, 
142.8, 142.2, 137.5, 133.6, 133.4, 127.8, 124.5, 124.4, 123.2, 122.7, 121.8, 121.0, 117.2, 116.7, 
114.7, 106.8, 98.0, 56.0, 55.7, 33.9, 33.8; HRMS (ESI) calcd for C15H14NO2 (M+H) 240.1019, 
found 240.1020. 
3.6. Acknowledgment  
We thank the National Science Foundation, the National Institutes of Health Center of 
Excellence for Chemical Methodology and Library Development at the University of Kansas (P50 
GM069663) (both to R.C.L.), the National Natural Science Foundation of China (No. 21002021), 
and the Ministry of Education of China (Scientific Research Foundation for the Returned Overseas 
Chinese Scholars) (both to F.S.) for financial support. Dr. Hung-An Ho and Dr. Kermal Harrata 
(both at Iowa State University) are acknowledged for their help in the spectroscopic analysis. 
3.7. References  
1. (a) Wittig, G. Naturwissenschaften 1942, 30, 696. (b) For a review, see: Sander, W. Acc. Chem. 
Res. 1999, 32, 669. 
2. Roberts, J. D.; Semenow, D. A.; Simmons, H. E., Jr.; Carlsmith, L. A. J. Am. Chem. Soc. 1956, 
78, 601. 
3. (a) Himeshima, Y.; Sonoda, T.; Kobayashi, H. Chem. Lett. 1983, 1211. (b) For the recent 
65 
development of functionalized aryne precursors, see: Kirkham, J. D.; Delaney, P. M.; Ellames, 
G. J.; Row, E. C.; Harrity, J. P. A. Chem. Commun. 2010, 46, 5154. 
4. (a) Liu, Z.; Larock, R. C. Org. Lett. 2003, 5, 4673. (b) Liu, Z.; Larock, R. C. Org. Lett. 2004, 
6, 99. (c) Liu, Z.; Larock, R. C. J. Org. Chem. 2006, 71, 3198. 
5. (a) Dubrovskiy, A. V.; Larock, R. C. Org. Lett. 2010, 12, 3117. (b) Ła̧czkowski, K. Z.; García, 
D.; Peña, D.; Cobas, A.; Pérez, D.; Guitián, E. Org. Lett. 2011, 13, 960. (c) Yoshioka, E.; 
Kohtani, S.; Miyabe, H. Org. Lett. 2010, 12, 1956. (d) Yoshida, H.; Watanabe, M.; Morishita, 
T.; Ohshita, J.; Kunai, A. Chem. Commun. 2007, 1505. (e) Yoshida, H.; Mimura, Y.; Ohshita, 
J.; Kunai, A. Chem. Commun. 2007, 2405. (f) Yoshida, H.; Ito, Y.; Yoshikawa, Y.; Ohshita, J.; 
Takaki, K. Chem. Commun. 2011, 47, 8664. (g) Liu, Y.-L.; Liang, Y.; Pi, S.-F.; Li, J.-H. J. Org. 
Chem. 2009, 74, 5691. (h) Biswas, K.; Greaney, M. F. Org. Lett. 2011, 13, 4946. (i) Pintori, D. 
G.; Greaney, M. F. Org. Lett. 2010, 12, 168. (j) Huang, X.; Xue, J. J. Org. Chem. 2007, 72, 
3965. (k) For a recent review, see: Peña, D.; Pérez, D.; Guitián, E. Angew. Chem., Int. Ed. 
2006, 45, 3579. 
6. Haber, J. C.; Lynch, M. A.; Spring, S. L.; Pechulis, A. D.; Raker, J.; Wang, Y. Tetrahedron Lett. 
2011, 52, 5847. 
7. Liu, Z.; Larock, R. C. J. Am. Chem. Soc. 2005, 127, 13112. 
8. Yoshida, H.; Shirakawa, E.; Honda, Y.; Hiyama, T. Angew. Chem., Int. Ed. 2002, 41, 3247. 
9. (a) Yoshioka, E.; Miyabe, H. Tetrahedron 2012, 68, 179. (b) Yoshioka, E.; Kohtani, S.; 
Miyabe, H. Angew. Chem., Int. Ed. 2011, 50, 6638. (c) Yoshida, H.; Ito, Y.; Ohshita, J. Chem. 
Commun. 2011, 47, 8512. 
10. For a recent review, see: Szostak, M.; Aubé, J. Org. Biomol. Chem. 2011, 9, 27. 
66 
11. For a similar study of aryne reactions with epoxides, leading to ring opening, see: 
Beltrán-Rodil, S.; Peña, D.; Guitián, E. Synlett 2007, 8, 1308. 
12. (a) Mucsi, Z.; Tsai, A.; Szori, M.; Chass, G. A.; Viskolcz, B.; Csizmadia, I. G. J. Phys. Chem. 
A 2007, 111, 13245. (b) Mucsi, Z.; Chass, G. A.; Viskolcz, B.; Csizmadia, I. G. J. Phys. Chem. 
A 2008, 112, 9153. (c) Deuri, S.; Phukan, P. Comput. Theor. Chem. 2012, 980, 49. 
13. For aryne processes with a loss of small molecules, see: (a) Wu, C.; Fang, Y.; Larock, R. C.; 
Shi, F. Org. Lett. 2010, 12, 2234. (b) Fang, Y.; Wu, C.; Larock, R. C.; Shi, F. J. Org. Chem. 
2011, 76, 8840. (c) McAusland, D.; Seo, S.; Pintori, D. G.; Finlayson, J.; Greaney, M. F. Org. 
Lett. 2011, 13, 3667. (d) Xie, C.; Zhang, Y. Org. Lett. 2007, 9, 781. (e) Lee, Y.-H.; Chen, 
Y.-C.; Hsieh, J.-C. Eur. J. Org. Chem. 2012, 247.  
14. Tadross, P. M.; Gilmore, C. D.; Bugga, P.; Virgil, S. C.; Stoltz, B. M. Org. Lett. 2010, 12, 
1224. 
15. Schmidt, R. G.; Bayburt, E. K.; Latshaw, S. P.; Koenig, J. R.; Daanen, J. F.; McDonald, H. A.; 
Bianchi, B. R.; Zhong, C.; Joshi, S.; Honore, P.; Marsh, K. C.; Lee, C.-H.; Faltynek, C. R.; 
Gomtsyan, A. Bioorg. Med. Chem. Lett. 2011, 21, 1338. 
16. Lange, J.; Bissember, A. C.; Banwell, M. G.; Cade, I. A. Aust. J. Chem. 2011, 64, 454. 
17. Urbach, A.; Muccioli, G. G.; Stern, E.; Lambert, D. M.; Marchand-Brynaert, J. Bioorg. Med. 
Chem. Lett. 2008, 18, 4163. 
18. (a) Anderson, K. W.; Tepe, J. J. Tetrahedron 2002, 58, 8475. (b) Anderson, K. W.; Tepe, J. J. 
Org. Lett. 2002, 4, 459. (c) Hu, Y.; Fu, X.; Barry, B.-D.; Bi, X.; Dong, D. Chem. Commun. 
2012, 48, 690. 
19. Kosolapoff, G. M.; Schoepfle, C. S. J. Am. Chem. Soc. 1954, 76, 1276. 
67 
20. Coppola, G. M.; Schuster, H. F. J. Heterocyclic Chem. 1989, 26, 957. 
21. Gomberg, M.; Tabern, D. L. J. Am. Chem. Soc. 1926, 48, 1345. 
22. Lin, Y.-C.; Chen, C.-T. Org. Lett. 2009, 11, 4858. 
23. Dubrovskiy, A. V.; Larock, R. C. Org. Lett. 2011, 13, 4136. 
24. Storoniak, P.; Krzyminski, K.; Bouzyk, A.; Koval'chuk, E. P.; Blazejowski, J. J. Therm. Anal. 
Calorim. 2003, 74, 443. 
25. Blanchard, C.; Fabre, J. M.; Montginoul, C.; Chaffia, B. A.; Torreilles, E.; Giral, L. J. 
Heterocyclic Chem. 1978, 15, 149. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
68 
CHAPTER 4 
Synthesis of 2H-Indazoles by the [ 3 + 2 ] Dipolar Cycloaddition of Sydnones with Arynes 
Reprinted with permission from J. Org. Chem. 2011, 76, 8840, Copyright (2011) American 
Chemical Society. 
Yuesi Fang,† Chunrui Wu,*,‡ Richard C. Larock,*,† and Feng Shi*,‡ 
†Department of Chemistry, Iowa State University, Ames, IA 50011, U.S.A. 
‡Key Laboratory of Natural Medicine and Immuno-Engineering of Henan Province, Henan 
University, Jinming Campus, Kaifeng, Henan 475004, China PR 
 
4.1. Abstract  
 
A rapid and efficient synthesis of 2H-indazoles has been developed using a [3 + 2] dipolar 
cycloaddition of sydnones and arynes. A series of 2H-indazoles have been prepared in good to 
excellent yields using this protocol, and subsequent Pd-catalyzed coupling reactions can be 
applied to the halogenated products to generate a structurally diverse library of indazoles.    
4.2. Introduction  
The synthesis of heterocyclic compounds has attracted significant attention for decades. Among 
the various heterocycles, the indazole system has received significant attention due to its diverse 
bioactivity.1 Although a number of methods for the preparation of indazoles are known, most 
methods target 1H-indazoles. Those focused on the selective and efficient preparation of 
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2H-indazoles, which also appear to have pharmaceutical promise,2  remain limited. Recently, 
significant efforts have been devoted to the development of synthetic routes towards 
2H-indazoles,3 as highlighted by the elegant chemistry developed by Halland (eq 1)3a and Song (eq 
2).3b However, it should be noted that most of these methods still have significant limitations. Thus, 
new routes are still desirable.  
 
 
Our two groups have extensive ongoing research programs in aryne chemistry directed toward 
biologically important heterocycles, including approaches involving Pd-catalyzed annulation 
reactions,4 electrophilic and nucleophilic reactions,5 inter- or intramolecular annulation reactions,6 
and insertion reactions.7 Aryne dipolar cycloadditions have provided synthetically useful methods 
for the synthesis of benzotriazoles,8 indazoles,9 and benzisoxazoles10 by reactions with azides, 
diazo compounds, and nitrile oxides, respectively.  
For the synthesis of 2H-indazoles, we have previously communicated a [3 + 2] cycloaddition 
approach involving arynes and readily accessible sydnones (eq 3).11 This chemistry, which offers 
very mild reaction conditions, high yields, and no contamination by 1H-indazoles, presumably 
involves an initial [3 + 2] cycloaddition to afford a bicyclic adduct, followed by spontaneous 
extrusion of a molecule of CO2 in a retro-[4 + 2] fashion. Herein, we wish to report the full details 
on this project, and demonstrate its potential application to the construction of a small library 
utilizing palladium-catalyzed cross-couplings of halogenated 2H-indazoles prepared by our 
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methodology. 
 
4.3. Results and Discussion  
Preparation of the sydnones. Sydnones are readily prepared from the corresponding amino 
acids12 by a sequence which involves N-nitrosation/cyclodehydration. Three different protocols, 
namely Protocol 1A [1.5 equiv of NaNO2, 0 ºC, 1 h, then acidify], Protocol 1B [2.0 equiv of 
NaNO2, HCl, then  0 ºC, 1 h], and Protocol 1C [1.5 equiv of i-amyl nitrite, DME, rt, 2 d] have 
been used in the nitrosation step, and two other protocols, namely 2A [Ac2O as solvent, 110 ºC, 2 h] 
and 2B [2 equiv of TFAA, Et2O, rt, 2 h] have been used for the cyclodehydration step. A variety of 
sydnones have been synthesized starting from readily available amino acids (Scheme 1, see the 
Experimental Section for details). However, preparation of some sydnones, especially those with 
an alkyl group at the C-4 position have not been successful.  
Scheme 1. Synthesis of Sydnones.  
 
Sydnones not readily derived from amino acids can be accessed by further functionalization of 
preformed monosubstituted sydnones. Thus, arylation and vinylation at the C-4 position of 
sydnones can be achieved from monosubstituted sydnones by Pd-catalyzed cross-coupling with 
aryl or vinylic halides using literature procedures (eq 4).13 Alkynylation at the C-4 position can be 
performed using the same protocol or by oxidative coupling with terminal alkynes (eq 5).14 
Monosubstituted sydnones can also be iodinated15 or acylated16 at the C-4 position by reacting 
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sydnones with ICl buffered with NaOAc/AcOH (eq 6) or acetic anhydride combined with NBS (eq 
7) respectively. 
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Reaction optimization. The reaction of o-(trimethylsilyl)phenyl triflate (1a) and 
N-phenylsydnone (2a) was investigated as the model reaction for optimization (Table 1). In the 
beginning, we found that using CsF in acetonitrile only afforded a 69% yield of 3aa with 
incomplete conversion of 2a, even upon a prolonged reaction time (entry 1). Running the reaction 
in THF led to complete conversion with a much improved 90% yield (entry 2). We quickly found 
that better results and shorter reaction times could be realized by changing the fluoride source from 
CsF to TBAF (entries 3 and 4). With this change, THF and acetonitrile exhibited no apparent 
difference in yields. However, THF is slightly preferred, because it appeared to afford a pure 
product (white vs. yellow in acetonitrile). In addition, when using THF as the solvent, the loadings 
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of both 1a and fluoride could be reduced while maintaining a near quantitative yield (entries 5 and 
6). The reaction provides a clean, spot-to-spot transformation with perhaps only a trace of the 
starting material; no other spots were observed on TLC analysis. This sydnone-aryne 
cycloaddition appears to represent one of the best approaches to 2H-indazoles in terms of 
efficiency and yield. The reaction conditions reported in Table 1, entries 5 and 6, which employ the 
same stoichiometry and concentration, but use of either solid TBAF or a THF solution of TBAF 
afford similar results. Thus, the procedures reported in entries 5 and 6 have been chosen as our 
standard reaction conditions for our study of additional substrates.  
Table 1. Reaction Optimizationa 
TMS
OTf
+
N
N O
O
Ph
N
N Ph
F-
1a 2a 3aa
 
entry 
1a 
(equiv) 
fluoride source 
(equiv) 
solvent 
T (ºC) 
/time (h) yield
b
 (%) 
1 1.5 CsF (2.5) MeCN rt, 36 69c 
2 1.5 CsF (2.5) THF 70, 24 90 
3d 1.5 TBAF (2.5) MeCN rt, 12 95e 
4d 1.5 TBAF (2.5) THF rt, 12 94 
5d 1.2 TBAF (1.5) THF rt, 12 98 
6f 1.2 TBAF (1.5) THF rt, 12 97 
a
 All reactions were carried out on a 0.4 mmol scale at 0.1 M concentration. b Isolated yield. c 
Incomplete conversion of 2a even after 2 days. d Solid anhydrous TBAF was used. e The product is 
significantly yellow, although no apparent impurity was detected by 1H NMR spectroscopy. f A 
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THF solution of TBAF (1 M) was used. 
Scope and limitations. The scope and limitations of our approach to 2H-indazoles have been 
tested, first using a range of structurally diverse sydnones (Table 2). For monosubstituted sydnones 
with an aryl group, the reaction smoothly afforded excellent yields of the corresponding 
2H-indazoles (entries 1-6), with a variety of functional groups tolerated, including halogens 
(entries 2 and 3), and alkyl (entry 4), ether (entry 5), and acetal (entry 6) groups. However, the 
electron deficient N-(4-nitrophenyl)sydnone 2g (entry 7) was found to be unreactive. Even with 
the addition of a second batch of 1.2 equiv of 1a after the first 1.2 equiv of 1a was consumed, 2g 
remained unreacted. N-Alkylsydnones (entries 8 and 9) also worked well under our reaction 
conditions, but in somewhat lower yields.  
With substitution in the C-4 position of the sydnone, we have observed limited success with 
alkyl groups. Except for the proline-derived sydnone 2j (entry 10), which has the 3- and 
4-substitution tethered into a ring, other sydnones were found unstable under our reaction 
conditions and afforded a fairly complex reaction mixture in the end. For example, sydnone 2k 
derived from leucine (entry 11) afforded only a 23% yield with ~10% recovery of the sydnone 
under our standard conditions, and 1.6 equiv of 1a and 2.4 equiv of TBAF had to be employed for 
the full conversion of 2k. On the other hand, sydnones with sp2- or sp- carbon units in the C-4 
position, including a vinyl group (entry 12), different aryl groups varying in their electronics 
(entries 13-16), different heterocyclic groups (entries 17 and 18), and an alkynyl group (entry 19), 
were all tolerated and the desired products were obtained in good to excellent yields, although in 
some cases (entries 18 and 19), incomplete conversion was observed. Successful substitution at the 
C-4 position of the sydnone has been extended to halogens, as illustrated in sydnones 2t and 2u 
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(entries 20 and 21), where 88% and 90% yields have been obtained. However, substitution of other 
electron-withdrawing groups at the C-4 position has not been tolerated. For example, 
4-acetylsydnone 2v was found to be unreactive with benzyne under our standard conditions (entry 
22), leading to complete recovery of the starting sydnone. The adverse effect of 
electron-withdrawing groups has also been observed in entry 13, where a lower yield was 
obtained. 
Table 2. Synthesis of 2H-Indazoles from Benzyne and Sydnonesa 
 
Entr
y 
sydnone Product 
yield
b
 (%) 
entr
y 
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b
 (%) 
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2a 
 
3aa 
98 12 
 
2l 
N
N Ph
 
3al 
79 
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2b 
 
3ab 
95 13 
 
2m 
 
3am 
71 
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2c 
 
3ac 
93 14 
 
2n 
 
3an 
90 
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2d 
 
3ad 
94 15 
 
2o 
 
3ao 
93 
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2e 
 
3ae 
92 16 
 
2p 
 
3ap 
91 
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2f 
 
3af 
91 17 
 
2q 
 
3aq 
~79e 
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2g 
 
3ag 
trace
c
 
18 
 
2r 
 
3ar 
72f 
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2h 
 
3ah 
77 19 
 
2s 
 
3as 
70g 
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2i 
 
3ai 
70 20 
 
2t 
 
3at 
88 
10 
 
2j 
 
3aj 
70 21 
 
2u 
 
3au 
90 
11 N
N O
O
Cl
 
2k 
 
3ak 
63d 22 
 
2v 
 
3av 
n.r.h 
a
  All reactions were carried out on approximately 0.4 mmol of sydnone at a concentration of 0.1 
M. b Isolated yield. c A trace amount of product was detected by GC-MS. Substrate 2g was still 
unreactive upon heating. d This reaction was performed with 1.6 equiv of 1a and 2.4 equiv of 
TBAF. e The reaction afforded a 52% yield of pure 3aq, together with another fraction of impure 
3aq (32% by weight, approximately 80-85% purity) that was very hard to purify. f With 15% 
recovery of 2r. g With 19% recovery of 2s. h With total recovery of 2v, 1a was consumed. Substrate 
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2v was still unreactive upon heating. 
Next, a variety of different aryne precursors have been tested under our optimized reaction 
conditions (Table 3). As can be seen, excellent yields can be achieved regardless of the aryne 
structure. Symmetrical aryne precursors 1b and 1c have been converted to the corresponding 
2H-indazoles 3ba (entry 1) and 3ca (entry 2), respectively in almost quantitative yields. 
Unsymmetrical aryne precursor 1d, which is neither electronically nor sterically biased, afforded 
mixtures of two possible regioisomers in nearly equal amounts (entry 3). Unsymmetrical aryne 
precursor 1e, which is partially biased electronically, led to an inseparable mixture of two isomers 
in a 1 : 0.8 ratio (entry 4). Unsymmetrical aryne precursor 1f, which is slightly biased by sterics, 
led to an inseparable mixture of two isomers in a 1 : 0.7 ratio (entry 5). An unsymmetrical 
naphthalyne precursor 1g was also reactive and led to an inseparable mixture of two isomers in 
equal amounts (entry 6). However, 2,3-pyridyne precursor 1h17 proved unsuccessful using our 
standard reaction conditions. We observed that all sydnone starting material was recovered when 
compound 1h was consumed (entry 7). 
An interesting observation was made when we carried out the reaction using the unsymmetrical 
aryne precursor 1i, which is both sterically and electronically biased. While we isolated two 
products, we were only able to assign one as the 4-MeO isomer (3ia) (33% yield) through 
extensive NMR spectroscopic analysis and comparison with literature values.11,18 We were unable 
to identify the other product. While HRMS suggested the identity as the desired regioisomeric 
product, the presence of extra aromatic protons, as well as two aliphatic methyl groups in the 1H 
NMR spectrum, clearly suggested otherwise. It was not until we reacted 1i with another sydnone 
2d that we realized what had happened. In the latter reaction, we again obtained two products. One 
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was the desired 4-MeO isomer (3id) in a 44% yield, and the other product was again unidentified. 
However, we were able to observe exactly the same extra aromatic protons and exactly the same 
extra methyl signals that were observed in the previously unidentified product, but here the 
integration no longer involved integers. That clearly suggested that these “unidentified” products 
were in fact mixtures of two compounds. The mixture obtained from 1i and 2a involved 
approximately a 1:1 ratio of two products. Therefore, the HRMS information was correct. The 
“unidentified” product from 1i and 2a actually contained the 7-MeO isomer 3ia’. The other 
component in the mixture was later attributed to m-anisidine based on 1H NMR spectral analysis 
and comparison with literature values. The existence of m-anisidine was also confirmed by 
GC-MS. Thus, by stirring this “unidentified” product with an excess of acetic anhydride and 
pyridine, followed by a regular work-up and silica gel chromatography, the pure 7-MeO isomer 
(3ia’) could be obtained in a 40% yield. The 1H NMR spectral data now matched the literature 
values.18 Similarly, compound 3id’, the 7-MeO isomer from the reaction of 1i and 2d, could be 
isolated pure in about a 42% yield.  
Table 3. Reaction with Other Aryne Precursorsa 
 
 
 
 
Entry sydnone aryne precursor product yieldb (%) 
78 
1 
Ar = Ph 
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3ba 
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98e 
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2d 
TMS
OTf
OMe
 
1i 
N
N
OMe
Me
 
3id 
44i 
   
N
N Me
OMe
 
3id’ 
42i 
a
  All reactions were carried out on 0.4 mmol of sydnone at a concentration of 0.1 M. b Isolated 
yield. c A 1:1 mixture of the 5-Me isomer and the 6-Me isomer was obtained. d An inseparable 
0.8:1 mixture of two isomers (5-MeO and 6-MeO) was obtained. The major isomer was not 
identified. e A 0.7:1 mixture of two inseparable isomers (4-Me and 7-Me) was obtained. The major 
isomer was not identified. f A 1:1 mixture of 3ga and 3ga’ was obtained. g All sydnone starting 
material was recovered when precursor 1h was consumed. h See the Supporting Information for 
the structure assignment. i The structures were assigned based on the polarity and 1H NMR 
coupling pattern of the two isomers obtained from entry 6. 
The regioselectivity in this cycloaddition, especially with the aryne derived from 1i, can be 
explained as shown in Scheme 2. For a sydnone, there are three resonance structures (A, B, and C, 
Scheme 2), and cycloaddition with the aryne should arise from the latter two. Since the aryne 
derived from 1i is known to be attacked preferentially by nucleophiles at the meta position (with 
respect to the OMe group) for both electronic and steric reasons,19 resonance structure B should 
lead to formation of the 7-OMe regioisomer 3ia’, while resonance structure C should lead to 
formation of the 4-OMe regioisomer 3ia. While we typically draw the structure of sydnones as 
either A or B, computational chemists long ago realized that despite the enolate nature and the 
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observed nucleophilic reactivity of C-4, the N-2 position actually carries a significant negative 
charge20 and may serve as the nucleophile in the aryne reaction. Although the charge distribution 
of sydnones has been controversial,21 experimental results involving the cycloaddition of sydnones 
with unsymmetrical alkynes have clearly suggested that both N-2 and C-4 can react as the 
nucleophilic site.22 Moreover, the molecular orbital analysis of sydnones indicates that the LUMO 
of sydnones has very similar coefficients for N-2 and C-4,23 rendering the N-2 and C-4 positions of 
a sydnone similar in reactivity. All these literature results support the formation of both isomers 
3ia and 3ia’ through cycloaddition, and the side-product, m-anisidine, appears to arise from a 
separate path during the formation of isomer 3ia.  Possibly, due to steric hindrance of the methoxy 
group, the [3 + 2] cycloaddition to form 3ia is partially disrupted and therefore occurs stepwise, 
which stops at betaine D.24 The addition of water may lead to the formation of E, which is attacked 
by hydroxide to form a ring-opened intermediate F. Intermediate F can further decompose to 
nitroso compound G, which is then reduced to m-anisidine. 
Scheme 2. Regioselectivity in the Cycloaddition Reaction and Proposed Mechanism for the 
Formation of m-Anisidine. 
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Mechanistic investigation. To gain further insight into this reaction, we conducted a brief 
Density Functional Theory and ab initio calculation of the reaction path using Gaussian 09. 
Geometry optimizations were performed with hybrid B3LYP functions in conjunction with the 
6-31G(d) basis set. Higher-level relative energies were computed at the MP2/6-311+G(d,p) level 
based on the B3LYP/6-31G(d) optimized geometries. The schematic potential energy surface of 
the reaction with zero-point energy corrections is plotted in Figure 1. As can be seen, the initial [3 
+ 2] cycloaddition is an exothermic step. A subsequent retro-[4 + 2] reaction is again exothermic. 
Since we were not able to find the transition states of these cycloaddition and cycloreversion 
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processes, a relatively smooth potential energy surface may exist. 
Figure 1. Schematic potential energy surface with zero-point energy (ZPE) corrections at the 
MP2/6-311+G(d,p) level (units in kJ mol-1). The values in parentheses are those obtained at the 
B3LYP/6-31G(d) level. The energy of the reactants is set to zero as a reference. 
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Elaboration of 2H-Indazoles. As our approach to 2H-indazoles tolerates halogen substituents, 
those halogen atoms offer an ideal site for further elaboration by subsequent Pd-catalyzed 
cross-couplings. Such a strategy can quickly afford a library of structurally diverse, highly 
functionalized 2H-indazoles. In this regard, we have demonstrated the feasibility of such 
elaborations by converting 3at to the corresponding 3-aryl- and 3-(1-alkynyl)-2H-indazoles using 
Suzuki-Miyaura25 and Sonogashira26 reactions, respectively (Scheme 3).27 By modifying the 
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structure of the sydnones and arynes,28 this approach can be easily exploited to provide more 
derivatives for potential biological activity screening. It should be noted that our direct new 
synthesis of alkynylsydnones14 is unable to prepare indazoles like 5at, and, therefore, the route 
described in Scheme 3 provides an effective route towards such compounds. 
Scheme 3. Suzuki-Miyaura and Sonogashira Coupling of 2H-Indazoles  
 
 
4.4. Conclusions 
This work affords an efficient, new, synthetic route to 2H-indazoles by the [3 + 2] cycloaddition 
of arynes and sydnones. The reaction is applicable to a variety of sydnones and silylaryl triflates 
and affords the corresponding cycloadducts in moderate to excellent yields. Compared with 
literature protocols, our approach offers very mild reaction conditions, high yields, and no 
contamination by 1H-indazoles.  The resulting halogen-substituted 2H-indazoles are readily 
elaborated to more complex products using known organopalladium chemistry. Thus, the 
versatility of the cycloaddition and the tolerance of halogen make this methodology ideal for 
pharmaceutical chemistry.  
84 
4.5. Experimental Section  
General Information. All reagents purchased from commercial sources were used as received. 
The solvents THF and MeCN were distilled over Na/benzophenone and CaH2, respectively. The 
aryne precursors were used as received; those not commercially available were prepared according 
to literature procedures.29,17 The sydnones were prepared as outlined below. The silica gel for 
column chromatography was supplied as 300-400 mesh or 230-400 mesh.30 Powdered CsF was 
used as received and stored in a desiccator. TBAF (either 1 M in THF solution or anhydrous solid) 
was used as received. The solid TBAF was stored in a desiccator as well. 
All melting points were measured and are uncorrected. The 1H and 13C NMR spectra were 
recorded and are referenced to the residual solvent signals (7.26 ppm for 1H in CDCl3 and 77.2 
ppm for 13C in CDCl3). 
All aryne cycloaddition reactions were carried out in oven-dried glassware and were 
magnetically stirred. A nitrogen atmosphere was not used, except that a balloon of nitrogen was 
attached to the reaction flask for the ventilation of CO2. 
Computational methods. All electronic structure calculations involved in this work utilized 
the Gaussian 09 program package.31 The geometries and frequencies of all the stationary points 
(including reactants, intermediates, and products) were calculated by Becke's three-parameter 
nonlocal-exchange functional with the nonlocal correlation functional of Lee-Yang-Parr (B3LYP) 
using the 6-31G(d) basis set. To get more reliable reaction energies, single-point corrections were 
performed by restricted or unrestricted second-order Møller-Plesset perturbation theory (MP2) 
with the 6-311+G(d, p) basis set using the B3LYP optimized geometries. 
Preparation of the sydnones. All the sydnones were prepared as follows. Due to long T1 
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relaxation times, the acquisition of 13C NMR spectra for many sydnones could not be achieved, 
even after an overnight acquisition of 8000 scans on a 400 MHz instrument. 
3-Phenylsydnone (2a).12a To a suspension of 5.00 g of N-phenylglycine (33 mmol) in 60 mL of 
water at 0 ºC was added dropwise a solution of 3.50 g of NaNO2 (51 mmol, 1.5 equiv) in 20 mL of 
water. The mixture was stirred at 0 ºC for an additional 20 min and the resultant clear red solution 
was filtered while cold. A scoop of activated charcoal (ca. 200-300 mg) was added and the mixture 
was stirred for a few minutes before being filtered again. The intermediate 
N-nitroso-N-phenylglycine was precipitated from the filtrate by the addition of 10 mL of 
concentrated HCl and was then collected by filtration. It was washed with cold water and dried 
overnight under a high vacuum. The resulting solid was then dissolved in 25 mL of acetic 
anhydride and the mixture was heated to 100 ºC for 1.5 h. After being cooled to room temperature, 
the resulting mixture was poured into 300 mL of ice water. A yellow solid formed, which was 
triturated by stirring for a few minutes in this cold water. The solid was filtered, washed thoroughly 
with water until no smell of acetic acid remained, and dried under a high vacuum overnight to 
afford 3.37 g of product (63% yield) as off-white crystals. This representative procedure for 
preparing sydnones from the corresponding amino acid is identified as Protocol 1: 1H NMR (400 
MHz, CDCl3) δ 7.77-7.58 (m, 5 H), 6.75 (s, 1 H). 
3-(4-Chlorophenyl)sydnone (2b). A mixture of 5.10 g of 4-chloroaniline (40 mmol), 5.14 mL 
of ethyl chloroacetate (48 mmol, 1.2 equiv), and 6.53 g of NaOAc•3H2O (48 mmol, 1.2 equiv) in 
10 mL of ethanol was refluxed in a 100 ºC oil bath overnight. After being cooled to room 
temperature, the mixture was poured into ice water, and the precipitate was filtered and dried. The 
crude product, N-(4-chlorophenyl)glycine ethyl ester, after crystallization from ethanol (4.01 g, 
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47% yield), was an off-white solid. It is strongly suggested that this intermediate be purified, either 
through recrystallization or column chromatography. The resulting ester (3.00 g, 14 mmol) was 
stirred with 1.01 g of LiOH (3.0 equiv) in 30 mL of THF/water (1:1) at 0 ºC. After 2 h at 0 ºC, the 
reaction mixture was gradually warmed up to room temperature, where the pH was adjusted to 3-4 
with concentrated HCl. The precipitate was filtered and dried to afford 2.53 g of 
N-(4-chlorophenyl)glycine (98% yield) as an off-white solid (62% overall yield). This 
representative procedure for preparing an amino acid is identified as Route 1.32 Sydnone 2b was 
then synthesized as an off-white solid (72% overall yield) from the resulting amino acid following 
Protocol 1: 1H NMR (400 MHz, CDCl3) δ 7.74-7.67 (m, 2H), 7.64-7.56 (m, 2H), 6.79 (s, 1H). 
3-(4-Bromophenyl)sydnone (2c). The corresponding amino acid was prepared from 
4-bromoaniline following Route 1 in a 65% overall yield. Sydnone 2c was synthesized from this 
amino acid following Protocol 1 as an off-white solid (50% overall yield): 1H NMR (400 MHz, 
CDCl3) δ 7.78 (d, J = 8.4 Hz, 2 H), 7.62 (d, J = 8.8 Hz, 2 H), 6.73 (s, 1 H). 
3-(4-Methylphenyl)sydnone (2d). The corresponding amino acid was prepared from 
4-methylaniline following Route 1 in a 53% overall yield. Sydnone 2d was synthesized from this 
amino acid following Protocol 1 as an off-white to cream solid (60% overall yield): 1H NMR (400 
MHz, CDCl3) δ 7.61 (d, J = 8.5 Hz, 2 H), 7.42 (d, J = 8.2 Hz, 2 H), 6.72 (s, 1 H), 2.49 (s, 3 H). 
3-(4-Methoxyphenyl)sydnone (2e). The corresponding amino acid was prepared from 
4-methoxylaniline following Route 1 in a 50% overall yield. Sydnone 2e was synthesized from 
this amino acid following Protocol 1 as an off-white solid (78% overall yield): 1H NMR (400 
MHz, CDCl3) δ 7.65 (d, J = 9.2 Hz, 2 H), 7.08 (d, J = 8.8 Hz, 2 H), 6.64 (s, 1 H), 3.91 (s, 3 H). 
3-(3,4-Methylenedioxyphenyl)sydnone (2f). The corresponding amino acid was prepared 
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from 3,4-methylenedioxyaniline following Route 1 in a 60% overall yield. Sydnone 2f was 
synthesized from this amino acid following Protocol 1 as a brown solid (27% overall yield): 1H 
NMR (400 MHz, CDCl3) δ 7.25-7.15 (m, 2 H), 6.96 (d, J = 8.3 Hz, 1 H), 6.64 (s, 1 H), 6.14 (s, 2 
H). 
3-(4-Nitrophenyl)sydnone (2g). To 0.75 g of glycine (10 mmol) was added 10 mL of 
tetrabutylammonium hydroxide in methanol (1 M, 10 mmol, 1.0 equiv.); the solvent was removed 
under vacuum, and the residue was dissolved in 20 mL of DMSO. p-Fluoronitrobenzene (1.55 g, 
11 mmol, 1.1 equiv) and 1.51 g of K2CO3 (11 mmol, 1.1 equiv ) were added and the mixture was 
allowed to react under gentle warming (45 ºC) with stirring until completion (monitored by TLC). 
The mixture was then poured into cold water, acidified with HCl, and extracted with ethyl acetate. 
The combined organic layers were evaporated under vacuum and the residue was purified by 
column chromatography (5:1 petroleum ether/EtOAc) to afford 1.2 g (65% yield) of the desired 
amino acid as a yellow solid.33 Sydnone 2g was then synthesized from this amino acid following 
Protocol 1 as an off-white solid (36% overall yield): 1H NMR (400 MHz, CDCl3) δ 8.52 (d, J = 8.8 
Hz, 2 H), 7,98 (d, J = 8.8 Hz, 2 H), 6.84 (s, 1 H). 
3-Methylsydnone (2h). To an ice-cold solution of 6.7 mL of conc. HCl and 3.56 g of sarcosine 
(40 mmol) in 10 mL of water, was added a saturated solution of 5.52 g of NaNO2 (80 mmol) in 
water. The mixture was stirred at 0 ºC for 1 h and then extracted with ethyl acetate three times. The 
combined organic layers were concentrated under a vacuum to obtain N-nitroso-N-methylglycine 
as a yellow oil. The resulting oil was dissolved in 4 mL of dry ether and charged dropwise with 
~500 µL of trifluoroacetic anhydride (3.6 mmol, 1.8 equiv) at 0 ºC. The reaction was stirred at 0 ºC 
for a few minutes and gradually warmed to room temperature and stirred for another 1 h. The 
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solvents were evaporated and the residue was dissolved in EtOAc. Solid NaHCO3 was added to 
neutralize the excess acid and was removed by filtration. The EtOAc was evaporated and the 
residue was purified by chromatography (2:1 petroleum ether/EtOAc) to yield 300 mg of the 
desired sydnone (8 % overall yield) as a yellow oil. This representative precedure for preparing 
sydnones from the corresponding amino acid is identified as Protocol 2: 1H NMR (400 MHz, 
CDCl3)  δ 6.32 (s, 1 H), 4.07 (s, 3 H). 
3-Benzylsydnone (2i). This sydnone was synthesized from N-benzylglycine as a white solid 
(39% overall yield) following Protocol 2: 1H NMR (400 MHz, CDCl3)  δ 7.45 (overlap, 3 H), 
7.39 (overlap, 2 H), 6.21 (s, 1 H), 5.36 (s, 2 H). 
3,4-Cyclopenta[c]sydnone (2j).This sydnone was prepared according to a literature 
procedure34 as a brown oil (~11% overall yield). 
3-(4-Chlorophenyl)-4-(isobutyl)-sydnone (2k). To a round-bottom flask equipped with a stir 
bar, was added 1.32 g of L-leucine (10 mmol), followed by 190 mg of CuI (1 mmol, 10 mol %), 
3.04 g of anhydrous K2CO3 (22 mmol, 2.2 equiv.), 2.87 g of 4-bromochlorobenzene (15 mmol, 1.5 
equiv.), and 9 mL of undistilled DMSO. The reaction system was flushed with nitrogen. The flask 
was sealed with a Teflon stopper and placed in a 70 ºC oil bath. The suspension was vigorously 
stirred. After 15 h, the stirring was found to be difficult, and another 4 mL of DMSO was added. 
The reaction was stopped at 40 h when the color changed from a purple-brown to blue. The 
reaction was poured into ice water and concentrated HCl was added until the pH reached 3-4. The 
precipitate was filtered, washed thoroughly with cold water (slightly acidified by HCl to pH ~4) 
and dried under a high vacuum to yield 2.6 g of crude N-(4-chlorophenyl)leucine as a slightly 
green solid (yield >100%).12f,g It should be noted that this method did not work for Met or Thr. This 
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crude amino acid was used in the next step without further purification. 
To a solution of 500 mg (~2 mmol considering possible impurities) of crude 
N-(4-chlorophenyl)leucine in 3 mL of undistilled DME was added dropwise ~400 µL of isoamyl 
nitrite (3 mmol, 1.5 equiv) at room temperature. The mixture was allowed to stir for 2 d before the 
solvent was removed under reduced pressure. The solid was triturated with petroleum ether and 
filtered. The cake was washed with petroleum ether and air dried. The solid was dissolved in 4 mL 
of dry ether and was charged dropwise with ~500 µL of trifluoroacetic anhydride (3.6 mmol, 1.8 
equiv) at 0 ºC. The reaction was stirred at 0 ºC for a few minutes and gradually warmed to room 
temperature and stirred for another 1 h. The solvents were evaporated and the residue was 
dissolved in EtOAc. The excess acid present was neutralized by the addition of solid NaHCO3, 
which was then removed by filtration. The EtOAc was evaporated and the residue was purified by 
chromatography (3:1 petroleum ether/EtOAc) to yield 130 mg of the desired sydnone (26% overall 
yield) as a light brown oil: 1H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.6 Hz, 2 H), 7.46 (d, J = 8.7 
Hz, 2 H), 2.37 (d, J = 7.4 Hz, 2 H), 1.88 (dt, J = 13.6, 6.8 Hz, 1 H), 0.80 (d, J = 6.6 Hz, 6 H). 
3-(4-Chlorophenyl)-4-(4-methoxyphenyl)sydnone (2o).13 To a mixture of 197 mg of 
N-(4-chlorophenyl)sydnone (1.0 mmol), 351 mg of 4-iodoanisole (1.5 mmol, 1.5 equiv), 11 mg of 
Pd(OAc)2 (0.05 mmol, 5 mol %), 26 mg of PPh3 (0.1 mmol, 10 mol %), and 276 mg of anhydrous 
K2CO3 in a 10 mL round-bottom flask was added 2 mL of undistilled DMF. The flask was fitted 
with an air condenser and placed in a 120 ºC oil bath overnight, during which time the reaction 
mixture was stirred open to the air. The mixture was cooled to room temperature, poured into 30 
mL of water, and extracted three times with EtOAc. The combined extracts were washed once with 
brine, dried over MgSO4, filtered, and evaporated. The residue was purified by column 
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chromatography (petroleum ether/EtOAc) to afford 145 mg of 2o as a yellow solid (48% yield). 
This representative procedure for preparing functionalized sydnones is identified as Protocol 3: 1H 
NMR (400 MHz, CDCl3) δ 7.57-7.51 (m, 2 H), 7.47-7.40 (m, 2 H), 7.24-7.17 (m, 2 H), 6.87-6.79 
(m, 2 H), 3.79 (s, 3 H). 
3-Phenyl-4-vinylsydnone (2l). This sydnone was prepared from sydnone 2a and vinyl bromide 
as a brown solid (40% yield) following Protocol 3: 1H NMR (300 MHz, CDCl3) δ 7.79-7.60 (m, 3 
H), 7.59-7.50 (m, 2 H), 6.40-6.16 (m, 2 H), 5.41 (d, J = 10.6 Hz, 1 H). 
4-(4-Acetylphenyl)-3-phenylsydnone (2m). This sydnone was prepared from sydnone 2a and 
4-bromoacetophenone as a yellow solid (30% yield) following Protocol 3: 1H NMR (300 MHz, 
CDCl3) δ 7.83 (d, J = 7.7 Hz, 2 H), 7.76-7.56 (m, 3 H), 7.54-7.44 (m, 2 H), 7.43-7.33 (m, 2 H), 2.54 
(s, 3 H). 
4-(4-Methoxyphenyl)-3-phenylsydnone (2n). This sydnone was prepared from sydnone 2a 
and 4-iodoanisole as a yellow solid (46% yield) following Protocol 3: 1H NMR (400 MHz, CDCl3) 
δ 7.66 (t, J = 7.2 Hz, 1 H), 7.58 (t, J = 7.2 Hz, 2 H), 7.48 (d, J = 7.6 Hz, 2 H), 7.22 (d, J = 8.8 Hz, 2 
H), 6.81 (d, J = 8.8 Hz, 2 H), 3.78 (s, 3 H). 
3,4-Bis(4-chlorophenyl)sydnone (2p). This sydnone was prepared from sydnone 2b and 
4-bromochlorobenzene as a brown solid (44% yield) following Protocol 3: 1H NMR (400 MHz, 
CDCl3) δ 7.60-7.55 (m, 2 H), 7.47-7.42 (m, 2 H), 7.31-7.27 (m, 2 H), 7.24 7.20 (m, 2 H). 
3-(4-Chlorophenyl)-4-(2-thiophenyl)sydnone (2q). This sydnone was prepared from sydnone 
2b and 2-iodothiophene as a brown solid (50% yield) following Protocol 3: 1H NMR (400 MHz, 
CDCl3) δ 7.65 (d, J = 8.4 Hz, 2 H), 7.53 (d, J = 8.4 Hz, 2 H), 7.35 (d, J = 3.7 Hz, 1 H), 7.28 (d, J = 
5.0 Hz, 1 H), 7.02 (t, J = 4.5 Hz, 1 H). 
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3-(4-Chlorophenyl)-4-(2-pyridyl)sydnone (2r). This sydnone was prepared from sydnone 2b 
and 2-bromopyridine as a brown solid (60% yield) following Protocol 3: 1H NMR (400 MHz, 
CDCl3) δ 8.25 (d, J = 4.6 Hz, 1 H), 8.11 (d, J = 8.0 Hz, 1 H), 7.75 (t, J = 7.8 Hz, 1 H), 7.52 (d, J = 
8.7 Hz, 2 H), 7.45 (d, J = 8.7 Hz, 2 H), 7.13 (dd, J = 7.4, 4.9 Hz, 1 H). 
3-(4-Chlorophenyl)-4-(phenylethynyl)sydnone (2s).14 A solution of 79 mg of sydnone 2b (0.4 
mmol) in 2 mL of toluene was charged with 4.5 mg of Pd(OAc)2 (5 mol %), 6.8 mg of CuCl2•2H2O 
(10 mol %), and 186 mg of Ag2O (2.0 equiv), and then heated to 75 ºC in an open flask. A solution 
of 88 µL of phenylacetylene (0.6 mmol) in 3 mL of toluene was added over 6 h using a syringe 
pump while the reaction was stirred open to the air. The reaction was allowed to stir for an 
additional 2 h after the addition, and then EtOAc and water were added. The layers were separated 
and the EtOAc was washed with brine, dried over MgSO4, filtered, and evaporated. The residue 
was purified by column chromatography (petroleum ether/EtOAc) to afford 82 mg of 2s as a 
yellow solid (69% yield): 1H NMR (400 MHz, CDCl3) δ 7.87-7.81 (m, 2 H), 7.67-7.61 (m, 2 H), 
7.44-7.31 (m, 5 H). 
4-Iodo-3-phenylsydnone (2t).15 To a solution of 243 mg of sydnone 2a (1.5 mmol) in 2.5 mL of 
acetic acid was added 185 mg of NaOAc (2.25 mmol, 1.5 equiv.), followed by a solution of 366 mg 
of ICl (2.25 mmol, 1.5 equiv.) in 1.5 mL of acetic acid. The mixture was allowed to stir for 3 h, 
then quenched with water and the solid was collected by filtration. The cake was washed with 
drops of cold ethanol and dried under vacuum to afford 272 mg of product (63%) as a brown solid. 
This representative procedure for preparing functionalized sydnones is identified as Protocol 4: 1H 
NMR (400 MHz, CDCl3) δ 7.73 (t, J = 7.2 Hz, 1 H), 7.67 (t, J = 7.6 Hz, 2 H), 7.60 (d, J = 7.6 Hz, 
2 H). 
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3-(4-Bromophenyl)-4-iodosydnone (2u). This sydnone was prepared from sydnone 2c as a 
brown solid (60% yield) following Protocol 4: mp 160-162 ºC; 1H NMR (400 MHz, CDCl3) δ 7.81 
(d, J = 8.8 Hz, 2 H), 7.50 (d, J = 8.8 Hz, 2 H); LRMS (ESI) 367 (M+H); HRMS (ESI) calcd for 
C8H5BrIN2O2 (M+H) 366.8574, found 366.8574. 
4-Acetyl-3-phenylsydnone (2v).16 To a solution of 0.81 g of sydnone 2a (5 mmol) in 5 mL of 
acetic anhydride was added 0.89 g of NBS (5 mmol). The mixture was allowed to stir for 4 h, 
poured into 20 mL of ice water, and extracted by EtOAc. The combined organic layers were 
washed with saturated NaHCO3 solution, dried over Na2SO4, and evaporated under vacuum. The 
residue was purified by column chromatography (5:1 petroleum ether/EtOAc) to afford 529 mg of 
product (52% yield) as colorless crystals: 1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 7.6 Hz, 2 H), 
7.43 (t, J = 8.0 Hz, 2 H), 7.23 (d, J = 7.6 Hz, 1 H). 
General procedure for the synthesis of 2H-indazoles. To an oven-dried 10 mL round-bottom 
flask equipped with a stir bar were added 140 mg of benzyne precursor (~0.48 mmol, ~1.2 equiv) 
and 0.4 mmol of sydnone. THF (4 mL) was added and the mixture was stirred until all solid 
dissolved. To this solution was added TBAF (~160 mg of solid or ~630 µL of 1M THF solution, 
~1.6 equiv) in one portion. The flask was sealed with a septum and a nitrogen balloon was attached. 
The reaction mixture was stirred at room temperature overnight. Upon completion, the reaction 
mixture was poured into saturated NaHCO3 and extracted three times with EtOAc. The combined 
extracts were washed once with brine, dried over MgSO4, filtered, and evaporated. The residue 
was purified by column chromatography (petroleum ether/EtOAc) to afford the 2H-indazole. 
2-Phenyl-2H-indazole (3aa). Following the general procedure, this product was isolated as a 
white solid: mp 79-81 ºC (lit35 81-82 ºC); Rf  = 0.45 (6:1 petroleum ether/EtOAc);36 1H NMR (400 
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MHz, CDCl3) δ 8.41 (s, 1 H), 7.92-7.89 (m, 2 H), 7.81 (dd, J = 8.8, 0.9 Hz, 1 H), 7.72 (d, J = 8.5 Hz, 
1 H), 7.56-7.50 (m, 2 H), 7.43-7.38 (m, 1 H), 7.34 (ddd, J = 8.8, 6.6, 1.1 Hz, 1 H), 7.12 (ddd, J = 
8.4, 6.6, 0.8 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 149.7, 140.5, 129.5, 127.9, 126.8, 122.7, 
122.4, 120.9, 120.40, 120.37, 117.9; LRMS (ESI): 217 (M+Na), 195 (M+H); HRMS (ESI): calcd 
for C13H11N2 (M+H) 195.0917, found 195.0916. 
2-(4-Chlorophenyl)-2H-indazole (3ab). White solid: mp 141-143 ºC; Rf = 0.50 (6:1 petroleum 
ether/EtOAc);36 1H NMR (400 MHz, CDCl3) δ 8.39 (s, 1 H), 7.89-7.84 (m, 2 H), 7.77 (d, J = 8.8 
Hz, 1 H), 7.71 (d, J = 8.5 Hz, 1 H), 7.53-7.48 (m, 2 H), 7.33 (ddd, J = 8.6, 6.6, 0.8 Hz, 1 H), 
7.17-7.09 (m, 1 H); 13C NMR (100 MHz, CDCl3) δ 149.8, 138.9, 133.5, 129.7, 127.1, 122.8, 122.7, 
122.0, 120.35, 122.30, 117.8; LRMS (ESI) 251 (M+Na), 229 (M+H); HRMS (ESI) calcd for 
C13H10ClN2 (M+H) 229.0527, found 229.0525. 
2-(4-Bromophenyl)-2H-indazole (3ac). Yellow solid: mp 146-148 ºC; Rf = 0.38 (5:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.36 (s, 1 H), 7.79-7.75 (m, 3 H), 7.68 (d, 
J = 8.4 Hz, 1 H), 7.63 (d, J = 9.2 Hz, 2 H), 7.32 (dd, J = 7.6, 6.8 Hz, 1 H), 7.11 (t, J = 7.6 Hz, 1 H); 
13C NMR (100 MHz, CDCl3) δ 150.1, 139.7, 132.8, 127.3, 123.1, 122.9, 122.4, 121.6, 120.6, 120.4, 
118.1; LRMS (ESI) 273 (M+H); HRMS (ESI) calcd for C13H10BrN2 (M+H) 273.0022, found 
273.0030. 
2-(4-Tolyl)-2H-indazole (3ad). White solid: mp 101-103 ºC; Rf = 0.44 (6:1 petroleum 
ether/EtOAc);36 1H NMR (400 MHz, CDCl3) δ 8.37 (d, J = 0.9 Hz, 1 H), 7.83-7.76 (m, 3 H), 7.71 
(dt, J = 8.5, 1.0 Hz, 1 H), 7.38-7.29 (m, 3 H), 7.11 (ddd, J = 8.4, 6.6, 0.8 Hz, 1 H), 2.43 (s, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 149.6, 138.3, 137.9, 130.1, 126.6, 122.7, 122.3, 120.8, 120.30, 120.28, 
117.9, 21.0; LRMS (ESI) 231 (M+Na), 209 (M+H); HRMS (ESI) calcd for C14H13N2 (M+H) 
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209.1073, found 209.1072. 
2-(4-Methoxyphenyl)-2H-indazole (3ae). Yellow solid: mp 130-132 ºC; Rf = 0.25 (5:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.30 (s, 1 H), 7.79 (d, J = 8.8 Hz, 3 H), 
7.69 (d, J = 8.4 Hz, 1 H), 7.31 (dd, J = 7.6, 7.2 Hz, 1 H), 7.10 (t, J = 7.4 Hz, 1 H), 7.01 (d, J = 8.8 
Hz, 2 H), 3.85 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 159.4, 149.7, 134.3, 126.7, 122.8, 122.6, 
122.4, 120.5, 120.4, 117.9, 114.8, 55.8; LRMS (ESI) 257 (M+Na), 225 (M+H); HRMS (ESI) calcd 
for C14H13N2O (M+H) 225.1022, found 225.1026. 
2-(3,4-Methylenedioxyphenyl)-2H-indazole (3af). Pale white solid: mp 117-118 ºC; Rf = 0.31 
(6:1 petroleum ether/EtOAc);36 1H NMR (400 MHz, CDCl3) δ 8.29 (s, 1 H), 7.77 (dd, J = 8.8, 0.9 
Hz, 1 H), 7.69 (d, J = 8.5 Hz, 1 H), 7.41 (d, J = 2.2 Hz, 1 H), 7.35-7.29 (m, 2 H), 7.11 (ddd, J = 8.4, 
6.6, 0.8 Hz, 1 H), 6.91 (d, J = 8.4 Hz, 1 H), 6.07 (s, 2 H); 13C NMR (100 MHz, CDCl3) δ 149.1, 
148.4, 147.3, 135.2, 126.7, 125.6, 122.3, 120.5, 120.2, 117.7, 114.4, 108.4, 103.1, 101.9; LRMS 
(ESI) 261 (M+Na), 239 (M+H); HRMS (ESI) calcd for C14H11O2N2 (M+H) 239.0815, found 
239.0812. 
2-Methyl-2H-indazole (3ah). Yellow oil: Rf = 0.21 (2:1 petroleum ether/EtOAc); 1H NMR 
(400 MHz, CDCl3) δ 7.88 (s, 1 H), 7.70 (d, J = 8.4 Hz, 1 H), 7.64 (d, J = 8.4 Hz, 1 H), 7.28 (t, J = 
7.2 Hz, 1 H), 7.07 (t, J = 7.4 Hz, 1 H), 4.21 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 149.2, 126.0, 
123.7, 122.3, 121.8, 120.1, 117.4, 40.5; LRMS (APCI) 133 (M+H); HRMS (APCI) calcd for 
C8H9N2 (M+H) 133.0760, found 133.0762. 
2-Benzyl-2H-indazole (3ai). Yellow oil: Rf = 0.31 (5:1 petroleum ether/EtOAc); 1H NMR (300 
MHz, CDCl3) δ 7.86 (s, 1 H), 7.73 (dd, J = 8.7, 0.9 Hz, 1 H), 7.61 (d, J = 8.4 Hz, 1 H), 7.34-7.30 (m, 
3 H), 7.27-7.23 (m, 3 H), 7.06 (dd, J = 8.1, 7.5 Hz, 1 H), 5.57 (s, 2 H); 13C NMR (100 MHz, CDCl3) 
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δ 149.0, 135.9, 129.1, 128.5, 128.1, 126.2, 123.0, 122.2, 121.9, 120.3, 117.7, 57.6; LRMS (APCI) 
209 (M+H); HRMS (APCI) calcd for C14H13N2 (M+H) 209.1073, found 209.1078. 
2,3-Dihydro-1H-pyrrolo[1,2-b]indazole (3aj). Off-white solid: mp 99-100 ºC; Rf = 0.31 (1:1 
CH2Cl2/EtOAc);36 1H NMR (400 MHz, CDCl3) δ 7.67 (d, J = 8.7 Hz, 1 H), 7.57 (d, J = 8.3 Hz, 1 H), 
7.26 (t, J = 7.6 Hz, 1 H), 7.03 (t, J = 7.5 Hz, 1 H), 4.42 (t, J = 7.3 Hz, 2 H), 3.18 (t, J = 7.2 Hz, 2 H), 
2.84-2.63 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 153.5, 138.8, 125.5, 120.3, 119.8, 117.6, 116.1, 
48.9, 25.7, 23.0; LRMS (ESI) 181 (M+Na), 159 (M+H); HRMS (ESI) calcd for C10H11N2 (M+H) 
159.0917, found 159.0915. 
2-(4-Chlorophenyl)-3-isobutyl-2H-indazole (3ak). Slightly orange solid: mp 77-79 ºC; Rf = 
0.47 (6:1 petroleum ether/EtOAc);36 1H NMR (400 MHz, CDCl3) δ 7.72-7.68 (m, 1 H), 7.65 (dt, J 
= 8.5, 1.0 Hz, 1 H), 7.55-7.44 (m, 4 H), 7.33 (ddd, J = 8.8, 6.6, 1.1 Hz, 1 H), 7.08 (ddd, J = 8.5, 6.6, 
0.8 Hz, 1 H), 2.91 (d, J = 7.4 Hz, 2 H), 2.04-1.89 (m, 1 H), 0.83 (d, J = 6.6 Hz, 6 H); 13C NMR (100 
MHz, CDCl3) δ 148.6, 138.7, 136.3, 134.8, 129.3, 127.6, 126.8, 121.5, 121.1, 120.4, 117.5, 34.1, 
29.2, 22.5; LRMS (ESI) 307 (M+Na), 285 (M+H); HRMS (ESI) calcd for C17H18ClN2 (M+H) 
285.1153, found 285.1151. 
2-Phenyl-3-vinyl-2H-indazole (3al). Yellow gel: Rf = 0.18 (5:1 hexanes ether/EtOAc); 1H 
NMR (400 MHz, CDCl3) δ 7.92 (d, J = 8.5 Hz, 1 H), 7.79 (d, J = 8.7 Hz, 1 H), 7.64-7.48 (m, 5 H), 
7.43-7.34 (m, 2 H), 7.23-7.15 (m, 1 H), 6.81 (dd, J = 17.8, 11.6 Hz, 1 H), 6.04 (dd, J = 17.8, 0.8 Hz, 
1 H), 5.53 (dd, J = 11.6, 0.9 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 148.8, 139.6, 133.2, 129.1, 
128.8, 126.7, 126.2, 124.9, 122.7, 120.6, 120.3, 118.0, 117.7; LRMS (EI) 220 (M), 219 (M-H); 
HRMS (EI) calcd for C15H12N2 (M) 220.1000, found 220.0990. 
3-(4-Acetylphenyl)-2-phenyl-2H-indazole (3am). Yellow solid: mp 135-137 ºC (lit18 136-138 
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ºC); Rf = 0.36 (2:1 hexanes/EtOAc); 1H NMR (300 MHz, CDCl3) δ 7.97 (d, J = 8.1 Hz, 2 H), 7.82 
(d, J = 8.8 Hz, 1 H), 7.72 (d, J = 8.5 Hz, 1 H), 7.47-7.36 (m, 8 H), 7.18 (t, J = 7.6 Hz, 1 H), 2.61 (s, 
3 H); 13C NMR (100 MHz, CDCl3) δ 197.3, 149.0, 139.9, 136.2, 134.4, 133.9, 129.6, 129.1, 128.6, 
128.6, 127.1, 125.9, 123.2, 121.8, 120.0, 117.9, 26.6; LRMS (EI) 312 (M); HRMS (EI) calcd for 
C21H16N2O (M) 312.1263, found 312.1262.  
3-(4-Methoxyphenyl)-2-phenyl-2H-indazole (3an). Yellow solid: mp 103-105 ºC; Rf = 0.52 
(2:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.4 Hz, 1 H); 7.69 (d, J = 8.4 Hz, 
1 H), 7.39 (d, J = 2.4 Hz, 2 H), 7.38-7.33 (m, 4 H), 7.27 (d, J = 8.8 Hz, 2 H), 7.12 (t, J = 7.6 Hz, 1 
H), 6.91 (d, J = 8.8 Hz, 2 H); 3.82 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 159.7, 149.0, 140.4, 
135.5, 131.1, 129.1, 128.3, 127.1, 126.1, 122.4, 122.2, 121.7, 120.8, 117.8, 114.4, 55.4; LRMS (EI) 
300 (M); HRMS (EI) calcd for C20H16N2O (M) 300.1263, found 300.1272. 
2-(4-Chlorophenyl)-3-(4-methoxyphenyl)-2H-indazole (3ao). Slightly brown solid: mp 
122-124 ºC; Rf = 0.39 (6:1 petroleum ether/EtOAc);36 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 
8.8 Hz, 1 H), 7.68 (d, J = 8.5 Hz, 1 H), 7.42-7.33 (m, 5 H), 7.30-7.26 (m, 2 H), 7.13 (ddd, J = 8.4, 
6.6, 0.7 Hz, 1 H), 6.99-6.91 (m, 2 H), 3.86 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 159.7, 149.0, 
138.8, 135.4, 133.9, 130.9, 129.2, 127.2, 127.1, 122.4, 121.8, 121.7, 120.6, 117.6, 114.4, 55.3; 
LRMS (ESI) 357 (M+Na), 335 (M+H); HRMS (ESI) calcd for C20H16ClN2O (M+H) 335.0946, 
found 335.0942. 
2,3-Bis(4-chlorophenyl)-2H-indazole (3ap). Pale white solid: mp 126-129 ºC; Rf = 0.52 (6:1 
petroleum ether/EtOAc);36 1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.8 Hz, 1 H), 7.66 (d, J = 8.5 
Hz, 1 H), 7.43-7.35 (m, 7 H), 7.32-7.27 (m, 2 H), 7.17 (ddd, J = 8.5, 6.6, 0.7 Hz, 1 H); 13C NMR 
(100 MHz, CDCl3) δ 149.1, 138.4, 134.7, 134.3, 134.1, 130.8, 129.35, 129.29, 128.0, 127.4, 127.1, 
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123.1, 121.8, 120.1, 117.8; LRMS (ESI) 361 (M+Na), 339 (M+H); HRMS (ESI) calcd for 
C19H13Cl2N2 (M+H) 339.0450, found 339.0448. 
2-(4-Chlorophenyl)-3-(2-thiophenyl)-2H-indazole (3aq). Yellow solid: mp 99-101 ºC; Rf = 
0.49 (6:1 petroleum ether/EtOAc).36 The product spot overlapped with a highly fluorescent spot 
that immediately follows the product spot. Performing column chromatography with 8:1:0.4 
petroleum ether/CH2Cl2/EtOAc offers some help in separation and purification of the desired 
product: 1H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 8.5 Hz, 1 H), 7.77 (d, J = 8.8 Hz, 1 H), 
7.49-7.35 (m, 6 H), 7.19 (ddd, J = 8.4, 6.6, 0.8 Hz, 1 H), 7.10 (dd, J = 5.1, 3.6 Hz, 1 H), 7.03 (dd, J 
= 3.6, 1.1 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 148.9, 138.4, 134.7, 129.9, 129.6, 129.3, 128.4, 
127.69, 127.65, 127.5, 127.3, 123.0, 121.9, 120.5, 117.7; LRMS (ESI) 333 (M+Na), 311 (M+H); 
HRMS (ESI) calcd for C17H12ClSN2 (M+H) 311.0404, found 311.0404. The contaminant (the 
fluorescent spot) shows a series of non-overlapped signals as follows: 7.87 (d, J = 8.5 Hz), 7.50 
(apparent t, J = 9.0 Hz), 7.13 (d, J = 3.8 Hz), 6.88 (d, J = 3.8 Hz). 
2-(4-Chlorophenyl)-3-(2-pyridyl)-2H-indazole (3ar). Slightly brown solid: mp 137-139 ºC; 
Rf = 0.25 (6:1 petroleum ether/EtOAc);36 1H NMR (400 MHz, CDCl3) δ 8.71-8.67 (m, 1 H), 7.93 (d, 
J = 8.5 Hz, 1 H), 7.81 (d, J = 8.8 Hz, 1 H), 7.71 (td, J = 7.8, 1.8 Hz, 1 H), 7.44-7.36 (m, 5 H), 7.32 
(d, J = 7.9 Hz, 1 H), 7.29-7.24 (m, 1 H), 7.21 (ddd, J = 8.5, 6.6, 0.7 Hz, 1 H); 13C NMR (100 MHz, 
CDCl3) δ 150.2, 149.2, 149.1, 139.1, 136.5, 134.3, 134.1, 129.2, 127.3, 127.1, 124.6, 123.6, 122.6, 
122.3, 120.7, 117.8; LRMS (ESI) 328 (M+Na), 306 (M+H); HRMS (ESI) calcd for C18H13ClN3 
(M+H) 306.0793, found 306.0790. 
2-(4-Chlorophenyl)-3-phenylethynyl-2H-indazole (3as). Yellow solid: mp 141-144 ºC; Rf = 
0.50 (6:1 petroleum ether/EtOAc).36 The product spot overlapped with some spots that have a long 
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wavelength UV absorption. Performing column chromatography with 8:1:0.4 petroleum 
ether/CH2Cl2/EtOAc offers some help in separation and purification of the desired product. The 
impurities do not show more than minimum contamination by 1H NMR spectroscopy: 1H NMR 
(400 MHz, CDCl3) δ 8.01-7.95 (m, 2 H), 7.87-7.78 (m, 2 H), 7.58-7.49 (m, 4 H), 7.43-7.36 (m, 4 
H), 7.25-7.21 (m, 1 H); 13C NMR (100 MHz, CDCl3) δ 148.7, 138.6, 134.3, 131.3, 129.19, 129.14, 
128.6, 127.6, 125.6, 125.5, 123.5, 121.9, 120.2, 118.2, 100.7, 77.7 (one overlapped signal); LRMS 
(ESI) 329 (M+H); HRMS (ESI) calcd for C21H14ClN2 (M+H) 329.0840, found 329.0837. 
3-Iodo-2-phenyl-2H-indazole (3at). Off-white solid: mp 104-105 ºC; Rf = 0.42 (5:1 petroleum 
ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 8.8 Hz, 1 H), 7.62 (d, J = 7.2 Hz, 2 H), 
7.50 (m, 4 H), 7.36 (dd, J = 7.6, 6.8 Hz, 1 H), 7.16 (t, J = 7.6 Hz, 1 H); 13C NMR (100 MHz, CDCl3) 
δ 150.1, 140.6, 129.4, 129.1, 128.4, 127.7, 126.8, 123.3, 121.2, 118.4, 76.2; LRMS (ESI) 321 
(M+H); HRMS (ESI) calcd for C13H10IN2 (M+H) 320.9883, found 320.9884. 
2-(4-Bromophenyl)-3-iodo-2H-indazole (3au). Yellow solid: mp 159-161 ºC; Rf = 0.38 (5:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 8.8 Hz, 1 H), 7.68 (d, J = 8.4 
Hz, 2 H), 7.54 (d, J = 8.8 Hz, 2 H), 7.47 (d, J = 8.4 Hz, 1 H), 7.38 (t, J = 7.4 Hz, 1 H), 7.18 (t, J = 
7.4 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 150.4, 139.6, 132.5, 132.4, 128.7, 128.4, 128.0, 123.6, 
121.3, 118.5, 76.0; LRMS (ESI) 399 (M+H); HRMS (ESI) calcd for C13H9BrIN2 (M+H) 398.8988, 
found 398.8988. 
5,6-Dimethyl-2-phenyl-2H-indazole (3ba). White solid: mp 133-135 ºC; Rf = 0.24 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.21 (s, 1 H), 7.87 (d, J = 7.8 Hz, 2 H), 7.56 (s, 1 
H), 7.49 (t, J = 7.8 Hz, 2 H), 7.40 (s, 2 H), 7.36 (t, J = 7.4 Hz, 1 H), 2.39 (s, 3 H), 2.34 (s, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 149.6, 140.5, 137.2, 132.3, 129.4, 127.3, 121.8, 120.5, 119.0, 118.6, 
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116.5, 21.1, 20.5; LRMS (EI) 222 (M), 207 (M-Me); HRMS (EI) calcd for C15H14N2 (M) 222.1157, 
found 222.1155. 
5,6-Dimethoxy-2-phenyl-2H-indazole (3ca). White solid: mp 147-148 ºC (lit37 149-150 ºC); Rf 
= 0.26 (2:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.21 (s, 1 H), 7.84 (d, J = 7.7 Hz, 2 H), 
7.49 (t, J = 7.9 Hz, 2 H), 7.34 (t, J = 7.4 Hz, 1 H), 7.06 (s, 1 H), 6.89 (s, 1 H), 3.97 (s, 3 H), 3.93 (s, 
3 H); 13C NMR (75 MHz, CDCl3) δ 152.0, 148.4, 146.6, 140.5, 129.5, 127.0, 120.0, 119.1, 117.4, 
96.9, 95.8, 55.9; LRMS (EI) 254 (M); HRMS (EI) calcd for C15H14N2O2 (M) 254.1055, found 
254.1059. 
5-Methyl-2-phenyl-2H-indazole and 6-methyl-2-phenyl-2H-indazole (3da + 3da’). Slightly 
yellow solid: Rf = 0.26 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3, mixture of isomers, two 
sets of signals) δ 8.32 (s, 1 H), 8.27 (s, 1 H), 7.89 (s, 2 H), 7.87 (s, 2 H), 7.71 (d, J = 8.9 Hz, 1 H), 
7.59 (d, J = 8.6 Hz, 1 H), 7.53-7.47 (m, 4 H), 7.55 (s, 1 H), 7.43 (s, 1 H), 7.41-7.34 (m, 2 H), 7.17 
(d, J = 8.6 Hz, 1 H), 6.96 (d, J = 8.5 Hz, 1 H), 2.48 (s, 3 H), 2.43 (s, 3 H); 13C NMR (100 MHz, 
CDCl3, mixture of isomers) δ 150.3, 148.7, 140.5, 136.7, 131.7, 129.8, 129.4, 127.6, 125.4, 123.0, 
121.1, 120.73, 120.70, 120.1, 119.8, 119.4, 118.3, 117.5, 116.1, 22.3, 21.8 (some overlap); LRMS 
(EI) 208 (M); HRMS (EI) calcd for C14H12N2 (M) 208.1000, found 208.1003. 
5-Methoxy-2-phenyl-2H-indazole and 6-Methoxy-2-phenyl-2H-indazole (3ea + 3ea’). 
Yellow solid: Rf = 0.25 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3, mixture of isomers, two 
sets of signals) δ 8.27 (s, 1H), 8.22 (s, 0.8 H), 7.84 (d, J = 8.4 Hz, 3.6 H), 7.68 (d, J = 9.2 Hz, 0.8 H), 
7.53 (d, J = 9.2 Hz, 1 H), 7.48 (t, J = 7.8 Hz, 3.6 H), 7.36-7.32 (m, 1.8 H), 7.04-7.02 (m, 1.8 H), 
6.86 (d, J = 2.0 Hz, 0.8 H), 6.80 (dd, J = 8.8, 1.6 Hz, 1 H), 3.87 (s, 3 H), 3.82 (s, 2.4 H); 13C NMR 
(100 MHz, CDCl3, mixture of isomers) δ 159.5, 155.6, 151.0, 146.9, 140.7, 140.6, 129.6, 127.6, 
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127.5, 122.9, 122.2, 121.4, 120.7, 120.53, 120.50, 119.46, 119.41, 118.7, 118.0, 96.4, 94.7, 55.5, 
55.4 (one overlapped signal); LRMS (ESI) 225 (M+H); HRMS (ESI) calcd for C14H13N2O (M+H) 
225.1022, found 225.1022. 
4-Methyl-2-phenyl-2H-indazole and 7-methyl-2-phenyl-2H-indazole (3fa + 3fa’). Yellow 
oil: Rf = 0.35 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3, mixture of isomers, two sets of 
signals) δ 8.35 (s, 1 H), 8.32 (s, 0.7 H), 7.88(dd, J = 8.4, 2.0 Hz, 3.4 H), 7.62 (d, J = 8.8 Hz, 1 H), 
7.52-7.46 (m, 4.1 H), 7.37-7.34 (m, 1.7 H), 7.23-7.19 (m, 1 H), 7.07-6.98 (m, 1.4 H), 6.84 (d, J = 
6.8 Hz, 1 H), 2.68 (s, 2.1 H), 2.54 (s, 3 H); 13C NMR (100 MHz, CDCl3, mixture of isomers) δ 
150.3, 150.0, 140.8, 140.7, 130.7, 129.7, 128.2, 127.93, 127.89, 127.4, 125.8, 124.3, 122.9, 122.7, 
121.7, 121.3, 121.1, 120.9, 119.7, 117.9, 115.4, 19.3, 17.3; LRMS (ESI) 209 (M+H); HRMS (ESI) 
calcd for C14H13N2 (M+H) 209.1073, found 209.1078. 
2-Phenyl-2H-benzo[g]indazole and 2-phenyl-2H-benzo[e]indazole (3ga + 3ga’). Yellow gel: 
Rf = 0.42 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3, mixture of isomers, two sets of 
signals) δ 8.74 (d, J = 8.0 Hz, 1 H), 8.71 (s, 1 H), 8.33 (s, 1 H), 8.12 (d, J = 7.6 Hz, 1 H), 7.93 (t, J 
= 7.2 Hz, 4 H), 7.83 (d, J = 8.0 Hz, 2 H), 7.74 (d, J = 9.2 Hz, 1 H), 7.62 (m, 2 H), 7.52 (m, 8 H), 
7.38 (m, 3 H); 13C NMR (100 MHz, CDCl3, mixture of isomers) δ 148.9, 147.7, 140.7, 140.6, 
132.9, 130.6, 129.72, 129.69, 129.3, 129.1, 128.6, 127.6, 127.5, 127.4, 127.2, 127.1, 126.9, 125.8, 
125.6, 124.7, 123.6, 122.8, 121.2, 120.6, 120.5, 120.2, 120.0, 118.5, 117.9, 117.5; LRMS (ESI) 
245 (M+H); HRMS (ESI) calcd for C17H13N2 (M+H) 245.1073, found 245.1064. 
4-Methoxy-2-phenyl-2H-indazole (3ia). Following the general procedure, this product was 
isolated as a white gel by collecting the first spot: Rf = 0.24 (5:1 hexanes/EtOAc); 1H NMR (400 
MHz, CDCl3) δ 8.48 (s, 1 H), 7.89 (d, J = 8.1 Hz, 2 H), 7.51 (t, J = 7.7 Hz, 2 H), 7.44-7.33 (m, 2 H), 
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7.31-7.18 (m, 1 H), 6.35 (d, J = 7.3 Hz, 1 H), 3.96 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 153.4, 
151.2, 140.4, 129.5, 127.70, 127.65, 120.7, 119.0, 116.8, 110.3, 98.8, 55.2; LRMS (EI) 224 (M), 
209 (M-Me); HRMS (EI) calcd for C14H12N2O (M) 224.0950, found 224.0950. The 2D NMR 
spectra and the analysis are included in the SI. 
7-Methoxy-2-phenyl-2H-indazole (3ia’). The second spot of the aforementioned column 
chromatography afforded a yellow gel: Rf = 0.12 (5:1 hexanes/EtOAc). This material was stirred 
with 1 mL of Ac2O and 1 mL of pyridine at room temperature for 30 min. Then the volatiles were 
evaporated under a vacuum, and the product purified by column chromatography: 1H NMR (400 
MHz, CDCl3) δ 8.36 (s, 1 H), 7.93 (d, J = 8.0 Hz, 2 H), 7.49 (t, J = 7.8 Hz, 2 H), 7.37 (t, J = 7.4 Hz, 
1 H), 7.26 (d, J = 8.4 Hz, 1 H), 7.02 (dd, J = 8.4, 0.8 Hz, 1 H), 6.58 (d, J = 7.2 Hz, 1 H), 4.04 (s, 3 
H); 13C NMR (100 MHz, CDCl3) δ 150.6, 143.5, 140.5, 129.6, 128.0, 124.5, 123.3, 121.2, 120.8, 
112.5, 103.3, 55.7; LRMS (ESI) 225 (M+H), 247 (M+Na), 471 (2M+Na); HRMS (ESI) calcd for 
C14H13N2O (M+H) 225.1022, found 225.1024. This regioisomer matches the reported 1H and 13C 
NMR spectral data.18 
4-Methoxy-2-(4-methylphenyl)-2H-indazole (3id). Following the general procedure, this 
product was isolated as a white gel by collecting the first spot: Rf = 0.30 (5:1 hexanes/EtOAc); 1H 
NMR (400 MHz, CDCl3) δ 8.43 (s, 1 H), 7.76 (d, J = 7.6 Hz, 2 H), 7.36 (d, J = 8.4 Hz, 1 H), 7.29 
(d, J = 7.6 Hz, 2 H), 7.24-7.20 (m, 1 H), 6.34 (d, J = 7.2 Hz, 1 H), 3.94 (s, 3 H), 2.40 (s, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 153.6, 151.3, 138.3, 137.9, 130.2, 127.7, 120.8, 119.1, 116.9, 110.4, 
98.9, 55.4, 21.2; LRMS (ESI) 239 (M+H); HRMS (ESI) calcd for C15H15N2O (M+H) 239.1179, 
found 239.1179. 
7-Methoxy-2-(4-methylphenyl)-2H-indazole (3id’). The second spot of the aforementioned 
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column chromatography afforded a yellow gel: Rf = 0.22 (5:1 hexanes/EtOAc). This material was 
stirred with 1 mL of Ac2O and 1 mL of pyridine at room temperature for 30 min. Then the volatiles 
were evaporated under vacuum, and the product purified by column chromatography: 1H NMR 
(400 MHz, CDCl3) δ 8.31 (s, 1 H), 7.80 (d, J = 8.4 Hz, 2 H), 7.26 (t, J = 9.2 Hz, 3 H), 7.01 (t, J = 
7.8 Hz, 1 H), 6.57 (d, J = 7.6 Hz, 1 H), 4.03 (s, 3 H), 2.39 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 
150.5, 143.3, 138.3, 137.9, 130.0, 124.4, 123.1, 121.0, 120.6, 112.4, 103.1, 55.6, 21.2; LRMS (ESI) 
239 (M+H), 261 (M+Na); HRMS (ESI) calcd for C15H14N2ONa (M+Na) 261.0998, found 
261.0999. 
Procedure for the Suzuki-Miyaura Coupling with Boronic Acids. To a 4 dram vial were 
added the starting material 3at (~0.4 mmol), the boronic acid (1.5 equiv.), KOH (3.0 equiv.) and 
Pd(PPh3)4 (5 mol %) in 20 : 5 : 1 toluene/ethanol/H2O (4 mL in total). The solution was vigorously 
stirred for 5 min at room temperature, flushed with argon and sealed, and then heated to 80 ºC until 
TLC revealed complete conversion of the starting material. Upon cooling to room temperature, the 
resulting reaction mixture was diluted with water and extracted with EtOAc. The combined 
organic layers were dried over MgSO4, concentrated, and purified by column chromatography to 
afford the following product.  
3-(3,4-Methylenedioxyphenyl)-2-phenyl-2H-indazole (4at). Following the general procedure, 
this product was isolated as a brown solid: mp 154-156 ºC; Rf = 0.31 (5:1 hexanes/EtOAc); 1H 
NMR (400 MHz, CDCl3) δ 7.78 (d, J = 8.8 Hz, 1 H), 7.68 (d, J = 8.8 Hz, 1 H), 7.45 (d, J = 6.8 Hz, 
2 H), 7.42-7.33 (m, 4 H), 7.12 (dd, J = 8.0, 7.2 Hz, 1 H), 6.87-6.81 (m, 2 H), 6.78 (s, 1 H), 5.98 (s, 
2 H); 13C NMR (100 MHz, CDCl3) δ 149.0, 148.1, 147.9, 140.2, 135.3, 129.2, 128.4, 127.2, 126.1, 
124.0, 123.5, 122.5, 121.8, 120.6, 117.8, 110.0, 108.9, 101.5; LRMS (ESI) 315 (M+H); HRMS 
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(ESI) calcd for C20H15N2O2 (M+H) 315.1128, found 315.1125. 
Procedure for the Sonogashira Coupling with a Terminal Alkyne. To a 4 dram vial was 
added the starting material 3at (~0.4 mmol), the alkyne (1.2 equiv.), PdCl2(PPh3)2 (3 mol %), CuI 
(3 mol %), DMF (1.5 mL) and Et2NH (1.5 mL). The solution was stirred at room temperature, 
flushed with argon and sealed, and then heated to 60 ºC until TLC analysis revealed complete 
conversion of the starting material. The solution was allowed to cool and diluted with EtOAc. The 
combined organic layers were dried over MgSO4, concentrated, and purified by column 
chromatography to afford the following product. 
3-(3-Methoxyprop-1-ynyl)-2-phenyl-2H-indazole (5at). Yellow oil: Rf = 0.25 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.91 (d, J = 7.6 Hz, 2 H), 7.78 (dd, J = 15.6, 8.8 
Hz, 2 H), 7.53 (t, J = 7.8 Hz, 2 H), 7.46 (t, J = 7.2 Hz, 1 H), 7.36 (t, J = 7.6 Hz, 1 H), 7.20 (t, J = 7.4 
Hz, 1 H), 4.41 (s, 2 H), 3.43 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 148.7, 140.2, 129.2, 128.9, 
127.5, 126.1, 124.7, 123.6, 120.2, 118.5, 117.7, 96.7, 75.4, 60.7, 58.0; LRMS (ESI) 263 (M+H); 
HRMS (ESI) calcd for C17H15N2O (M+H) 263.1179, found 263.1180. 
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CHAPTER 5 
Synthesis of Isoindoles and 9,10-Dihydro-9,10-epiminoanthracenes by Aryne Dipolar 
Cycloaddition with Münchnones 
Yuesi Fang, and Richard C. Larock,* 
Department of Chemistry, Iowa State University, Ames, IA 50010, U.S.A. 
 
5.1. Abstract  
 
Münchnones react with arynes under mild reaction conditions to afford 1:1 and 1:2 adducts. The 
1:1 adduct, a 2H-isoindole, is formed by a [3 + 2] cycloaddition/[4 + 2] cycloreversion sequence, 
while the 1:2 adduct, a 9,10-dihydro-9,10-epiminoanthracene, is formed by a further [4 + 2] 
cycloaddition of the isoindole with the aryne. 
5.2. Introduction  
Recently, we have reported that the cycloaddition of arynes and sydnones affords high yields of 
isoindazoles.1 As another representative cyclic 1,3-dipole,2 münchnones have also attracted 
significant attention from the synthetic community.3 With our continuing interest in aryne 
cycloaddition chemistry, we were encouraged to examine the aryne cycloaddition chemistry of 
münchnones, which might hopefully lead to the formation of 2H-isoindoles.4 
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5.3. Results and Discussion  
  Preparation of the Münchnones. Münchnones can be prepared from amino acids as shown in 
Scheme 1. Münchnones with electron-withdrawing groups at the 4-position can be isolated as 
crystalline materials and exhibit satisfactory bench top stability. We started by preparing 
münchnones from sarcosine and benzoyl chloride, followed by treatment with acetic and 
trifluoroacetic anhydride, which lead to the münchnones 1a (R1 = Ph, R2 = Me, R3 = Me) and 1b 
(R1 = Ph, R2 = Me, R3 = CF3).5 Using a number of other aroyl chlorides and butyric anhydride, we 
were able to prepare a number of other closely related münchnones in good to excellent yields. 
Unfortunately, the preparation of münchnones with more diverse substitution has not been 
successful. Because an aqueous solution is used in the first step, the range of starting materials that 
can be employed is quite limited due to rapid hydrolysis of the acyl chloride. 
While keeping in mind that for sydnones the presence of electron-withdrawing groups at the 
4-position shuts down the aryne cycloaddition process,1 we hoped that replacement of the nitrogen 
of the sydnones by a carbon (position-2) in the preparation of münchnones would allow for a slight 
increase in the electron density of the latter and thus provide the desired reactivity with arynes. 
Scheme 1. Preparation of Münchnones. 
 
  Reaction and Mechanism. Indeed, although münchnone 1b proved unreactive towards 
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benzyne under the standard reaction conditions that were used for sydnones, münchnone 1a 
reacted smoothly with benzyne to afford two products, which were identified as isoindole 3a and a 
1:2 adduct 9,10-dihydro-9,10-epiminoanthracene 4a (Table 1, entry 1). The formation of these two 
products can be explained by the mechanism illustrated in Scheme 2. Thus, isoindole 3a is first 
formed by a [3 + 2] cycloaddition/[4 + 2] cycloreversion sequence, while the 1:2 adduct 4a is 
apparently formed by further [4 + 2] cycloaddition of the isoindole with benzyne, a process which 
has been observed previously.4a,6 The ratio of the two products depends on the reaction conditions 
and the stoichiometry as summarized in Table 1. Using a 2-fold excess of the aryne led to the 
exclusive formation of 4a in a high yield (entry 5). 
Table 1. Survey of the Reaction Conditions.a 
 
entry 1a : 2a F-/equiv solvent, temp 3a (%b) 4a (%b) 
1 1 : 1 TBAF/1.5 THF, rt 25 31 
2 1 : 1 CsF/1.5 MeCN, rt 24 27 
3 1 : 1.5 TBAF/2.2 THF, rt 40 47 
4 1 : 2 TBAF/3.0 THF, rt - 76 
5 1 : 3 TBAF/4.5 THF, rt - 86 
6 1.1 : 1 TBAF/1.6 THF, rt 21 27 
7 1.5 : 1 TBAF/2.2 THF, -78 ºC to rt 33 42 
a
 All reactions were carried out on a 0.25 mmol scale in 4 mL of the solvent for 1 d. b Isolated yield. 
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Scheme 2. Reaction Mechanism. 
 
  Scope and Limitations. The scope of the 9,10-dihydro-9,10-epiminoanthracene synthesis has 
been briefly examined (Table 2). While the presence of a trifluoroacetyl group in the 4 position of 
the münchnone gave none of the desired tricyclic product (entry 1), an electron-withdrawing 
acetyl group works well and the acetyl group can be replaced by a butyryl group (4f, entry 6). The 
reaction affords good yields of 9,10-dihydro-9,10-epiminoanthracenes with a variety of aryl 
groups present in the 2 position (R1) of the münchnone, including phenyl groups with 
electron-withdrawing (4b and 4c, entries 2 and 3) and -donating (4d and 4e, entries 4 and 5) groups. 
A heteroaryl group (4g) can also be employed in this reaction (entry 7). Different arynes have been 
examined in this reaction and been found to afford products 4h through 4j in high yields (entries 
8-10). Unfortunately, it is difficult to prepare münchnones with a wide variety of other substituents 
present in order to more fully explore the scope of this process. 
Table 2. Synthesis of 9,10-Dihydro-9,10-epiminoanthracenes.a 
1
N
O
EWG
Me
O
R1
TBAF (4.5 equiv)
THF, rt, 1d
N
Me
EWG
R1
OTf
TMS
R3
R3 R3
2
4
4
5
 
entry münchnone aryne precursor product yieldb (%) 
1 
 
1b 
2a nr -c 
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Table 2 continued 
2 
 
1c 
2a 
 
4b 
75 
3 
 
1d 
2a 
 
4c 
76 
4 
 
1e 
2a 
 
4d 
88 
5 
 
1f 
2a 
 
4e 
89 
6 
 
1g 
2a 
 
4f 
92 
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Table 2 continued 
7 
 
1h 
2a 
 
4g 
60 
8  
1a 
2b 
 
4h 
88 
9 1e 2b 
 
4i 
85 
10 1a 2c 
 
4j 
75 
a
 All reactions were carried out on a 0.25 mmol scale in 4 mL of THF with 3 equiv of aryne 
precursor and 4.5 equiv of TBAF. b Isolated yield. c All münchnone starting material was 
recovered. 
  The scope of the 2H-isoindole (3) synthesis has also been briefly examined on selected 
münchnones using only 1.5 equiv of two different aryne precursors (Table 3). Some reactions 
afford modest yields to isoindoles, which exhibit various levels of instability. Although carefully 
controlling the stoichiometry, we failed to obtain decent amounts of the desired 2H-isoindoles 3b 
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and 3c from münchnones bearing electron-deficient aromatic groups (entries 1 and 2). Both 
münchnones afforded predominantly the 1:2 adducts 4b and 4c under our reaction conditions. 
Similar results have been seen when using a thiophene-containing starting material (entry 6). 
However, modest amounts of the 2H-isoindoles 3d, 3e, and 3f have been obtained when using 
tolyl-substituted münchnones or a benzoyl-substituted substrate, although these products were 
accompanied by large amounts of the corresponding 9,10-dihydro-9,10-epiminoanthracenes 4 
(entries 3-5). A similar pattern of reactivity has been observed when using a dimethyl-substituted 
aryne precursor (entries 7 and 8). 
Table 3. Synthesis of 2H-Isoindoles.a 
 
entry münchnone aryne precursor product 3 yieldb (%) 
product 4 (% 
yieldc) 
1 1c 2a 
 
3b 
8d 4b (52%) 
2 1d 2a 
 
3c 
traced 4c (55%) 
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Table 3 continued 
3 1e 2a 
N
Ac
Me
Me
 
3d 
37 4d (48%) 
4 1f 2a 
N
Ac
Me
Me
 
3e 
41 4e (46%) 
5 1g 2a 
N
Ph
Me
O
 
3f 
33 4f (53%) 
6 1h 2a 
 
3g 
9d 4g (42%) 
7 1a 2b 
 
3h 
traced 4h (62%) 
8 1e 2b 
 
3i 
15 4i (57%) 
a
 All reactions were carried out on a 0.25 mmol scale in 4 mL of THF with 1.5 equiv of aryne 
precursor and 2.2 equiv of TBAF. b Isolated yield. c GC yield. d Detected by GC-MS. 
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5.4. Conclusions  
  In summary, we have shown that münchnones and arynes react under mild reaction conditions to 
afford 2H-isoindoles by a [3 + 2] cycloaddition/[4 + 2] cycloreversion sequence. However, these 
compounds are highly reactive towards arynes under our reaction conditions and can thus only be 
obtained in relatively low yields. Instead, they readily react further with an excess of aryne to 
afford 9,10-dihydro-9,10-epiminoanthracenes in good to excellent yields by a [4 + 2] 
cycloaddition.  
5.5. Experimental Section  
General Information. The solvent THF was distilled over Na/benzophenone, and 
dichloromethane was distilled over CaH2. Anhydrous MeCN and the aryne precursors were used 
as received from commercial sources. Silica gel for column chromatography was supplied as 
230-400 mesh from a commercial source. Powdered CsF and TBAF (1 M in THF solution) were 
used as received and stored in a desiccator. 
All melting points are uncorrected. The 1H and 13C NMR spectra were recorded and are 
referenced to the residual solvent signals (7.26 ppm for 1H and 77.2 ppm for 13C in CDCl3). A 
QTOF analyzer was used for all of the HRMS measurements. 
  Synthesis of the Münchnones. Compounds 1a through 1h were prepared as follows.  
  4-Acetyl-3-methyl-2-phenylmünchnone (1a). To a solution of 1.335 g (15 mmol) of sarcosine 
and 1 g (25 mmol) of NaOH in 20 mL of water was added 1.4 g (10 mmol) of benzoyl chloride in 
one portion. The mixture was allowed to stir for 12 h before acidifying with 10% aq HCl and 
extracting three times with EtOAc. The combined organic layers were evaporated under high 
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vacuum to obtain 1.9 g (9.8 mmol) of N-methylhippuric acid as a white solid. This compound was 
dissolved in 20 mL of acetic anhydride and allowed to stir at 100 ºC for 1 h before being poured 
into ice water. Solid NaHCO3 was added to neutralize the mixture and 1.78 g (8.2 mmol, 82% 
overall yield) of münchnone 1a was obtained as a yellow solid after filtration: mp 118-120 ºC; 1H 
NMR (400 MHz, CDCl3) δ 7.71-7.58 (m, 5 H), 4.14 (s, 3 H), 2.47 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 186.5, 161.8, 133.3, 129.7, 129.3, 121.5, 109.5, 99.8, 37.2, 27.7; HRMS (ESI) calcd for 
C12H12NO3 (M+H) 218.0812, found 218.0810. 
  3-Methyl-2-phenyl-4-(2,2,2-trifluoroacetyl)münchnone (1b). This münchnone was prepared 
according to a literature procedure5 as a pale white solid (85% overall yield). 
  4-Acetyl-2-(4-chlorophenyl)-3-methylmünchnone (1c). The above procedure was applied to 
1.335 g (15 mmol) of sarcosine and 1.75 g (10 mmol) of 4-chlorobenzoyl chloride, followed by 20 
mL of acetic anhydride, to afford 2.16 g (8.6 mmol, 86% overall yield) of münchnone 1c as a 
yellow solid: mp 101-103 ºC; 1H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 8.8 Hz, 2 H), 7.58 (d, J = 
8.8 Hz, 2 H), 4.14 (s, 3 H), 2.46 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 186.6, 161.6, 148.5, 140.0, 
130.5, 130.2, 119.8, 99.8, 37.2, 27.6; HRMS (ESI) calcd for C12H11ClNO3 (M+H) 252.0422, found 
252.0415. 
  4-Acetyl-2-(4-fluorophenyl)-3-methylmünchnone (1d). The above procedure was applied to 
1.335 g (15 mmol) of sarcosine and 1.59 g (10 mmol) of 4-fluorobenzoyl chloride, followed by 20 
mL of acetic anhydride, to afford 1.83 g (7.8 mmol, 78% overall yield) of münchnone 1d as a soft 
yellow material: 1H NMR (400 MHz, CDCl3) δ 7.72 (t, J = 5.6 Hz, 2 H), 7.29 (t, J = 8.0 Hz, 2 H), 
4.12 (s, 3 H), 2.45 (s, 3 H); the 13C NMR spectrum could not be obtained due to decomposition; 
HRMS (ESI) calcd for C12H11FNO3 (M+H) 236.0717, found 236.0713. 
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  4-Acetyl-3-methyl-2-(p-tolyl)münchnone (1e). The above procedure was applied to 1.335 g 
(15 mmol) of sarcosine and 1.54 g (10 mmol) of 4-methylbenzoyl chloride, followed by 20 mL of 
acetic anhydride, to afford 2.08 g (9.0 mmol, 90% overall yield) of münchnone 1e as a yellow solid: 
mp 135-137 ºC; 1H NMR (400 MHz, CDCl3) δ 7.59 (d, J = 8.4 Hz, 2 H), 7.39 (d, J = 8.0 Hz, 2 H), 
4.13 (s, 3 H), 2.47 (s, 3 H), 2.46 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 186.4, 161.8, 149.9, 144.5, 
130.4, 129.2, 118.6, 99.7, 37.2, 27.6, 22.0; HRMS (ESI) calcd for C13H14NO3 (M+H) 232.0968, 
found 232.0963. 
  4-Acetyl-3-methyl-2-(m-tolyl)münchnone (1f). The above procedure was applied to 1.335 g 
(15 mmol) of sarcosine and 1.54 g (10 mmol) of 3-methylbenzoyl chloride, followed by 20 mL of 
acetic anhydride, to afford 2.12 g (9.2 mmol, 92% overall yield) of münchnone 1f as a yellow solid: 
mp 108-109 ºC; 1H NMR (400 MHz, CDCl3) δ 7.51 (d, J = 2.0 Hz, 1 H), 7.49-7.45 (m, 3 H), 4.13 
(s, 3 H), 2.47 (s, 3 H), 2.46 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 186.4, 161.8, 149.8, 139.9, 
134.2, 129.8, 129.5, 126.4, 121.4, 99.8, 37.2, 27.6, 21.6; HRMS (ESI) calcd for C13H14NO3 (M+H) 
232.0968, found 232.0965. 
  4-Butyryl-3-methyl-2-phenylmünchnone (1g). The above procedure was applied to 1.335 g 
(15 mmol) of sarcosine and 1.4 g (10 mmol) of benzoyl chloride, followed by 20 mL of butyric 
anhydride, to afford 1.1 g (4.5 mmol, 45% overall yield) of münchnone 1g as a soft yellow material: 
1H NMR (300 MHz, CDCl3) δ 7.71-7.59 (m, 5 H), 4.15 (s, 3 H), 2.82 (t, J = 7.5 Hz, 2 H), 1.71 (tq, 
J = 7.5, 7.2 Hz, 2 H), 1.00 (t, J = 7.5 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 189.8, 161.5, 149.6, 
133.2, 129.6, 129.3, 121.6, 99.7, 41.3, 37.3, 18.4, 14.1; HRMS (ESI) calcd for C14H16NO3 (M+H) 
246.1125, found 246.1118. 
  4-Acetyl-3-methyl-2-(thiophen-2-yl)münchnone (1h). The above procedure was applied to 
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1.335 g (15 mmol) of sarcosine and 1.46 g (10 mmol) of thiophene-2-carbonyl chloride, followed 
by 20 mL of acetic anhydride, to afford 1.76 g (7.9 mmol, 79% overall yield) of münchnone 1h as 
a yellow solid: mp 142-143 ºC; 1H NMR (400 MHz, CDCl3) δ 7.81-7.78 (m, 2 H), 7.29 (dd, J = 5.2, 
4.0 Hz, 1 H), 4.28 (s, 3 H), 2.45 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 186.1, 161.1, 144.9, 133.7, 
133.6, 129.1, 122.2, 99.1, 35.9, 27.7; HRMS (ESI) calcd for C10H10NO3S (M+H) 224.0376, found 
224.0370. 
  Synthesis of the 9,10-Dihydro-9,10-epiminoanthracenes.  
  Compounds 4a through 4j were prepared according to the following representative procedure. 
To an oven-dried vial was added sequentially 0.75 mmol of the aryne precursor, 0.25 mmol of 
münchnone, 3 mL of THF, and 1.125 mL of 1M TBAF/THF solution (1.125 mmol). A nitrogen 
atmosphere was not required, except that a balloon of nitrogen was attached to the reaction vial for 
ventilation of the CO2. The reaction was allowed to stir for 24 h before being quenched with aq 
NaHCO3 and extracted three times with EtOAc. The combined organic layers were washed with 
brine, dried over Na2SO4, filtered, and concentrated. The residue was purified by column 
chromatography (petroleum ether/ EtOAc) to afford the desired products. 
  1-(11-Methyl-10-phenyl-9,10-dihydro-9,10-epiminoanthracen-9-yl)ethanone (4a). The 
representative procedure was applied to 54.3 mg (0.25 mmol) of münchnone 1a to afford 69.9 mg 
(0.22 mmol, 86% yield) of compound 4a as a yellow solid: mp 111-113 ºC; Rf = 0.62 (2:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.02 (br s, 1 H), 7.87 (d, J = 8.0 Hz, 2 H), 
7.56 (t, J = 8.0 Hz, 2 H), 7.49 (t, J = 6.8 Hz, 2 H), 7.18-7.02 (br m, 6 H), 2.55 (s, 3 H), 2.02 (s, 3 H); 
13C NMR (100 MHz, CDCl3) δ 207.0, 150.7, 150.0, 146.9, 146.2, 132.7, 130.1, 128.9, 128.7, 
126.05, 125.98, 125.88, 125.7, 125.6, 124.9, 122.1, 119.3, 84.3, 81.6, 32.4, 28.3; HRMS (ESI) 
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calcd for C23H20NO (M+H) 326.1539, found 326.1532. 
  1-[10-(4-Chlorophenyl)-11-methyl-9,10-dihydro-9,10-epiminoanthracen-9-yl]ethanone 
(4b). The representative procedure was applied to 62.9 mg (0.25 mmol) of münchnone 1c to afford 
67.5 mg (0.19 mmol, 75% yield) of compound 4b as a yellow solid: mp 118-120 ºC; Rf = 0.4 (5:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.99 (br s, 1 H), 7.80 (d, J = 8.4 Hz, 2 H), 
7.52 (d, J = 8.4 Hz, 2 H), 7.42 (d, J = 7.6 Hz, 1 H), 7.12-7.03 (br m, 6 H), 2.53 (s, 3 H), 1.99 (s, 3 H); 
13C NMR (100 MHz, CDCl3) δ 206.3, 151.2, 150.0, 147.0, 146.5, 134.8, 132.2, 131.5, 129.1, 126.1, 
125.83, 125.78, 124.6, 121.7, 119.4, 84.7, 81.4, 32.4, 28.1; HRMS (ESI) calcd for C23H19ClNO 
(M+H) 360.1150, found 360.1143. 
  1-[10-(4-Fluorophenyl)-11-methyl-9,10-dihydro-9,10-epiminoanthracen-9-yl]ethanone 
(4c). The representative procedure was applied to 58.8 mg (0.25 mmol) of münchnone 1d to afford 
65.2 mg (0.19 mmol, 76% yield) of compound 4c as a yellow gel-like material: Rf = 0.3 (5:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.00 (br s, 1H), 7.85 (td, J = 7.2, 2.4 Hz, 2 
H), 7.43 (br s, 1 H), 7.24 (t, J = 8.4 Hz, 2 H), 7.10-7.06 (br m, 6 H), 2.53 (s, 3 H), 1.99 (s, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 206.3, 164.2, 161.7, 151.3, 150.1, 147.2, 146.6, 132.05, 131.97, 130.5, 
129.7, 129.4, 129.3, 126.1, 124.7, 121.8, 119.4, 115.9, 115.7, 84.6, 81.4, 32.3, 28.1; HRMS (ESI) 
calcd for C23H19FNO (M+H) 344.1445, found 344.1455. 
  1-[11-Methyl-10-(p-tolyl)-9,10-dihydro-9,10-epiminoanthracen-9-yl]ethanone (4d). The 
representative procedure was applied to 57.8 mg (0.25 mmol) of münchnone 1e to afford 74.6 mg 
(0.22 mmol, 88% yield) of compound 4d as a yellow solid: mp 87-89 ºC; Rf = 0.28 (5:1 petroleum 
ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.01 (br s, 1 H), 7.76 (d, J = 8.0 Hz, 2 H), 7.47 (br s, 
1 H), 7.37 (d, J = 8.0 Hz, 2 H), 7.26-7.06 (br m, 6 H), 2.55 (s, 3 H), 2.48 (s, 3 H), 2.02 (s, 3 H); 13C 
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NMR (100 MHz, CDCl3) δ 206.6, 151.6, 150.2, 147.6, 146.7, 138.4, 130.4, 130.0, 129.5, 126.0, 
125.7, 125.6, 124.8, 122.0, 119.3, 84.7, 81.7, 32.4, 28.1, 21.4; HRMS (ESI) calcd for C24H22NO 
(M+H) 340.1696, found 340.1694. 
  1-[11-Methyl-10-(m-tolyl)-9,10-dihydro-9,10-epiminoanthracen-9-yl]ethanone (4e). The 
representative procedure was applied to 57.7 mg (0.25 mmol) of münchnone 1f to afford 75.5 mg 
(0.22 mmol, 89% yield) of compound 4e as a yellow solid: mp 146-148 ºC; Rf = 0.3 (5:1 petroleum 
ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.01 (br s, 1 H), 7.66 (d, J = 8.8 Hz, 2 H), 7.50 (br s, 
1 H), 7.45 (t, J = 8.0 Hz, 1 H), 7.31 (d, J = 7.2 Hz, 1 H), 7.20-7.03 (br m, 6 H), 2.55 (s, 3 H), 2.47 
(s, 3 H), 2.03 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 206.6, 151.6, 150.1, 147.5, 146.7, 138.5, 
133.4, 130.6, 129.5, 129.4, 128.7, 127.2, 126.0, 124.9, 122.0, 119.3, 84.7, 81.9, 32.5, 28.1, 21.8; 
HRMS (ESI) calcd for C24H22NO (M+H) 340.1696, found 340.1690. 
  1-[11-Methyl-10-phenyl-9,10-dihydro-9,10-epiminoanthracen-9-yl]butan-1-one (4f). The 
representative procedure was applied to 61.2 mg (0.25 mmol) of münchnone 1g to afford 81.3 mg 
(0.23 mmol, 92% yield) of compound 4f as a yellow solid: mp 160-161 ºC; Rf = 0.41 (5:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.04 (br s, 1 H), 7.88 (dd, J = 7.2, 1.6 Hz, 
2 H), 7.56 (t, J = 7.2 Hz, 2 H), 7.49 (t, J = 6.8 Hz, 2 H), 7.15-6.99 (br m, 6 H), 2.99-2.85 (m, 2 H), 
2.01 (s, 3 H), 1.82 (tq, J = 7.6, 7.2 Hz, 2 H), 1.02 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 
δ 208.6, 151.5, 150.5, 147.4, 147.0, 133.6, 130.1, 128.8, 128.6, 125.9, 124.8, 121.9, 119.4, 84.5, 
81.9, 41.9, 32.5, 16.8, 14.0; HRMS (ESI) calcd for C25H24NO (M+H) 354.1852, found 354.1862. 
  1-[11-Methyl-10-(thiophen-2-yl)-9,10-dihydro-9,10-epiminoanthracen-9-yl]ethanone (4g). 
The representative procedure was applied to 55.8 mg (0.25 mmol) of münchnone 1h to afford 49.6 
mg (0.15 mmol, 60% yield) of compound 4g as a yellow gel-like material: Rf = 0.5 (2:1 petroleum 
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ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.99 (br s, 1 H), 7.58 (br s, 1 H), 7.53 (td, J = 4.8, 1.2 
Hz, 2 H), 7.32 (br s, 1 H), 7.13-7.03 (br m, 5 H), 6.72 (d, J = 7.2 Hz, 1 H), 2.53 (s, 3 H), 2.04 (s, 3 
H); 13C NMR (100 MHz, CDCl3) δ 206.3, 156.0, 151.3, 149.4, 147.4, 145.7, 136.4, 129.8, 129.4, 
127.4, 127.2, 126.2, 124.2, 121.7, 120.6, 119.3, 115.5, 84.4, 78.9, 32.4, 28.1; HRMS (ESI) calcd 
for C21H18NOS (M+H) 332.1104, found 332.1104. 
1-(2,3,6,7,11-Pentamethyl-10-phenyl-9,10-dihydro-9,10-epiminoanthracen-9-yl)ethanone 
(4h). The representative procedure was applied to 54.3 mg (0.25 mmol) of münchnone 1a to afford 
83.9 mg (0.22 mmol, 88% yield) of compound 4h as a yellow solid: mp 226-227 ºC; Rf = 0.54 (2:1 
petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 7.6 Hz, 2 H), 7.74 (s, 1 H), 
7.52 (t, J = 7.6 Hz, 2 H), 7.45 (t, J = 7.2 Hz, 1 H), 7.21 (s, 1 H), 6.89 (d, J = 4.0 Hz, 1 H), 6.85 (d, 
J = 6.8 Hz, 1 H), 2.51 (s, 3 H), 2.16-2.10 (br m, 12 H), 1.99 (s, 3 H); 13C NMR (100 MHz, CDCl3) 
δ 207.1, 149.3, 148.1, 145.1, 144.4, 133.9, 133.6, 133.4, 130.2, 128.7, 128.5, 128.0, 127.0, 126.2, 
123.4, 120.7, 116.8, 84.6, 81.7, 32.5, 28.1, 20.04, 20.02; HRMS (ESI) calcd for C27H28NO (M+H) 
382.2165, found 382.2175. 
1-(2,3,6,7,11-Pentamethyl-10-(p-tolyl)-9,10-dihydro-9,10-epiminoanthracen-9-yl)ethanon
e (4i). The representative procedure was applied to 57.8 mg (0.25 mmol) of münchnone 1e to 
afford 84.0 mg (0.21 mmol, 85% yield) of compound 4i as a yellow solid: mp 190-191 ºC; Rf = 
0.31 (5:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 8.0 Hz, 2 H), 7.37 (d, 
J = 8.0 Hz, 2 H), 7.22 (s, 1 H), 6.94 (s, 1 H), 6.87 (s, 1 H), 6.38 (s, 1 H), 2.54 (s, 3 H), 2.48 (s, 3 H), 
2.22-2.14 (br m, 12 H), 2.01 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 207.2, 154.2, 149.4, 148.1, 
145.2, 144.4, 138.3, 137.8, 133.8, 133.6, 133.4, 130.8, 130.1, 129.4, 128.0, 127.0, 126.3, 84.6, 
81.5, 32.4, 28.1, 21.5, 20.1, 20.0; HRMS (ESI) calcd for C28H30NO (M+H) 396.2322, found 
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396.2327. 
1-(2,3,6,7-Tetramethoxy-11-methyl-10-phenyl-9,10-dihydro-9,10-epiminoanthracen-9-yl)
ethanone (4j). The representative procedure was applied to 54.3 mg (0.25 mmol) of münchnone 
1a to afford 83.5 mg (0.19 mmol, 75% yield) of compound 4j as a yellow gel-like material: Rf = 0.2 
(2:1 petroleum ether/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.84 (dd, J = 8.4, 1.6 Hz, 2 H), 7.67 (s, 
1 H), 7.57 (t, J = 7.6 Hz, 2 H), 7.49 (d, J = 7.6 Hz, 1 H), 7.04 (s, 1 H), 6.77 (s, 1 H), 6.67 (s, 1 H), 
3.89-3.75 (br m, 12 H), 2.52 (s, 3 H), 1.99 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 207.4, 146.7, 
146.5, 146.4, 146.2, 144.5, 143.5, 140.1, 140.0, 133.7, 130.0, 129.0, 128.7, 110.3, 109.9, 107.3, 
104.6, 84.8, 82.2, 56.6, 56.5, 32.6, 28.1; HRMS (ESI) calcd for C27H28NO5 (M+H) 446.1962, 
found 446.1966. 
  Compounds 3a, 3d, 3e, 3f, and 3i were prepared according to the following representative 
procedure. To an oven-dried vial was added sequentially 0.375 mmol of the aryne precursor, 0.25 
mmol of münchnone, 3.5 mL of THF, and 0.55 mL of 1M TBAF/THF solution (0.55 mmol). A 
nitrogen atmosphere was not required, except that a balloon of nitrogen was attached to the 
reaction vial for ventilation of the CO2. The reaction was allowed to stir for 24 h before being 
quenched with aq NaHCO3 and extracted with EtOAc. The combined organic layers were washed 
with brine, dried over Na2SO4, filtered, and concentrated. The residue was purified by column 
chromatography (petroleum ether/ EtOAc) to afford the desired products. 
  1-(2-Methyl-3-phenyl-2H-isoindol-1-yl)ethanone (3a). The representative procedure was 
applied to 54.3 mg (0.25 mmol) of münchnone 1a to afford 24.9 mg (0.10 mmol, 40% yield) of 
compound 3a as a yellow solid: mp 105-107 ºC; Rf = 0.15 (5:1 petroleum ether/EtOAc); 1H NMR 
(400 MHz, CDCl3) δ 7.93 (d, J = 8.8 Hz, 1 H), 7.58-7.54 (m, 3 H), 7.52-7.48 (m, 3 H), 7.35 (tq, J = 
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7.6, 1.2 Hz, 1 H), 7.11 (tq, J = 7.6, 1.2 Hz, 1 H), 4.18 (s, 3 H), 2.78 (s, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 186.7, 135.9, 133.5, 130.8, 130.0, 129.2, 129.1, 126.6, 124.3, 122.2, 121.8, 121.4, 119.9, 
37.4, 31.0; HRMS (ESI) calcd for C17H16NO (M+H) 250.1226, found 150.1227. 
  1-[2-Methyl-3-(p-tolyl)-2H-isoindol-1-yl]ethanone (3d). The representative procedure was 
applied to 57.8 mg (0.25 mmol) of münchnone 1e to afford 24.4 mg (0.09 mmol, 37% yield) of 
compound 3d as a green solid: mp 86-88 ºC; Rf = 0.14 (5:1 petroleum ether/EtOAc); 1H NMR (400 
MHz, CDCl3) δ 7.92 (J = 8.8 Hz, 1 H), 7.57 (d, J = 8.4 Hz, 1 H), 7.40-7.33 (m, 5 H), 7.10 (tq, J = 
7.6, 0.8 Hz, 1 H), 4.17 (s, 3 H), 2.77 (s, 3 H), 2.47 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 186.5, 
139.2, 136.3, 130.6, 129.8, 129.2, 127.0, 126.6, 124.3, 122.0, 121.6, 121.5, 119.8, 37.4, 30.9, 21.6; 
HRMS (ESI) calcd for C18H18NO (M+H) 264.1383, found 264.1385. 
  1-[2-Methyl-3-(m-tolyl)-2H-isoindol-1-yl]ethanone (3e). The representative procedure was 
applied to 57.8 mg (0.25 mmol) of münchnone 1f to afford 27.0 mg (0.10 mmol, 41% yield) of 
compound 3e as a green solid: mp 68-70 ºC; Rf = 0.19 (5:1 petroleum ether/EtOAc); 1H NMR (400 
MHz, CDCl3) δ 7.92 (d, J = 8.8 Hz, 1 H), 7.57 (d, J = 8.4 Hz, 1 H), 7.44 (t, J = 7.2 Hz, 1 H), 
7.37-7.26 (m, 4 H), 7.10 (t, J = 7.6 Hz, 1 H), 4.18 (s, 3 H), 2.78 (s, 3 H), 2.46 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 186.6, 138.8, 136.3, 131.3, 130.0, 129.9, 129.2, 128.9, 127.9, 126.6, 124.4, 
122.0, 121.7, 121.5, 119.8, 37.4, 30.9, 21.7; HRMS (ESI) calcd for C18H18NO (M+H) 264.1383, 
found 264.1384. 
  1-(2-Methyl-3-phenyl-2H-isoindol-1-yl)butan-1-one (3f). The representative procedure was 
applied to 61.2 mg (0.25 mmol) of münchnone 1g to afford 22.9 mg (0.08 mmol, 33% yield) of 
compound 3f as a blue solid: mp 79-81 ºC; Rf = 0.27 (5:1 petroleum ether/EtOAc); 1H NMR (400 
MHz, CDCl3) δ 7.91 (d, J = 8.8 Hz, 1 H), 7.58-7.54 (m, 3 H), 7.51-7.48 (m, 3 H), 7.34 (tq, J = 7.6, 
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1.2 Hz, 1 H), 7.10 (tq, J = 7.6, 0.8 Hz, 1 H), 4.18 (s, 3 H), 3.08 (t, J = 7.2 Hz, 2 H), 1.89 (tq, J = 7.6, 
7.2 Hz, 2 H), 1.11 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 189.9, 135.8, 130.8, 130.2, 
129.1, 129.0, 128.4, 126.5, 124.3, 122.1, 121.8, 121.4, 120.0, 44.3, 37.6, 18.5, 14.4; HRMS (ESI) 
calcd for C19H20NO (M+H) 278.1539, found 278.1540. 
  1-[2,5,6-Trimethyl-3-(p-tolyl)-2H-isoindol-1-yl]ethanone (3i). The representative procedure 
was applied to 57.8 mg (0.25 mmol) of münchnone 1e to afford 10.9 mg (0.04 mmol, 15% yield) of 
compound 3i as a yellow solid: mp 110-112 ºC; Rf = 0.13 (5:1 petroleum ether/EtOAc); 1H NMR 
(400 MHz, CDCl3) δ 7.66 (s, 1 H), 7.38-7.34 (m, 4 H), 7.29 (s, 1 H), 4.12 (s, 3 H), 2.75 (s, 3 H), 
2.47 (s, 3 H), 2.42 (s, 3 H), 2.29 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 186.1, 139.0, 136.8, 135.6, 
131.8, 130.6, 129.7, 128.8, 127.3, 123.7, 121.1, 120.4, 119.4, 30.9, 21.62, 21.56, 21.50, 20.4; 
HRMS (ESI) calcd for C20H22NO (M+H) 292.1696, found 292.1700. 
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CHAPTER 6 
General Conclusions 
  Due to their convenience, functional group tolerance, and the mild reaction conditions under 
which they provide the corresponding arynes, Kobayashi-type aryne precursors, namely 
o-(trimethylsilyl)aryl triflates, have been widely employed in organic synthesis.  In this thesis, 
we have developed a number of new applications of these aryne precursors in organic synthesis. 
  Chapter 1 provides the reader a brief overview of arynes, including their generation, and the 
typical reactions they undergo. 
  Chapter 2 describes the development of 2,3-pyridyne, one type of hetaryne, generated from a 
Kobayashi-type of aryne precursor.  It is remarkable that amine nucleophiles attack the 2 
position of 2,3-pyridyne exclusively, affording 2-aminopyridines.  Additionally, a series of 
benzonaphthyridinones have been synthesized by reacting 2,3-pyridyne with o-aminobenzoates. 
  Chapter 3 examines the reactions of β-lactams and arynes.  Acridones are generated from 
β-lactams, as well as from 2,3-dihydroquinolin-4-ones. This unique process involves an unusual 
extrusion of a molecule of ethylene.   
  Chapter 4 reports a rapid and efficient synthesis of 2H-indazoles using a [3 + 2] dipolar 
cycloaddition of sydnones and arynes.  It is noteworthy that 2H-indazoles are generated without 
contamination by 1H-indazoles.  Subsequent Pd-catalyzed coupling reactions can be applied to 
the halogenated products to generate a library of indazoles. 
  Chapter 5 describes new methodology for synthesizing 2H-isoindoles and 
9,10-dihydro-9,10-epiminoanthracenes from arynes and münchnones, which involves a [3 + 2] 
dipolar cycloaddition very similar to the first step of the sydnone reactions.  After cycloreversion, 
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the resulting 2H-isoindoles, being extremely reactive to arynes, immediately form 
9,10-dihydro-9,10-epiminoanthracenes quite efficiently. 
  The success of these reactions is made possible by the versatility of the Kobayashi aryne 
precursors.  Although elimination of the TMS and OTf groups reduces the effective atom 
utilization of the benzyne precursor, the mild reaction conditions under which the aryne is 
generated have attracted significant attention and contributed to the rapid growth in synthetic 
aryne chemistry.  However, it is noticeable that since 1983, when Kobayashi first introduced 
this type of benzyne formation, little progress was made in this area until the early 2000’s.  
Recently, aryne chemistry appears to be a particularly “hot” area in organic synthesis.  So what 
is likely to be the next powerful synthetic methodology employing arynes to be disclosed?  
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APPENDIX A. CHAPTER 2 1H AND 13C NMR SPECTRA 
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APPENDIX B. CHAPTER 3 1H AND 13C NMR SPECTRA 
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APPENDIX C. CHAPTER 4 COMPUTATIONAL DATA, 1H AND 13C NMR SPECTRA 
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Coordinates obtained from computational results: 
 
R1 benzyne 
C 0.70365 1.05843 0.00003 
C -0.70358 1.05847 0.00003 
C -1.46151 -0.13352 -0.00013 
C -0.62556 -1.23765 0.00009 
C 0.62546 -1.23764 0.00008 
C 1.46151 -0.1336 -0.00013 
H 1.22878 2.01132 0.00016 
H -1.22865 2.01139 0.00016 
H -2.54672 -0.13475 -0.00006 
H 2.54673 -0.13491 -0.00005 
 
R2, sydnone 2a 
C 2.81574 0.31815 -0.13556 
C 1.514 0.85201 -0.334 
O 2.5172 -1.0016 0.38566 
H 1.2161 1.78972 -0.76772 
C -0.79846 -0.01409 0.0136 
C -1.41618 1.20673 0.2868 
177 
C -1.53894 -1.1576 -0.28968 
C -2.80777 1.28152 0.24544 
H -0.82136 2.07531 0.54927 
C -2.92934 -1.06831 -0.31762 
H -1.0267 -2.08914 -0.50068 
C -3.56477 0.14763 -0.05559 
H -3.29834 2.22631 0.45905 
H -3.51557 -1.95122 -0.55386 
H -4.64855 0.21113 -0.08462 
N 0.6343 -0.0989 0.0442 
N 1.1799 -1.21021 0.48699 
O 3.95146 0.68979 -0.29818 
 
 
 
 
 
178 
Intermediate 
C 1.11713 0.5297 -0.71018 
C 0.74732 -1.03278 0.91162 
C 1.2765 0.37694 0.67049 
H 0.48957 -1.36369 1.91332 
C 1.8655 1.37634 1.42447 
C 1.50332 1.66386 -1.39216 
C 2.24975 2.55188 0.75445 
C 2.07237 2.69401 -0.62317 
H 2.02175 1.2718 2.49425 
H 1.37175 1.75505 -2.46535 
N -0.30571 -1.15909 -0.121 
C -1.56801 -0.51804 -0.00222 
C -2.09659 -0.18532 1.25088 
C -2.33141 -0.29362 -1.15847 
C -3.37941 0.35769 1.34366 
H -1.51996 -0.35153 2.1549 
C -3.6032 0.26138 -1.05157 
H -1.91821 -0.5562 -2.12588 
C -4.13808 0.58848 0.19754 
H -3.77863 0.60741 2.32302 
179 
H -4.18322 0.43412 -1.95421 
H -5.13306 1.01697 0.27432 
C 1.76602 -1.94649 0.19669 
O 2.56639 -2.72158 0.63655 
O 1.60086 -1.69834 -1.14845 
N 0.49924 -0.69524 -1.25091 
H 2.69132 3.36619 1.32183 
H 2.37863 3.61547 -1.1097 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
180 
P1, 2H-indazole 3aa 
C 1.73401 -0.64588 0.11918 
C 0.51588 1.19706 -0.19819 
C 1.83934 0.76712 -0.12743 
C 3.11394 1.37977 -0.2464 
C 2.901 -1.44218 0.25601 
C 4.22816 0.58506 -0.11286 
C 4.12033 -0.81824 0.1383 
H 3.20516 2.44582 -0.43608 
H 2.81554 -2.50741 0.44688 
H 5.21762 1.02599 -0.19778 
H 5.03264 -1.40051 0.23718 
N 0.45094 -1.04425 0.19444 
N -0.25882 0.09431 0.00156 
C -1.68101 0.03849 0.00631 
C -2.31749 -1.17069 -0.29223 
C -2.43253 1.17894 0.30815 
C -3.70921 -1.22773 -0.29847 
H -1.71211 -2.04201 -0.5101 
C -3.825 1.11002 0.28763 
H -1.93872 2.10554 0.58175 
181 
C -4.46907 -0.09029 -0.01562 
H -4.20155 -2.16772 -0.53162 
H -4.40517 1.99754 0.52413 
H -5.55408 -0.14048 -0.02527 
H 0.08578 2.16405 -0.40735 
 
 
 
P2, CO2 
C 0 0 0 
O 0 0 1.16917 
O 0 0 -1.16917 
 
 
 
 
 
 
 
 
 
182 
Copies of 1H and 13C NMR Spectra 
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2D NMR Spectra for 3ia. 
NOESY, showing OMe group close to the H at 6.35 ppm 
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HMQC 
 
 
 
 
211 
HMBC. The cross-peak of Hg-C1 supports this regioisomer. However, an equally important 
cross-peak of Ha-C4 is not ovserved. 
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APPENDIX D. CHAPTER 5 1H AND 13C NMR SPECTRA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
219 
Temperature effect on 1H NMR of 9,10-Dihydro-9,10-epiminoanthracene. 
N MeAc
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Temperature effect on 13C NMR of 9,10-Dihydro-9,10-epiminoanthracene. 
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